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Abstract 
As a developing country with relatively limited arable land, China has invested heavily in the 
development and use of genetically modified crops to boost agricultural productivity. 
Biotechnology is designated as a strategic emerging industry in China and the government has 
encouraged and supported extensive biotechnology research. The potential of this new 
technology, and the expectations of it in boosting agricultural production, are very high - but 
these are also mixed with public concern as to its safety and potential impacts on the 
environment in China. Important issues about biosafety and the need for appropriate regulation 
of the development and (then) release into the environment of agricultural genetically modified 
organisms (GMOs) have been prevalent in recent years. China has introduced legislation on 
biosafety management, but the regulatory system for GMOs has been criticized for being vague 
and lacking enforceability. A series of recent actions indicate that the Chinese government is 
aware of the need to revise its biotechnology regulatory system, but transforming the complex 
system of multi – level governance currently applied to agricultural biotechnology in China will 
be challenging. 
 
The European Union has a precautionary approach to GMOs, and a comprehensive and 
integrated regulatory framework for managing the development and release of GMOs. The EU 
model has practical relevance to establishing the shape of legislative reforms in China. This 
thesis will survey the regulatory framework of agricultural GMOs in both China and the EU, 
specifically in the range of GM crops and GM food and feed. It adopts a comparative 
methodology, and provides a detailed analysis on the regulation of key issues: including risk 
assessment and the approval processes for developing new agricultural GMOs, their cultivation, 
marketing and safety assessment within the EU and China. The thesis identifies valuable 
lessons and precedents from the EU and considers how they might be adopted to provide 
possible solutions for legislative reform in China.
 ii 
 
Acknowledgements 
Undertaking this PhD has been a truly life-changing experience for me and it would not have 
been possible to do without the support and guidance that I received from many people. 
 
I would like to first and foremost say a very big thank you to my principle supervisor Prof. 
Christopher Rodgers for all the support and encouragement he gave me. I used to be stuck in 
very difficult situation during these years, his kindness, understanding, encouragement and 
outstanding supervision has always been a great source of inspiration to me during the hard 
days. Without his guidance and constant feedback this PhD thesis would not have been 
achievable. I am also grateful for the supervision by my subsidiary supervisor, Dr. Ole 
Pedersen, for contributing valuable suggestions and critical assessments.  
 
I would also like to acknowledge the encouragement and advice I received from Dr. Ding 
Chen. I greatly appreciate the all the staff of Newcastle Law School who could always warm 
my heart with their greatest kindness. 
 
From January to April in 2014, I had a fieldwork carried out back in China. I am very pleased 
to acknowledge Prof. Yunbo Luo from China Agricultural Univeristy, and Prof. Wenxuan Yu 
from China University of Political Science and Law, the interview with them was very 
enlightening. Although the result of fieldwork did not directly contribute to this thesis, this 
valuable experience shall benefit me in the future. 
 
And finally, I would like to thank my lovely parents, Liqun Ma and Yazhen Wang. I thank them 
for their tolerance and patience on the unexpected extra time I spent and for the understanding 
on my absent from family during these years. Because of their infinite love and full support, I 
am lucky enough to be able to pursue my dream and no need to worry about anything else. 
Especially during the last period of writing the thesis, my mother came all the way to look after 
me, helped me to recuperate from sickness and be able to finalize the thesis. They make 
 iii 
 
everything possible, as they always do. Last but not least, I greatly appreciate their constant 
efforts on restraining themselves to probe when this thesis might be completed.
 iv 
 
List of Abbreviations 
ACRE—Advisory Committee on Releases to the Environment (UK) 
 
AQSIQ--General Administration for Quality Supervision, Inspection and Quarantine of 
People’s Republic of China 
 
CAC--Codex Alimentarius Commission  
 
EFSA--the European Food Safety Authority 
 
GMOBC--National Genetically Modified Organisms Biosafety Committee of People’s 
Republic of China 
 
MEE--the Ministry of Ecology and Environment of People’s Republic of China 
 
MOA--the Ministry of Agriculture and Rural Affairs of People’s Republic of China 
 
MOST--the Ministry of Science and Technology of People’s Republic of China 
 
NHC--the National Health Commission of People’s Republic of China (formerly the Ministry 
of Health) 
 
NDPC--the National Development and Planning Commission of People’s Republic of China 
 v 
 
Table of Contents 
Abstract ...................................................................................................................................... i 
Acknowledgements ................................................................................................................... ii 
List of Abbreviations ............................................................................................................... iv 
Table of Contents ...................................................................................................................... v 
Chapter 1 Introduction ............................................................................................................ 1 
1.1 Context ......................................................................................................................... 1 
1.2 Research Questions ..................................................................................................... 8 
1.3 Methodology ................................................................................................................ 9 
Chapter 2 Regulation of Agricultural GMOs in China ...................................................... 11 
2.1 Introduction .............................................................................................................. 11 
2.2 Overview of the Development of Agricultural GMOs in China ........................... 12 
2.2.1 Goals and Strategies ....................................................................................... 13 
2.2.2 Agricultural biotechnology research institutions .......................................... 14 
2.2.3 The current situation of GM crops production in China .............................. 16 
2.3 The Legal Regime of Agricultural Biotechnology ................................................. 19 
2.3.1 Historical evolution of GMO regulation ........................................................ 21 
2.3.2 Regulatory authorities and their competences .............................................. 28 
2.4 Substantive Regulations on Agricultural Biotechnology ...................................... 35 
2.4.1 Regulations on research activities .................................................................. 35 
2.4.2 Regulation on production and processing ..................................................... 38 
2.4.3 Regulation on marketing ................................................................................ 39 
2.4.4 Regulation on GMOs Labelling ..................................................................... 40 
2.4.5 Regulations on imports and exports of agricultural GMOs .......................... 42 
2.4.6 Regulations of liability and law enforcement ................................................ 45 
2.5 International Aspect of the GMOs Regulations ..................................................... 46 
2.5.1 General overview of China and international treaties .................................. 47 
2.5.2 Convention on biological diversity and biosafety protocol ........................... 48 
 vi 
 
2.6 Conclusion ................................................................................................................. 53 
Chapter 3 Regulatory Regime for Genetically Modified Organisms in the European 
Union ........................................................................................................................................ 59 
3.1 Introduction .............................................................................................................. 59 
3.2 The Moratorium on Authorisation of GMOs in the EU ....................................... 61 
3.2.1 Previous food safety crises .............................................................................. 61 
3.2.2 The scientific uncertainty of GMOs ............................................................... 63 
3.3 The Regulation Regime of Agricultural GMOs in the EU .................................... 64 
3.3.1 The precautionary principle in the EU .......................................................... 66 
3.3.2 The EU legislation for the contained use of GMOs ...................................... 70 
3.3.3 The deliberate release of GMOs into the environment ................................. 72 
3.4 The Regulation on GM Food and Feed .................................................................. 80 
3.4.1 The legislative framework before 2003 .......................................................... 81 
3.4.2 The legislative framework after 2003 ............................................................. 85 
3.4.3 The risk assessment ........................................................................................ 87 
3.4.4 The single authorization procedure ............................................................... 90 
3.4.5 Traceability and labelling regime ................................................................... 92 
3.4.6 The main changes between pre-2003 and post-2003 legislative framework 97 
3.5 Multi-Level Governance of GMOs in the EU ........................................................ 98 
3.6 Public Participation in the EU Authorisation Procedures for GMOs ............ 101 
3.6.1 The Convention on Biological Diversity and the Cartagena Protocol ....... 103 
3.6.2 The Aarhus Convention ................................................................................ 104 
3.6.3 Public participation in authorisation for GMOs in the EU ........................ 105 
3.7 Co-existence Measures in the EU .......................................................................... 107 
3.8 Environmental Liability Regime in the EU .......................................................... 109 
3.9 The Recent Reform of the Rules for GMOs Authorized for Cultivation .......... 113 
3.10 Conclusion ............................................................................................................. 118 
Chapter 4 Multi Level Environmental Governance of GMOs: Comparative Aspects .. 119 
4.1 General Background Comparison ........................................................................ 121 
4.1.1 Governance on GMOs biosafety in the EU ................................................. 121 
 vii 
 
4.1.2 GM Governance in China ............................................................................ 123 
4.2 Multi-level Governance and Agricultural Biosafety ........................................... 125 
4.2.1 Multi-level governance and the politics of agricultural GMOs in the EU . 125 
4.2.2 The governance of agricultural GMOs biosafety in China ........................ 129 
4.3 Risk Assessment ...................................................................................................... 132 
4.3.1 The EFSA and risk assessment in the EU ................................................... 134 
4.3.2 GMOs safety evaluation system in China .................................................... 136 
4.4 Co-existence Policy ................................................................................................. 140 
4.5 Labelling and Traceability ..................................................................................... 144 
4.5.1 Review of the EU’s legislation on GMOs labelling and traceability .......... 146 
4.5.2 A review of Chinese legislation on GM food labelling ................................ 150 
4.5.3 Possible improvements for the GM labelling legislation in China ............. 153 
Chapter 5 Conclusion ........................................................................................................... 155 
5.1 Introduction ............................................................................................................ 155 
5.2 Research Questions and Main Findings ............................................................... 159 
5.3 Limitations of the Research ............................................................................. 164 
5.4 Prospects and Proposals ......................................................................................... 165 
5.4.1 Proposals for strengthening the environmental governance of GM technology
 ................................................................................................................................ 166 
5.4.2 Labelling and consumer choice ................................................................... 173 
5.4.3 Co-existence of GMOs and non-GM agriculture ........................................ 176 
5.5 Conclusion ............................................................................................................... 177 
Bibliography .......................................................................................................................... 179 
 
 1 
 
Chapter 1 Introduction 
1.1 Context  
In the history of the development of human society, people constantly struggled with the 
population, the resources and the environment. The lesson we learned from the history is that 
each time the technical revolution may brought the solutions. Since 1980s, the development 
and application of the genetic recombination and transformation have boosted the 
development of biotechnology to a new generation and at the meanwhile, brought numerous 
interests to the economic. The genetically modified organisms result from genetic engineering 
experiment in which genetic material is transferred from one organism to another, so that the 
recipient organism will have a new trait. The genetic technique is expected to allow more 
cost-effective crops and herds with desirable characteristics that are not available using 
up-to-date breeding technology. The transgenic technique allows genetic material to be 
transferred between organisms that are altogether unrelated to each other.  
 
The very first genetically modified organism—transgenic tobacco with antibiotic resistant 
gene indicates that the utilization modern biotechnology in a new stage and in 1994, the 
commercialization of transgenic long-shelved tomato could be seen as the beginning of large 
scale application of transgenic agricultural plants.1 The industrialization of the biotechnology 
promotes the global trade of its products and especially the development and the application 
the agricultural biotechnology draws much attention. The development of Genetically 
Modified Organisms (GMOs) for use in arable crop production and the food production system 
have been considered as one of the great advances of the modern biotechnology.  
 
Nowadays, the GMOs is no longer a novel concept to people since they have been widely used 
in agricultural production, food and feed production with the purpose of enhancing the 
                                                 
1  Dayuan Xue (ed.), Biosafety and Regulation for Genetically Modified Organisms (Beijing Science Press, 2009), see the 
Foreword and p42. 
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economic benefits and human health.2 Nevertheless, as the same as any new invitation in 
human society, the application of GMOs in agricultural production or narrowly speaking, the 
food production has been a controversial issue since the advent of this new technology. The 
foundation of the transgenic technology is the technology of recombination of DNA which 
breaks the biological barrier in the nature and allows scientists to artificially create new species 
which would not be existed under natural conditions. On the one hand, this breakthrough 
technology is regarded as the proof of human beings’ increasing ability of controlling the 
environment which might benefit the environment as well as human ourselves. For example, 
the application of the pesticide-resistant crops might dramatically decrease the usage of 
pesticide and benefits the environmental protection; the crops with traits of insects-resistance, 
the drought-resistance or disease-resistance could lead to higher yields and benefits the farmers, 
especially the farmers in the developing countries.3 On the other hand, there are concerns about 
the biosafety. Biosafety includes the concerns on the risks of cross-pollination and of the 
disruption to the cellular ecology of plants, the possible potential effect on the biodiversity and 
natural environmental as a whole and the unknown risk, for example the GMOs may provoke 
allergies for human beings as well as the animals,4 and the possibility of unintended genetic 
drift between different species.5 In a broader way, all the concerns shows that people’s deeper 
and anxiety about the way which people change the world and the way people transform the 
environment.6 The knowledge of the safety and the potential risks of the newly invited GMO 
products numerous research and study, obtaining a certain answer may needs examinations 
from generation to generation. However, regardless of all the concerns the new biotechnology, 
it has been widely used in various ways including medication, agricultural cultivation and food 
and feed production. The products of GMOs have commonly appeared in the field, on the 
market shelves and on people’s tables.  
 
Along with its rapid development and application, the transgenic technology has raises the new 
                                                 
2  Lucia Roda, ‘Risk Analysis and GM Foods: Scientific Risk assessment’ (2009) 4 European Food and Feed Law 253. p 253 
3  Terri Raney, ‘Economic Impact of Transgenic Crops in Developing Countries’ (2006) 17 Current Opinion in Biotechnology 1 
4  Christopher Rodgers,  ‘Implementing  the Community  Environmental  Liability Directive: Genetically Modified Organisms 
and  the  Problem  of Unknown Risk’  in  Luc Bodiguel  and Michael  Cardwell  (eds)  The  Regulation  of Genetically Modified 
Organisms : Comparative Approaches (OUP 2010) p.200 
5  World Health Organization: Modern food biotechnology, human health and development: an evidence‐based study (2005) 
6  Maria Lee, EU Regulation of GMOs: Law and Decision Making for a New Technology (Edward Elgar, 2008) p.1 
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challenges for environmental governance of issues such as risk assessment, the criteria and 
thresholds to be applied for risk analysis prior to the approval of new biotechnology products, 
strategies for increasing consumer awareness and choice, and legal issues of environmental 
liability. To establish a sound and perfect regulatory system for the new biotechnology used in 
agricultural production causes difficulties and contradiction to governments around the world. 
It might because that the perfect balance between the desire of considerable economic and 
social interests and worries about unpredictable consequences of growing and consuming 
GMOs in large scale to the environment and the human beings is almost impossible to achieve.  
 
Legally administrating the release of GMOs into the environment and the consumption of GM 
food and feed pose important questions for policy makers. However, due to the scant and 
uncertain scientific evidence as to the potential risks to health and the wider environment 
arising from the use of GMOs and GM food products, there is no universal consensus on the 
optimum approach for the administrative regulation of GMOs and GM products. Governance 
of the environmental and health risks varies from country to country. The approach may vary 
according to the different countries’ knowledge of GM technology and their national conditions. 
However, there is one constant factor-- designing appropriate governance structures to regulate 
the GM technology used in agricultural production and food production is a challenge in every 
country or region and there is a strong tension between the economic and social benefits that the 
technology may offers and protecting the environment and people’s health to the greatest extent 
from its potential unforeseen consequences 
 
China is a large agricultural country with the most population in the world, in spite of the 
economy rapidly develops in various aspects in the recent decades, the agriculture is always 
regarded as the most important pillar of the economy and the lifeblood of the nation. Under the 
pressure of the large population and relatively limited arable land, the modern technology has 
often been seen as an important and effective measure to increase crops yields and ensure 
national grain security.7 The research and development of agricultural technology started from 
                                                 
7  Wanhua Yang, ‘Regulations of Genetically Modified Organisms in China’, (2003) 12 (1) Review of European Community and 
International Environmental Law 99 p.99 
 4 
 
the 1980s and government has invested heavily in the process and has been promoted several 
national research and development programmes. By the year of 2000, there were more than 90 
research institutions participated into the research and development of agricultural GMOs.8 
The nature of centralized governance and financial system of China offers the research and 
development programmes of GMOs the reliable funding and stable base, the process of GMOs’ 
scientific research and development is rapid.9 China has one of the largest cultivated areas of 
transgenic agricultural crops compare to other the developing countries.10 According to the 
previous study, China started promoting commercially cultivation of Bt cotton since 1997 with 
the growing area of 30,000 hm2 which extended to 230,000 hm2 in the following year. In 2004 
this number has increased to 350,000 to 400,000 hm2 which account for almost 2/3 of the total 
cultivation area of cotton.11 Furthermore, China also relies heavily on imported GM crops. 
According to the statistics, China has been importing soybeans since 1999 mainly used in 
cooking oil production. In 2000 the gross of the imported soybean is less than 20 million tons 
which is almost as much as the total gross of domestic soybean production; while in 2008 this 
number has increased to nearly 38 million tons. Nearly 70 percent of the imported soybeans are 
transgenic, mainly from the US, Argentina and Brazil.12  
 
The repaid development of biotechnology and increasing demands of GMOs products not 
only brings challenges to the scientists in the biotechnology field but also rises a legal 
issue—how China should build the legal framework of agricultural biotechnology in order to 
ensure its normal and orderly development as well as to protect the biosafety.  
 
China is one of the counties with abundant biodiversity and because of the long history of 
agriculture there is very rich biological genetic resource, the Chinese government thus took 
great cautious attitude on safety management of genetically modified organisms. As early as 
1993 the former State Science and Technology Commission (Now the Ministry of Science 
                                                 
8  X Qing  and  J. Wade, GAIN Report No. CH0046,  ‘Current  Status of Chinese GMO Development and Regulation’  Foreign 
Agricultural Service USDA 2000 
9  See n.8 p.99 
10  See n.3 
11  See n.1, the preface. 
12  Ibid. 
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and Technology) enacted the ‘Administrative Measure on Genetically Engineering Safety 
Management’13 which is the earliest legislation in the history related to GMOs safety. In 
order to regulate the constantly increased agricultural biotechnology research and 
environmental release, the State Council issued ‘Administrative Regulation on the Biosafety 
of Agricultural Genetically Modified Organisms’ 14  in 2001 and the Ministry of the 
Agricultural issued three administrative measures as auxiliaries in the following year. The 
2001 Regulation and its auxiliary measures constituted the regulatory framework of 
agricultural GMOs safety management in China and marked the start of the comprehensive 
safety management on each section of agricultural GMOs including the research and 
experiment, the production and process, the import and export as well as marketing. 
 
The need of improving the current Chinese governance regime on GMOs is not triggered by the 
domestic situation but also by influence from international society. China signed the Protocol to 
accede to the WTO on November 11, 2001 and formally became the 143rd party of the WTO 
on December 11, 2001. The WTO membership of China triggered a process of amendment of 
existing domestic laws that were in conflict with the WTO rules. The process was completed 
when the membership started in 2001. To a certain extent, China is still at the stage of learning 
and getting familiar with the WTO rules. 
  
WTO membership brings uncertainties for China’s agricultural regulation in several ways. 
Firstly, there is no certainty whether China’s current GMO regulatory framework is compatible 
with WTO rules. It is still too early to draw any conclusions as the US-EU GMO dispute on the 
EU regulation on GMOs is still pending at the WTO Dispute Settlement Body.15 The outcome 
of this dispute shall produce an important impact on China’s GMO policy and its regulatory 
framework. Whatever the outcome of the dispute will be, on one hand, the regulation of 
agricultural GMOs should not be used as a tool of discrimination and trade barrier; on the other 
                                                 
13  Administrative Measure on Genetically Engineering Safety Management, Decree No.17 (1993) of the State Science and 
Technology Commission 
14  Administrative Regulation on the Biosafety of Agricultural Genetically Modified Organisms, adopted at the 38th Meeting 
of the State Council on May 9, 2001, promulgated by the Decree No. 304 of the State Council of the People’s Republic of 
China of 2001 on May 21, 2001, and effective as of the date of promulgation. 
15  Hui Li, ‘WTO Agricultural GMOs Trade Disputes and Review on EU’s Administration on GMOs’, (2007) 2 Global Law Review 
35 
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hand, the increasing public concern on the potential adverse impact of the GMO on the 
environment and human health should not be overlooked or neglected. The consumer should be 
informed and should have choices. The Chinese consumers, especially those in the urban areas, 
are increasingly demanding more information on the food products they consume. 
 
Secondly, since China’s agricultural GMO regulation was to a certain extent pushed forward by 
the Biosafety Protocol, the relationship between the Biosafety Protocol and the WTO rules is 
relevant. The question is, in case of conflict, which one, the Biosafety Protocol or the WTO, 
may override the other. Hopefully the US-EU GMO dispute could give some hint on how to 
resolve this issue. However, since this thesis will mainly focus on studying the governance 
regime on GMOs biosafety in China and EU, the WTO aspect here as a less relevant aspect to 
the research and in the following content of the thesis it would not be discussed in further detail. 
 
It is commonly agreed that in order to establish the rule of law, firstly there have to be laws 
and secondly, these laws have to be effectively implemented. At the present, China has more 
or less achieved the first step since laws and administrative regulations and measures have 
been issues in the last twenty years. In spite of some deficiencies still exist, the framework of 
the biosafety regulation has been achieved in great extent. However, the second condition is 
more difficult to achieve. The lack of effective implementation could be due to lack of clarity 
in the law and regulation, but clarity alone cannot guarantee effective implementation of a law. 
The political, economic, social and cultural environment behind the weak implementation is 
complicated.  
 
The European Union and the US have highly developed multi-level governance arrangements 
for regulating agricultural biotechnology; these jurisdictions are two representative systems 
which present two inherently different attitudes to the regulatory approaches on biotechnology 
used in agricultural production and the food industrial production. However, there is at least one 
common factor between those two regulatory frameworks —they are both well developed and 
offer examples of different approaches to risk assessment, consumer choice and environmental 
protection that can be studied as comparators offering insights into the potential development 
 7 
 
and refinement of the governance of GM biotechnology in China. 
 
The writer chose the EU legal management framework as the object of study for the following 
reason. Even though the state conditions including the size of population, the land area, the 
governing method and the extend of genetic techniques used in agricultural production, are 
obviously different. However, the legislative idea of agricultural biosafety between China and 
the EU are very similar, for example they both regard the precautionary principle as the guiding 
principle and apply compulsory labelling requirements for GMO products. Overall, the 
European countries began to pay attention on biosafety issues from early 1980s and considered 
the management and risk assessment on environmental release of GMOs. The EU and its 
Member States then enacted a series of law and legal documents and issued detailed approval 
procedures and technical guidelines. Until today, the European Union is the region with the 
strictest management on biosafety that the GMOs products are totally banned from market and 
field trail in the some of the Member States. Also, the European Union implement a strict 
GMOs labelling method and product traceability system. Most importantly, the EU and China 
share the same opinion on the precautionary principle should be the conceptual foundation of 
legislation on biosafety. Therefore, the writer considered the EU’s multi-level governance on 
GMOS and the legal framework as highly valuable and some of the approaches on GMOs 
management are feasible in China which should be learned from in order to develop a cohesive 
and comprehensive legal system on agricultural GMOs at the national level as well as the 
provincial level.  
 
Therefore, this thesis will study and analyse the regulatory approaches on agricultural biosafety 
of the European Union and the China. The regulatory frameworks of EU and its member states 
could be seen as characteristic of a precautionary approach to biotechnology and its regulation. 
This research aims to analyse both of them and assess whether – and if so how - the valuable 
experience of the EU and its member states can offer guidelines and solutions for some of the 
problems facing Chinese agriculture and food supply in the future. There is one Chinese 
proverb saying that “To the country people is all-important; to the people foodstuff is 
all-important; to the foodstuff safe is all-important.” Due to the fact that increasing use of 
 8 
 
biotechnology in agricultural production may bring food safety issues, it is necessary and 
urgent to take preventive measures and to regulate as effective as possible on this controversial 
food source.  
 
1.2 Research Questions  
RQ 1 What can China learn from the EU in relation to the regulation of agricultural 
biotechnology? 
RQ 1.2 What is the role of law in regulating agricultural biotechnology and its use in food 
production in the EU, and China? 
RQ 1.3 What is the role of the precautionary principle in EU and Chinese law on agricultural 
biotechnology and its use in food production?  
RQ 1.4 What principles are applied in undertaking risk assessments prior to authorizing the use 
of biotechnology products in food production in the EU, and China? 
RQ 1.5 What are the principal differences between the regulatory regimes for agricultural 
biotechnology and its use in food production in the EU and China? 
RQ 1.6 What can China learn from the EU and its member states, and from their regulatory 
approach to biotechnology and its use in food production? 
 
RQ 2 To what extent, and how, can regulatory measures minimize the risk of environmental 
damage arising from the use of agricultural biotechnology, while also maximizing its potential 
benefits in food production? 
 
RQ 3 .1 To what extent, and if so how, do regulatory measures in China promote and protect 
“organic” (‘green food’) food production? 
RQ 3.2 Should China adopt coexistence measure for GM and non-GM production, and if so 
what model should be adopted for GM coexistence measures? 
 
RQ 4 What reforms to the regulation of agricultural biotechnology are desirable and/or 
 9 
 
necessary in order to protect the environment in the PR of China while also maximizing its 
potential benefits in food production?  
 
1.3 Methodology  
This research will use a comparative method in studying the regulatory framework on 
biotechnology (GM technology) used in agricultural food production between the European 
Union. The thesis will firstly examine the governance arrangements for the release of GMOs 
into the environment in China (Chapter 2). It will then examine the comparable arrangements in 
the EU and its member states (Chapter 3). It will be seen that both jurisdictions adopt a complex 
multi-level governance approach to the different issues involved in assessing risk, setting 
standards for public safety and environmental regulation, and then arranging for the labeling 
and traceability of food products containing GM material. This is inevitable: assessing risk, for 
example, is a scientific matter that must be undertaken by scientific experts; setting standards 
for the level of risk that is acceptable in the public interest is a matter for central or local 
government bodies (as the case may be); while overall policy on GM technology will usually be 
a political matter for the central government. A number of differing bodies will typically be 
involved in making decisions relevant to the governance of biotechnology products, their 
production and use: scientific committees, governmental level review panels, local or central 
government bodies, and (as to their use in production) landowners and farmers. These roles are 
allocated to different bodies in EU law and Chinese law. The thesis will draw comparisons 
between the governance arrangements within the EU and China (Chapter 4) and then conclude 
by offering suggestions for reform of the regulatory model for Chinese law (Conclusion).  
 
The research was executed using a doctrinal study method. The research reviews all the 
relevant legislative provisions in China and in European Union law for the regulation of GM 
agriculture, and for the use of GM products in the food chain. Research was conducted in China 
to gather relevant legal and policy documentation, and the thesis uses Chinese legal literature to 
interrogate the issues that agricultural biotechnology raises for multi-level governance in the 
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Chinese context. The research methodology adopted was granted ethical approval by the 
Research Ethics Committee of the Faculty of Humanities and Social Sciences, Newcastle 
University, in October 2013. 
 
This thesis will study the different regulatory approaches on agricultural biotechnology for food 
production adopted in the EU and China. The thesis will aim to evaluate options for guiding 
China to achieve a higher level in regulating agricultural biotechnology – both for the 
protection of the environment and for protecting food safety and food supply. The primary 
focus will be on studying the regulatory approaches on agricultural biotechnology for food 
production which are used in the European Union and China. In order to achieve this purpose, 
the writer will structure the thesis in the following order. In Chapter 2, there will be an 
introduction on the regulatory framework and management system of agricultural GMOs in 
China, the development of the agricultural biotechnology will also be included. At the end of 
this chapter, there will be a conclusion discussing the shortcomings of the current Chinese 
governance regime on agricultural GMOs and the necessity of learning advanced experience 
from other countries and governments. In Chapter 3, the EU’s multi-level governance system 
on GMOs will be detailed discussed and in Chapter 4 there will be an analyse on the differences 
between two different governance regimes on the agricultural GMOs of the EU and China. In 
the final part of this thesis, the writer will state the main findings of the research as well as the 
possible improvements and development which the Chinese regime may take by learning the 
EU example.
  
 
1
 
Chapter 2 Regulation of Agricultural GMOs in China 
2.1 Introduction 
It is forecasted that in the near future the cultivation area devoted to genetically modified crops 
in developing countries will exceed that in industrialized countries.1 However, the applications 
of agricultural biotechnology have been criticized because of their possible potential risks for 
the environment, human health and social economic consequences, particularly among the 
developing countries.  
 
Over the past years, Chinese government made a large amount of investment and resources into 
the research and development programmes of the genetically modified technology and has 
become one of the largest growers of GM crops in the world. According to the survey report 
published by the International Service for the Acquisition of Agro-biotech Applications 
(ISAAA) in 2012, China has become the sixth largest producer of agricultural transgenic crops 
in the world by the total cultivation area of four million hectares.2 The issues of biosafety in 
China is particularly significant due to the national factors and international factors. 
Domestically speaking, China has made great efforts on investment in biotechnology and the 
research and development be carried out inside the country has achieved great improvements. 
There are many biotechnological research institutes have been set up in the country, mostly 
funded by the government have developed a large range of GM crops varieties and innovated 
new varieties of GM crops, for example, the rice genome was decoded by a Chinese team.3 
Chinese Bt cotton competes with Monsanto’s flagship Bollgard and according to many 
                                                 
1  Peter  Ho,  Jennifer  H.  Zhao,  Dayuan  Xue  and  Jac.  A.  A.  Swart,  ‘Biotech  Politics  in  an  Emerging  Economy:  Is  China  a 
Developmental  Risk  Society?’  Heather  Xiaoquan  Zhang  (ed.),  Rural  Livelihoods  in  China:  Political  Economy  in  Transition 
(Routledge 2015) 
2  Andrew  Anderson‐Sprecher  and  Ma  Jie,  ‘Peoples  Republic  of  China  Agricultural  Biotechnology  Annual  2014’  (Global 
Agricultural Information Network, United States Department of Agriculture, Foreign Agricultural Service 2014 GAIN Report 
Number: 14032) 
3   James  Keeley,  ‘Regulaing  Biotechnology  in  China:  the  Politics  of  Biosafety’  IDS  Working  Paper  208,  Institute  of 
Development  Studies  2003  http://www.eldis.org/go/home&id=14842&type=Document#.VlLq3HbhAdU  accessed  Oct  17, 
2014 
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researchers and farmers that it performs well.4  
 
In order to administrate the increasing biotech research and manage the safety of its product, in 
the year of 2001, Chinese State Council promulgated the Administrative Regulation on the 
Biosafety of Agricultural Genetically Modified Organisms (hereafter referred as the 2001 
Regulation).5 This regulation aims to strengthen the safety management of agricultural GMOs, 
to safeguarding the health of human, protecting the ecological environment and to promote 
research of biotechnology, and it regulates the safety controls over the laboratory research, field 
testing, production, processing, marketing, and other applications of agricultural biotechnology. 
The auxiliary administrative measures issued by relevant agencies provided detailed 
explanation and implementation methods of the regulation.  
 
This chapter aim to introduce the current status and development of the agricultural 
biotechnology research and commercialization, review the China’s polices and legal 
framework governing both agricultural biotechnology research and its applications. In order to 
achieve these objectives, this chapter is organized as follows. The next section provides an 
overview of China’s development of agricultural GMOs. The second to the fifth sections will 
focus on biosafety management and regulations respectively from the institutional aspect, the 
substantive aspect and the international aspect. Finally, the sixth section provide a brief 
summary of this chapter.  
 
2.2 Overview of the Development of Agricultural GMOs in China 
 
China used to face the predicament of unbalanced relation between the demand of agricultural 
products and supply. Since the implementation of the policy of reform and opening, this 
                                                 
4  Ibid. 
5  Administrative Regulation on the Biosafety of Agricultural Genetically Modified Organisms, adopted at the 38th Meeting of 
the State Council on May 9 2001, promulgated by the Decree No. 304 of the State Council of the People’s Republic of China 
of 2001 on May 21, 2001. 
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situation has been improved in great extent. The agriculture in China has entered into a new 
stage of the development and shall focus on adjustment of the agricultural structure, 
improvement of food quality, increasing of farmer income, improving ecological environment 
and implementation of the sustainable development of the rural area. The popularization of 
new scientific technology, especially the biotechnology and information technology in 
agricultural production is the solution designated by the government.6 
 
2.2.1 Goals and Strategies 
The research and development of agricultural GMOs in China started from the mid of 1980s. 
Due to the nature of China’s central-planned economy, especially the centralized financial 
system, the research and development of agricultural GMOs in China, unlike that in the 
developed countries which private companies perform most of the agricultural biotechnology 
research, the research and development of GMOs heavily relied on public funding from the 
government. In order to achieve the multifaceted goals of the biotechnology development, 
China invested in various national biotechnology programmes. 7  The goals of the 
biotechnology development is defined by the Chinese government as to safeguard the nation’s 
food security, to increase agricultural production efficiency and farmer income, to promote 
sustainable development of agriculture, to protect the environment and human health, and to 
enhance the competitivity of Chinese agriculture as well as the modern biotechnology itself in 
the international agricultural market and the international biotechnology research field.8  
 
From the early 1980s, the plan of promoting the technology in general was firstly raised in the 
‘7th Five-Year Plan’ in section five.9 in general the biotechnology has been promoted and 
                                                 
6  ‘The Outline of Agricultural Science and Technology Development (2001‐2010)’, the State Council, Decree No. 12, issued 
on April 28th 2001. 
7  Jianping Kou, Qiaoling Tang, Xianfa Zhang, ‘Agricultural GMO Safety Administration in China’, (2015) 14(11) Journal of 
Integrative Agriculture 2157 p2157 
8  Jikun  Huang  and  Qinfang  Wang,  ‘Biotechnology  Policy  and  Regulation  in  China’,  IDS  Working  Paper  195,  Institute  of 
Development Studies 2003 < https://www.ids.ac.uk/files/Wp195.pdf> accessed Oct 17 2014 
9  The ‘Five‐Year Plan’ is the crucial part of the long‐term Chinese national economic plan, the main function of the Five‐Year 
Plan  is  to  set  up  goals  and  direction  of  national  economic  further  development,  and  to  guide  the  national  major 
construction projects, productivity distribution,  the proportions of national economy. The 7th Five‐Year Plan  is the plan of 
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incorporated into several national research and development programs for science and 
technology programmes, mainly for achieving the purpose of more rapid economic growth. 
The development process of the transgenic technology in China could be divided into two 
stages. The first stage is from 1986 to 2000 start with the launch of the ‘863 Plan’ namely the 
National High-Technology Research and Development Programme. The main objective is 
this plan is to reach the world technology frontiers level, encouraging to learn from the 
advanced technology and the main research in the field of gene cloning and plan gene 
transformation as well as the early-stage industrialization.10 There also were other significant 
programmes launched in the same period, including the ‘973 Plan’, the Initiative of National 
Key Laboratories on Biotechnology, the Key Science Engineering Programme and established 
several special foundation projects including the Special Foundation for Transgenic Plants 
Research and Commercialization, the Special Foundation for High-tech Industrialization, 
Natural Science Foundation, and the Foundation for High-Tech Commercialization, etc.11 For 
those projects approved by these projects, programs and plans, the government provided 
funding and relevant policies favorable to the research and development activities. In the early 
years of 21st century, China entered into the second stage of the biotechnology development 
which aimed to comprehensive and independent innovation and large-scale industrialization 
and ultimately establishing the agricultural biotechnology industry.12 
 
2.2.2 Agricultural biotechnology research institutions 
The national agricultural biotechnology research in China is mainly carried out by 
governmental departments and institutions instead of private sectors. The Ministry of 
                                                                                                                                                        
national economic and social development from 1985 to 1990. Currently China is taking its 13th Five‐Year Plan. 
10  The ‘863 Plan’ was a high scientific and technology development programme funded by the government and launched in 
March of 1986. The  ‘863 Plan’  included a  large number of applications and basic research projects with a 10 billion RMB 
investment from the government (equivalent to 2 billion US dollars for the time). Biotechnology  is one of the priorities of 
the program. The projects funded  in biotechnology  include two areas, the agriculture (47.28% of the biotechnology fund) 
and  the  medicine  (52.72%  of  the  biotechnology  fund).  See  Summary  of  the  Biotechnology  in  the  863  Program  of Our 
Country    , http://www.863.gov.cn/1/1/index.htm (Accessed Oct 19 2015) 
11Jikun  Huang  and  Qinfang  Wang,  ‘Biotechnology  Policy  and  Regulation  in  China’,  IDS  Working  Paper  195,  Institute  of 
Development Studies 2003 < https://www.ids.ac.uk/files/Wp195.pdf> accessed Oct 17 2014 
12  Zhen Zhu, ‘Research Proceeding in the Development of GMOs in China’ in Dayuan Xue ed., Risk Assessment and 
Regulation of Genetically Modified Organisms: Proceedings of the International Biosafety Forum—Workshop 4 Beijing (2011 
China Environmental Science Press) p.8 
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Agriculture, the Chinese Academy of Sciences, the State Forestry Bureau and the Ministry of 
Education are the major authorities which are main responsible for agricultural biotechnology 
research.13 Among the others, the role of the Ministry of Agriculture in the biotechnology 
research is the most important. There are three research academies affiliated to the Ministry of 
Agriculture which respectively are the Chinese Academy of Agricultural Science, the Chinese 
Academy of Tropical Agriculture and the Chinese Academy of Fisheries. Those research 
academies establish their own research institutes and laboratories to conduct biotechnology 
research programme.14  
 
The agricultural biotechnology research is also carried out by institutes external to the Ministry 
of Agriculture’s research system. For example, the research institutes affiliate to the Chinese 
Academy of Forestry and the State Forest Bureau as well as some universities directly affiliated 
to the Ministry of Education which are capable of the independent research, for example the 
Beijing University, Fudan University, and China Agricultural University.15  
 
At the provision level, the institutional framework is similar to the national level and play an 
importation role of contribution to the agricultural biotechnology development. There are in 
total of 34 provinces16 in China and each province have agricultural university and academy 
of agricultural science. Normally there would be institutes and laboratories of agricultural 
biotechnology research which funded by the local government or national government 
attached to the provincial agricultural universities and academies.17 It is very obvious that 
Chinese government heavily invests resources on agricultural biotechnology research and has 
great ambition to achieve higher level of research ability and international competitiveness. 
According to the latest information available, China has now obtained more than 300 genes 
with important traits which could be used in various biotech crops in order to improve 
                                                 
13  Jikun Huang  and Qinfang Wang,  ‘Biotechnology  Policy  and  Regulation  in  China’,  IDS Working  Paper  195,  Institute  of 
Development Studies 2003 < https://www.ids.ac.uk/files/Wp195.pdf> accessed Oct 17 2014, p.6 
14  Ibid. 
15  Ibid. 
16  To be precise, there are 34 provincial‐level administrative regions, including 23 provinces, 5 autonomous regions, 4 
municipalities and 2 special administrative regions. 
17  Jikun Huang  and Qinfang Wang,  ‘Biotechnology  Policy  and  Regulation  in  China’,  IDS Working  Paper  195,  Institute  of 
Development Studies 2003 < https://www.ids.ac.uk/files/Wp195.pdf> accessed Oct 17 2014, p.6 
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nutrition, resist drought, enhance salt and alkali tolerance.18  
 
2.2.3 The current situation of GM crops production in China 
Due to the importance of agriculture for China and the expected role of GM plants in 
agriculture, they have received much attention, support and publicity. China is one of the 
members of the six ‘founder biotech crops countries’ and now the sixth largest GM crops 
producer of in the world with a total cultivated area of 4 million hectares. According to the 
2015 report published by the International Service for the Acquisition of Agro-biotech 
Applications (ISAAA), China has planted 3.7 million hectares of biotech crops: 3.7 million 
hectares of biotech cotton, 7,000 hectares of virus resistant papaya and 543 hectares of Bt 
poplar.19 From 1994 to 2016, China has approved 60 biotech crops strains for cultivation and 
use in food and feed production which include 17 strains of maize, 12 strains of Argentina 
canola, 10 strains of cotton, 10 strains of soybean, 3 strains of tomato, 2 strains of rice, 2 strains 
of poplar, 1 strain of papaya, 1 strain of sweet pepper, 1 strain of sugar beet and 1 strain of 
petunia.20 However, due to the concerns of the public opinion and the pressure from the 
domestic seed industry, only a few of the approved events are being commercialized today and 
the most widely planted GM crop in China is Bt cotton and virus resistant papaya.21 The 
information of approved biotech crop event for commercialization could be found on the 
Ministry of Agriculture’s official website.22 The transgenic crops which are approved for 
commercialization need to firstly obtain a ‘Safety Certificate’ from the Ministry of Agriculture 
and currently the majority of the safety certificates are for the domestically developed varieties 
                                                 
18  Jianping Kou, Qiaoling Tang, Xianfa Zhang, ‘Agricultural GMO Safety Administration in China’, (2015) 14(11) Journal of 
Integrative Agriculture 2157 p2157 
19  Biotech  Country  Facts  &  Trends—China  2015,  Report  from  International  Service  for  the  Acquisition  of  Agro‐biotech 
Applications  (ISAAA) 
[https://www.isaaa.org/resources/publications/biotech_country_facts_and_trends/download/Facts%20and%20Trends%20‐
%20China.pdf] last accessed 08 Dec 2016 
20   ISAAA  Brief  No.52,  ‘Global  Status  of  Commercialized  Biotech/GM  Crops:  2016  ‘,  p.41    < 
http://www.isaaa.org/resources/publications/briefs/52/download/isaaa‐brief‐52‐2016.pdf> accessed Oct 10, 2017 
21  Andrew  Anderson‐Sprecher  and  Ma  Jie,  ‘Peoples  Republic  of  China  Agricultural  Biotechnology  Annual  2014’  (Global 
Agricultural Information Network, United States Department of Agriculture, Foreign Agricultural Service 2014 GAIN Report 
Number: 14032) 
22  MOA’s website <http://www.moa.gov.cn/ztzl/zjyqwgz/spxx/> last accessed 08 Dec 2016 
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of Bt cotton.23  
 
At the present, the Bt cotton is the most widely planted biotech crop in China. In 2011, total 
cotton cultivation area of cotton is 5.45 million hectares and 71.5 of them is biotech cotton and 
in 2015 this number increased 3.8 million hectares. The virus resistant papaya is only planted in 
Guangdong Province, Hainan Province and Guangxi Province on approximately 8,550 hectares 
according to report of 2016.24 In addition, in 2002 the State Forest Administration (SFA) 
passed commercialization permission of two GM forestry plants events, both are insect 
resistant poplar and according to the latest statistics available, the total grown area is 542 
hectares.25 Generally speaking, biotech crops cultivation must be approved on a provincial 
basis with one exception. The Bt cotton is approved by the Ministry of Agriculture which could 
be cultivated in three major cotton-producing areas covers various provinces and regions. 
These cotton producing areas include: the Yangtze River Reaches Area(covering Sichuan 
Province, Hubei Province, Hunan Province, Jiangxi Province, Zhejiang Province, most part of 
Jiangsu Province and Chongqing Municipality, Huainan City of Anhui Province, and Nanyang 
City and Xinyang City of Henan Province); the Yellow River Reaches Area (covering 
Shandong Province, Henan Province (except Nanyang City), Hebei Province, Beijing City, 
Tianjin Municipality, Shaanxi Province, and Shanxi Province, Huaibei City of Anhui Province, 
Xuzhou City of Jiangsu Province), and the Northwestern Inland Area (covering Xinjiang 
Province, Gansu Province, Ningxia Province, and Inner Mongolia Province).26 
 
In spite of the heavy investments on the agricultural biotechnology research that Chinese 
government has been promoting, there is no genetically modified grains or staple crops have 
                                                 
23   Concluded  from  the  information  provided  by  the  MOA’s  website  < 
http://www.moa.gov.cn/ztzl/zjyqwgz/spxx/201706/t20170614_5678550.htm> accessed Oct 10, 2017 
24  Biotech  Country  Facts  &  Trends—China  2015,  Report  from  International  Service  for  the  Acquisition  of  Agro‐biotech 
Applications  (ISAAA) 
[https://www.isaaa.org/resources/publications/biotech_country_facts_and_trends/download/Facts%20and%20Trends%20‐
%20China.pdf] last accessed 08 Dec 2016, p41 
25  Joshua  E.  Lagos  and Ma  Jie,  ‘Peoples  Republic  of  China  Agricultural  Biotechnology  Annual  2013’  (Global  Agricultural 
Information Network, United  States Department  of Agriculture,  Foreign Agricultural  Service  2013 GAIN Report Number: 
13033); and the note 19, p41 
26  Andrew  Anderson‐Sprecher  and  Ma  Jie,  ‘Peoples  Republic  of  China  Agricultural  Biotechnology  Annual  2014’  (Global 
Agricultural Information Network, United States Department of Agriculture, Foreign Agricultural Service 2014 GAIN Report 
Number: 14032) 
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been permitted for commercialization. In 2009, two transgenic crops varieties which are the 
insect resistant rice and a high-phytase maize both developed by Chinese domestic research 
institutes obtained the biosafety certificates for food and feed use from the Ministry of 
Agriculture for the first time. According to the seed variety registration regulation in the Seed 
Law27, after obtaining the biosafety certificates, any new seed variety must complete the 
registration process before commercialization. However, the Ministry of Agriculture did not 
complete the final step toward the domestic commercialized cultivation before the biosafety 
certificates expired in 2014.28 The future of these domestically developed varieties is now 
unclear. 
 
Even though the information of ongoing biotech research and development is not published and 
provided by the competent authorities based on the consideration of confidentiality and 
intellectual property, it can be tell from the publications on approval information by the 
Ministry of Agriculture, major crops include insect resistant corn, high lysine corn, resistance 
to pre-harvest germination wheat, and insect resistant soybeans29 are undergoing field trials 
which could be at the intermediary experimental staged or the environmental release stage.30 
 
As mentioned above, China has heavily invested in biotech research and seed development 
programmes carried out by government funded research institutes and universities. In July 
2008, the State Council approve the ‘Special Project on Breeding New Biotech Variety’ in 2008 
and in the following 12 year a total amount of over 24 billion RMB of funding (the funding 
came from the national government, local government and companies) had been invested into 
the project.31 As an important part of the ‘Long and Mid Term National Development Outline 
                                                 
27  ‘Seed Law of the People’s Republic of China,’ adopted at the 16th Meeting of the National People’s Congress Standing 
Committee on 8 July, 2000, amended at the 17th Meeting of the 12th National People’s Congress Standing Committee on 4 
November, 2015. Article 22 
28  These  two  insect‐resistant  risk varieties and  the high phytase corn variety obtained  the safety certificates again  in  Jan 
2015. 
29  This information is available on the MOA official website < http://www.moa.gov.cn/ztzl/zjyqwgz/spxx/> (accessed on Oct 
09, 2015) 
30  Global Agricultural Information Network (GAIN), Report No.CH15032, Agricultural Biotechnology Annual—China 
Considering Major Revisions to Biotechnology Regulations (USDA Foreign Agricultural Service, 21 December 2015)   
31  Andrew Anderson‐Sprecher and Ma Jie, ‘Peoples Republic of China Agricultural Biotechnology Annual 2014’ (Global 
Agricultural Information Network, United States Department of Agriculture, Foreign Agricultural Service 2014 GAIN Report 
Number: 14032) 
  
 
1
for Science and Technology (2006-2020)’ , the project focuses on both agricultural biotech crop 
and biotech animal research and targets to develop varieties with new genetic traits in order to 
improve the ability of resisting insect, disease, and stress.32 
 
On the contrary to the national programmes, the private investment is the biotechnology 
research is not only very limited but also strictly administrated and controlled. The foreign 
investment is banned from all the transgenic research and production activities but allowed in 
the production traditional or hybrid seed in the way of joint capital with Chinese companies 
control the share.33 
 
2.3 The Legal Regime of Agricultural Biotechnology 
In order to have a better understanding of how GMOs are regulated in China, it is necessary to 
have a brief overview of Chinese legal system: the organization and relationship among various 
laws. There are two aspects of relevance to the GMOs regulation: the horizontal relationship 
among different laws at the central level and the vertical relationship between national and 
local laws. 
 
Since China is a unitary state, national laws are superior and override conflicting local laws: in 
the hierarchy of legal norms, the Constitutional provision regarding environmental protection 
ranks highest.34 Second are the laws issued by the National People’s Congress, for example, 
                                                 
32   The  Long  and  Midterm  National  Development  Plan  for  Science  and  Technology  (2006‐2020) 
http://www.gov.cn/jrzg/2006‐02/09/content_183787.htm (Accessed on 10 Nov, 2015) 
33  Andrew Anderson‐Sprecher and Ma Jie, ‘Peoples Republic of China Agricultural Biotechnology Annual 2014’ (Global 
Agricultural Information Network, United States Department of Agriculture, Foreign Agricultural Service 2014 GAIN Report 
Number: 14032) 
34  See Ying, Song. "The Chinese environmental lawmaking framework.", Chinese Journal of International Law, Spring 2002 
Issue. Constitution of the People’s Republic of China, adopted at the 5th Meeting of the 5th National People’s Congress and 
promulgated for  implementation by the Proclamation of the National People’s Congress on December 4, 1982. Provisions 
regarding environmental protection including: 
Article 9 All mineral resources, waters, forests, mountains, grassland, unreclaimed land, beaches and other natural resources 
are owned by the state, that is, by the whole people, with the exception of the forests, mountains, grasslands, unreclaimed 
land and beaches  that are owned by collective  in accordance with  the  law. The state ensures  the  rational use of natural 
resources  and  protects  rare  animals  and plants. Appropriation or  damaging of  natural  resources  by  any  organization  or 
individual by whatever means is prohibited.   
And Article 26 The state protects and  improves  the environment  in which people  live and  the ecological environment.  It 
prevents  and  controls  pollution  and  other  public  hazards.  The  state  organizes  and  encourages  afforestation  and  the 
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the 2014 Environmental Protection Law35 and the 2000 Fishery Law36. The third type will be 
the administrative laws, often in the form of a regulation issued by the State Council, for 
example, the 2001 Administrative Regulation on the Safety of Agricultural GMOs37. Fourth are 
the ministerial rules (usually in the form of ‘administrative measures’) issued by ministries, 
commissions and administrations or agencies. For example, the 2002 Administrative Measures 
on the Safety of the Import of Agricultural GMOs38 by the Ministry of Agriculture.  
 
Within the set of laws that is ranked second, some laws have more general objectives and 
targets, than others (for example, the “Environmental Protection Law” is more general than the 
“Marine Environmental Protection Law”). Laws ranked third and fourth often have very 
specific objectives and targets. With regard to the effect of each rank of legal norms, Article 63 
of the ‘Administrative Procedural Law’39 provides that in handling administrative cases, the 
People's Courts shall in order take the law, administrative rules and regulations and local 
regulations as the criteria. Local regulations and applicable to those administrative cases within 
the local administrative region.40 In comparison, with regard to the legal effect of those 
administrative rules issued by the ministries, commissions and agencies or by local 
municipalities, the People's Courts shall refer to them. In case of conflicts among these 
administrative rules, it is within the discretion of the State Council to make interpretation and 
decisions. In accordance with the Legislation Law41, administrative regulations have higher 
                                                                                                                                                        
protection of forests. 
35  Environmental Protection Law of the People's Republic of China. Adopted at the 11th Meeting of the 7th National People’s 
Congress Standing Committee on December 26, 1989, amended at the 8th Meeting of the 12th National People’s Congress 
Standing Committee on April 4, 2014. 
36  Fishery Law of the People’s Republic of China. Adopted at the 14th Meeting if the 6th National People’ Congress Standing 
Committee on January 10, 1986, amended at the 18th Meeting of the 9th National People’s Congress Standing Committee on 
October 31, 2000. 
37  A different translation in English is ‘Regulation on Administration of Agricultural Genetically Modified Organisms Safety’, 
adopted at the 38th Meeting of the State Council on May 9, 2001, promulgated by the Decree No. 304 of the State Council of 
the People’s Republic of China of 2001 on May 21, 2001, and effective as of the date of promulgation. 
38  ‘Administrative Measures on the Safety of the Import of Agricultural Genetically Modified Organisms’, promulgated by the 
Decree No. 9 of  the Ministry of Agriculture on  January 5, 2001,  and  amended by  the Decree No. 38 of  the Ministry of 
Agriculture on July 1, 2004. 
39  ‘Administrative Procedure Law of the People’s Republic of China’, adopted at the Second Session of the Seventh National 
People's Congress on April 4, 1989, promulgated by Order No. 16 of the President of the People's Republic of China on April 
4, 1989, and effective as of October 1, 1990; amended by the 28th Meeting of the 12th National People’s Congress Standing 
Committee on 27 June, 2016 
40    Administrative Procedure Law, Art. 63. 
41  ‘Legislation Law of  the People’s Republic of China’, adopted at  the 3rd Meeting of  the 9th National People’s Congress 
Standing Committee on March 15, 2000,  amended at  the 3rd Meeting of  the 12th National People’s Congress  Standing 
Committee on March 15, 2015   
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legal authority than local decrees and administrative or local rules.42 
 
2.3.1 Historical evolution of GMO regulation 
The evolution of GMO regulation in China can be divided into two separate periods. The first 
period began with the 1993 MOST Genetic Engineering Measures and the second period 
started from the 2001 State Council Regulation and is ongoing.  
 
The regulation of GMOs in China started in 1993 when the formerly State Science and 
Technology Commission (now has been changed into the Ministry of Science and Technology, 
hereinafter referred as the MOST) issued the ‘Administrative Measures on the Safety of 
Genetic Engineering’ (hereinafter referred as the 1993 MOST GE Measures).43 An initial legal 
framework on GMO regulation was then established and the GMOs were regarded as a purely 
scientific matter. The 1993 MOST GE Measures provided standards and management regime 
for each stage in the process of genetic engineering including the laboratory operation safety 
and safety control measures,44 from research in the laboratory and field experimentation in 
small scale, and pre-market production testing of the use of transgenic products. The main 
function of the MOST is to enhance the national research and development of science and 
technology, the 1993 MOST GE Measures thus designated the MOST as the competent 
authority of developing and supervising the national administration of genetic engineering45.  
A National Genetic Engineering Safety Committee under the MOST was established to 
supervise and coordinate overall administration of genetic engineering safety among different 
government agencies. Later the Ministry of Agriculture (MOA) issued the ‘Implementation 
Measures on the Safety of Agricultural Genetic Engineering46 (hereinafter referred as the 1996 
                                                 
42  Ibid. Art 72 regulates that the People’s Congress and its Standing Committee at the provincial level, of the municipalities, 
of  the  autonomous  regions  could  legislate  local  regulations  based  on  specific  situation  and  actual  demands.  The  local 
regulations shall not be conflicted to the Constitutional law, the law and the administrative regulations. 
43  ‘Administrative Measures on the Safety of Genetic Engineering’, Decree No.17 (1993) of the State Commission of Science 
and Technology 
44  Ibid. Art 4 and 5. 
45  Ibid. Art 4. 
46  ‘Implementation Measures on the Safety of Agricultural Genetic Engineering’ Decree No.7 (1996) of the Ministry of 
Agriculture (MOA Decree 7/1996) 
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MOA Measures) in 1996 and the State Tobacco Monopoly Administration issued the 
‘Administrative Measures on the Research and Application of Tobacco Genetic Engineering’ 
47(hereinafter referred as the 1998 Tobacco Measures) in 1998 to provide more detailed rules on 
Tobacco genetic engineering research and application. After these three administrative acts 
were issued, there were some discussions about whether a more comprehensive national law 
should be promulgated by the National People’s Congress within the committees of the 
Congress, as consistent with Chinese legislative practice. But such an approach was dropped, 
mainly due to the resistance from the science community. The Congress agreed that the time 
was not ripe and there was no further legislative action for the GMOs afterwards until the year 
of 2001.  
 
In May 2001, the State Council issued a new ‘Administrative Regulation on the Biosafety of 
Agricultural GMOs’48 (hereinafter referred as the 2001 State Council Regulation), which 
belongs to the third rank in the legal hierarchy. It repealed the 1996 MOA Measures on 
Agricultural GMOs. There are several points that are noteworthy about this change. To start 
with, it is a regulation instead of the ministerial administrative measures, which means that it is 
more comprehensive in nature. Secondly, although the regulation still deals with agricultural 
GMOs, it was not issued by the Ministry of Agriculture but by the superior authority, the State 
Council. This change enhanced the legal effect of the act and had institutional implications, 
which will be discussed later. However, the MOA was still the initiator and drafter of this 
regulation under the designation of the State Council.  
 
The 2001 State Council Regulation could be seen as the basis of Chinese legislation on 
agricultural GMOs biosafety. It outlined the basic and comprehensive management system on 
GMOs from the objectives of laws to the institutions of management. In the Article 3 of the 
2001 State Council Regulation, the definition of the agricultural genetically modified organism 
                                                 
47  ‘Administrative Measures on the Research and Application of Tobacco Genetic Engineering’, promulgated by the State 
Tobacco Monopoly Administration on March 26,1998. 
48  ‘Administrative Regulation on the Biosafety of Agricultural Genetically Modified Organisms’, adopted at the 38th Meeting 
of the State Council on May 9, 2001, promulgated by the Decree No. 304 of the State Council of the People’s Republic of 
China of 2001 on May 21, 2001, and effective as of the date of promulgation. 
  
 
2
which is “…the subject of the regulation has been provided: the agricultural genetically 
modified organisms include: animals, plants, microorganisms and their products which 
genomic structures have been modified by genetic engineering technologies for the use in 
agricultural production or processing, which mainly include:  
1) genetically modified animals, plants (including plant seeds, breeding livestock and poultry, 
aquatic fry and seeds) and microorganisms;  
2) products of genetically modified animals, plants and microorganisms;  
3) products directly processed from genetically modified agricultural products;  
4) seeds, breeding livestock and poultry, aquatic fry and seeds, pesticides, veterinary drugs, 
fertilizers, additives and other products containing ingredients of genetically modified animals, 
plants and microorganisms or their products.”49  
 
The regulation also provide the definition of agricultural genetically modified organisms safety, 
which is “…the protection of human being, animals, plants and microorganisms and the 
ecological environment against the danger or potential risk arising from agricultural genetically 
modified organisms. 50  Any activities of research, experiment, production, processing, 
marketing, import and export related to agricultural genetically modified organisms within the 
territory of China must conform to the Regulations.”51 
 
The Article 4 entitles the competent agricultural administrative department of the State Council 
which is the Ministry of the Agriculture, “is responsible for the nationwide supervision and 
administration of agricultural genetically modified organisms safety. Also, the competent 
agricultural administrative departments of local governments at or above the county level are 
responsible for the supervision and administration of agricultural genetically modified 
organisms’ safety within their respective administrative areas. The competent public health 
administrative departments of local governments at or above the county level are, in 
                                                 
49  The 2001 Regulation, Article 3. The English translation of the Regulation is available on the official website of the Ministry 
of Agriculture, see < http://english.agri.gov.cn//governmentaffairs/lr/st/201301/t20130115_8106.htm> last accessed Oct 27, 
2017 
50  Ibid, Art 3.   
51  Ibid, Art 2. 
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accordance with the relevant provisions of the Food Hygiene Law, responsible for the 
supervision and administration of the hygiene and safety of genetically modified food within 
their respective administrative areas.”52 
  
One of the greatest contribution of the 2001 State Council Regulation is that it establishes an 
Inter-Ministerial Joint Conference system for GMOs safety administration. The 
Inter-Ministerial Joint Conference is, according to the Regulation, “composed of responsible 
persons from the departments of agriculture, science and technology, environmental protection, 
public health, foreign trade and economic cooperation, inspection and quarantine, and the 
responsible person from other relevant departments.” The conference is in charge of directing 
and creating China’s comprehensive policy on GMO regulations and shall be responsible for 
the discussion and coordination of major issues involved in the administration of agricultural 
genetically modified organisms’ safety.53 
 
Most important part of this regulation is that it defined a full set of institutional system with 
matter of GMOs safety management. The first will be the class-based administration and 
evaluation system. The 2001 Regulation institutes a class-based administration and evaluation 
system for agricultural GMOs safety. Agricultural GMOs are classified into Classes I, II, III 
and IV according to the extent of their risks to human beings, animals, plants, microorganisms 
and the ecological environment. To be specific, Class I refers to no or unlikely risk; Class II 
refers to low risks; Class III refers to medium risks and Class IV refers to high risks. The 
specific standards for the classification are to be formulated by the competent agricultural 
administrative department of the State Council which the MOA.54 Table 3.1 below illustrates 
the administrative requirements for different classes of GMOs and the in different stages.  
 
 
 
                                                 
52  Ibid, Art 4.   
53  Ibid, Art 5. 
54  Ibid, Art 6. 
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Table 2.1 Administrative requirement for GMOs from laboratory research to production55 
Management 
Stage 
Safety 
Class 
Management 
System 
Administration 
Authority 
Accepted 
Authority 
Authorized 
Document 
Laboratory 
Research 
Class  I, 
II 
n/a  Institutional 
biosafety 
committee  of 
agriculture 
n/a  n/a 
  Class 
III, IV 
Report  Office  of 
biosafety 
administration 
of  agricultural 
GMOs (MOA) 
Science  and 
Technology 
Development 
Centre, MOA 
n/a 
Field Testing  Class  I, 
II, III, IV 
Report  Office  of 
biosafety 
administration 
of  agricultural 
GMOs (MOA) 
Science  and 
Technology 
Development 
Centre, MOA 
n/a 
Environmental 
Release 
Testing 
n/a  Examination 
and Approval 
Office  of 
biosafety 
administration 
of  agricultural 
GMOs (MOA) 
Science  and 
Technology 
Development 
Centre, MOA 
Approval 
Documents 
Productive 
Testing 
n/a  Examination 
and Approval 
Office  of 
biosafety 
administration 
of  agricultural 
GMOs (MOA) 
Science  and 
Technology 
Development 
Centre, MOA 
Approval 
Documents 
Application  n/a  Examination  Office  of  Science  and  Safety 
                                                 
55  The detailed requirements are provided by Article 10 to Article 16 of the 2001 Regulation. See also Dayuan Xue (ed.), 
Biosafety and Regulation for Genetically Modified Organisms (Beijing Science Press, 2009) p225 
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for  Safety 
Certificate 
and Approval  biosafety 
administration 
of  agricultural 
GMOs (MOA) 
Technology 
Development 
Centre, MOA 
Certificate 
 
Secondly, it establishes an evaluation system for agricultural GMOs safety. The competent 
agricultural administrative department of the State Council is in charge of formulating 
standards and technical norms for safety evaluation of agricultural genetically modified 
organisms. 56  The Ministry of Agriculture organizes National Agricultural Biotechnology 
Committee twice a year to dispose the application of safety evaluation on agricultural GMOs.57 
Thirdly, in the process of production and handling the GMOs products, it establishes a 
production and marketing licensing institution. A production license and a marketing license 
shall be obtained from the competent agricultural administrative department of the State 
Council for the production and marketing by any unit or person intend to produce or market 
genetically modified seeds, breeding livestock and poultry, or aquatic fry and seeds.58 The 
2001 Regulation also institutes a labeling system for GMOs and “the catalogue of agricultural 
genetically modified organisms subject to labeling administration shall be determined, adjusted 
and published by the competent agricultural administrative department of the State Council in 
consultation with the other relevant departments of the State Council.” 59  The labelling 
requirement will be discussed later with more details. Furthermore, it institutes the application 
measures60 and inspection and quarantine measures61 for importing and exporting agricultural 
GMOs into/out of the territory of China.  
 
In order to implement this regulation, the MOA subsequently issued the following more 
detailed ministerial acts. The first one is the ‘Administrative Measures on the Safety of the 
Import of Agricultural GMOs’62 (hereinafter referred as the 2002 MOA Import Measures), the 
                                                 
56  Ibid, Art 7. 
57  Dayuan Xue (ed.), Biosafety and Regulation for Genetically Modified Organisms (Beijing Science Press, 2009). p 225 
58  Ibid, Art 19 and Art 26. 
59  Ibid, Art 8. The detailed requirements for GMOs labelling will be explained in the following sections. 
60  Ibid, Art 31, Art 32 and Art 33. 
61  Ibid, Art 34 and Art 35. 
62  ‘Administrative Measures on the Safety of the Import of Agricultural Genetically Modified Organisms’, promulgated by the 
Decree No. 9 of  the Ministry of Agriculture on  January 5, 2002,  and  amended by  the Decree No. 38 of  the Ministry of 
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‘Administrative Measures on the Labeling of Agricultural GMOs’63 (hereinafter referred as the 
2002 MOA Labeling Measures) and the ‘Administrative Measures on the Safety Assessment of 
Agricultural GMOs’64 (hereinafter referred as the 2002 MOA Assessment Measures) in July 
2002. These measures were supposed to be applicable from March 20 2002, but in fact, the 
entry into force was postponed till April 20, 2004.65 On February 20, 2004, the MOA issued 
Ministerial Communication No. 349, which formally confirmed that the MOA should conduct 
‘normal’ administration in accordance with the 2001 Regulation and three MOA Measures. It 
means that the ‘normal’ rules and procedures provided by the four administrative legal 
documents were applied as from April 20, 2004.  
 
Apart from these specific laws on agricultural GMOs, other laws also have provisions relevant 
to the GMOs. After promulgation of three Administrative Measures to implement the 2001 
State Council Regulation, the Ministry of Agriculture issued a ‘Administrative Measures on 
Examination and Approval of Agricultural Generically Modified Organisms Processing’. 66 
This Measure is formulated according to the relevant provisions of 2001 State Council 
Regulation, for the purpose of intensifying the administration of examination and approval of 
agricultural genetically modified organisms processing. 67  The General Administration of 
Quality Supervision, Inspection and Quarantine (AQSIQ) issued the ‘Administrative Measures 
on the Inspection and Quarantine of the Import and Export of GMO Products’68 in 2004 
(hereinafter referred as the 2004 AQSIQ Inspection Measures).  
 
Another particular administrative measure is noteworthy that the Ministry of Health69 issued 
                                                                                                                                                        
Agriculture on July 1, 2004. 
63  ‘Administrative Measures  on  the  Labeling  of  Agricultural GMOs’ Decree No.10  (2002)  of  the Ministry  of  Agriculture, 
issued on 5 January 2002 (MOA Decree 10/2002) 
64  ‘Administrative  Measures  on  the  Safety  Assessment  of  Agricultural  GMOs’  Decree  No.8  (2002)  of  the  Ministry  of 
Agriculture, issued on 5 January 2002 (MOA Decree 8/2002) 
65  Web Commentary “China’s Regulation on the Trade of Agricultural Product GMOs”, http://www.agri.gov.cn (last accessed 
Oct 17, 2015). MOA, Communication No. 349 (February 20, 2004), http://www.agri.gov.cn (last accessed October 17, 2015). 
66  ‘Administrative  Measures  on  Examination  and  Approval  of  Agricultural  Generically  Modified  Organisms  Processing’, 
Decree No. 59 (2006) of the Ministry of Agriculture, issued on January 27, 2006 (MOA Decree 59/2006) 
67  Ibid, Art 1. 
68  Adopted at the meeting of the General Administration of Quality Supervision, Inspection and Quarantine of the People’s 
Republic of China on September 5, 2001, promulgated by Decree No. 62 of the Director‐General on May 24, 2004 
69  Formerly the Ministry of Health, in the reforms of 2013 the ministry has been dissolved and its functions integrated into 
the new agency called the National Health and Family Planning Commission (NHFPC), in 2018 the agency has been changed 
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the ‘Administrative Measures on the GM Food Hygiene’70 (hereinafter referred to as 2002 
MOH GM Food Measures), based on the ‘Law of the People’s Republic of China on Food 
Hygiene’71 (1995) of the National People’s Congress. In the past decades, Chinese society has 
changed in various aspects, the Food Hygiene Law needed to be amended for adapting the 
current situation. In order to solve the food safety problems which occurred with the social 
development, the Food Hygiene Law was replace by the new ‘Law of the People’s Republic of 
China on Food Safety’72 in 2009. However, the 2002 MOH GM Food Measures was repealed 
in 2007. GMO Foodstuffs are now subject to the 2001 State Council Regulation and currently 
there is no particular and separate legislation regulating GMO foodstuffs.  
 
2.3.2 Regulatory authorities and their competences 
As described above, the evolution of GMO regulation in China can roughly be divided into two 
periods: 1993 to 2001 and 2001 to now. It was the MOST that started the regulation of GMOs in 
China, with the 1993 MOST GE Measures, which covered all the stages and activities of 
genetic engineering: experiments, trials and industrial production, even though, at the time 
China was in fact only at the stage of research and development. At that time import or export 
of GMOs was not a considerable issue either internationally or domestically. The material 
scope was limited. It was a framework and administrative measures, providing general 
principles. Other relevant ministries or agencies were allowed to make more detailed rules. In 
1996 the MOA and in 1998 the Tobacco Administration issued two relevant measures 
concerning GMOs within their respective competences. As there was a multi-agency 
regulatory system, the cooperation and co-ordination among the ministries and agencies was 
automatic, free from difficulties and without explicit and detailed procedural requirements.  
 
                                                                                                                                                        
into  the National Health  Commission  (NHC)  after  the National  People’s  Congress  and  the  Chinese  Political  Consultative 
Conference which are convened once a year, usually in spring. 
70  ‘Administrative Measures on the GM Food Hygiene’, Decree No.28 (2002) of the Ministry of Health, issued on 8 April 2002 
71  ‘Law  of  the  People’s  Republic  of  China  on  Food  Hygiene’,  adopted  at  the  16th Meeting  of  the  8th National  People’s 
Congress Executive Committee on October 31, 1995, abolished at 2009 and be replaced by the ‘Law of the People’s Republic 
of  China  on  Food  Safety’,  adopted  at  the  7th  Meeting  of  the  11th  National  People’s  Congress  Executive  Committee  on 
February 28, 2009 
72  Ibid. 
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The second period, starting with the 2001 State Council Regulation, made the situation slightly 
different. The Regulation came from the superior authority, the State Council, but the 
Regulation expressly delegated the regulatory competence on agricultural GMOs to the MOA. 
The MOA is responsible for the regulation of research, seeds and crops, field trials, production, 
environmental release and commercialization, consumer information of labeling on GM food, 
import and export of GMO agricultural products.73 It is not responsible for health and safety 
regulation of GM food and inspection and quarantine of import and export of GMOs. The 
Ministry of Environmental Protection74 is responsible for the environmental regulation and for 
the implementation of the Biodiversity Convention75 and the Biosafety Protocol76 in general, 
but it does not have a significant role in the regulation of agricultural GMOs. Currently, it is still 
multi-agency regulatory system, but the regulatory competence has been concentrated in the 
MOA. 
 
The second period of the evolution of GMOs regulation in China shows one unique element 
regarding to the institutional setting of agricultural GMO biosafety management which is very 
different from some other countries and the EU with advances system of GMOs biosafety 
management regime. It is understandable that the policy makers designate the MOA to be in the 
center role of agricultural biotechnology management since the agricultural affairs are the 
fundamental duty of the MOA which should be more familiar to and has more expertise on the 
GMOs than other ministries. Furthermore, the environmental assessment in agricultural 
production regarding to the pesticide use is also carried out by the MOA as well. It seems the 
MOA is more than competent to fulfill the job of agricultural biosafety management. However, 
this system has brought many critics. The opponent argues that the MOA shall not be both the 
‘judgement’ and the ‘player’ in the biosafety management, this institutional setting might cause 
                                                 
73  See the 2001 State Council Regulation Art 8, Art 9, Art 19, Art 26, Art 31and Art 39. 
74  Formerly  the  State  Environmental  Protection  Administration  (SEPA),  was  upgraded  to  the  Ministry  of  Environmental 
Protection in 2008; in 2018, the Ministry has been renamed into the Ministry of Ecology and Environment of PRC after the 
National People’s Congress and  the Chinese Political Consultative Conference which are convened once a year, usually  in 
spring. 
75  China  signed  the  Convention on Biological Diversity  (CBD)  in  1992,  the  Standing  Committee  of  the National  People’s 
Congress ratified the Convention. In 1993 the CBD entered into force for China on December 29 of 1993. 
76  The  2000  Biosafety  Protocol  was  adopted  on  January  29,  2000  in  Montreal  of  Canada  and  entered  into  force  on 
September 11, 2003. On August 8, 2000, China signed the Protocol and on April 27, 2005 has approved the Protocol. 
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lack of enough attention to the environmental risks of GMOs, or even involve potential 
conflicts of interests because the MOA is primarily responsible for agricultural production, 
with many biotechnologies developed under MOA’s own research system and also, the MOA is 
the competent authority to formulate the relevant standards and technical norms of agricultural 
biosafety evaluation.77 
 
The Ministry of Agriculture and Rural Affairs (MOA) 
In accordance with the 1993 MOST GE Measures, the MOA is responsible for the safety 
aspects of agricultural GMOs. In fact, agricultural GMOs take a majority part of China’s GMO 
research and development. Medical biotechnology is not included in the agricultural 
biotechnology. In comparison with the 1996 MOA Measures, the 2001 State Council 
Regulation gave a more active role and competence to the MOA. The MOA is directly affiliate 
to the State Council, and the State Council have the responsibility to the MOA to carry out 
supervision and management of agricultural GMO biosafety.78 The main responsibility of the 
MOA includes the formulation of agricultural biotechnology policy, the approval of biotech 
agricultural crops for import and domestic production. Currently the MOA also take the place 
of the Ministry of Science and Technology in the management and distribution funding from 
central government to Chinese institutes and universities for the agricultural biotechnology 
research and development.79 In principle, if any rules or institutional arrangements of 1993 
MOST GE Measures are in conflict with the 2001 State Council Regulation, the latter will 
override the former because it is issued by the State Council, not by the MOA that is at the same 
level of the MOST.  
 
The Inter-Ministerial Joint Conference for Biosafety of Agricultural GMOs is established 
within the State Council. The responsible person from the seven national level ministries and 
agencies including the Ministry of Agricultural, the Ministry of Environmental Protection, the 
                                                 
77  Jikun Huang and Qinfang Wang, ‘Biotechnology Policy and Regulation in China’, IDS Working Paper 195, Institute of 
Development Studies 2003 < https://www.ids.ac.uk/files/Wp195.pdf> accessed Oct 17 2014, p12. 
78  Wenxuan  Yu  and Canfa Wang,  ‘Agro‐GMO Biosafety  Legislation  in China: Current  Situation, Challenges  and  Solutions’ 
(2012) 13 (4) Vermont Journal of Environmental Law 865, 870. 
79  USDA GAIN Annual Report 2014, supra note 2. 
  
 
3
General Administration for Quality Supervision, Inspection and Quarantine, the Ministry of 
Science and Technology, the Ministry of Commerce, the National Development and Reform 
Commission and the National Health and Family Planning Commission shall participate. The 
Conference takes place irregularly and the main responsibility of the Conference members are 
to study, coordinate and decide on important issues concerning the safety of agricultural 
GMOs. 80  It shall be noticed that the Inter-Ministerial Conference do not actually make 
decisions on the agricultural biosafety relevant events, the coordination purpose of the 
Conference is more important when a biotech policy affects multiple ministries.81  
 
Within the MOA, a National Agriculture GMO Biosafety Committee is established. This is a 
national level committee and it consists of 64 experts in the research, production, processing, 
inspection and quarantine, health and environment of agricultural GMOs.82 The selection of 
the member is based on areas of their expertise. These members normally only work in the 
Committee for part time and they are mostly scientists study in the different discipline 
including agronomy, biotechnology, plant protection, animal science, microbiology, 
environmental protection and toxicology. For example, the first Committee was composed of 
56 experts/scientific members, 29 of the members are responsible for making recommendation 
and decisions on GM plants; 9 members are dedicated to examining recombined 
microorganisms for plants; 12 members for transgenic animals and recombined 
microorganisms for animals; and 6 members for GM aquatic orgnisms. A few members also 
have positions within the MOA and other agricultural related government agencies.83 The 
competence of MOA covers all the activities concerning agricultural GMOs, including 
research84, intermediate trial85 production and processing86, marketing87, imports and exports88. 
                                                 
80  See 2001 State Council Regulation Art.5. 
81  USDA GAIN Annual Report 2014. 
82  Ibid, Art 9. 
83  This introduction was referenced from Jikun Huang, Ruifa Hu, Scott Rozelle and Carl Pray, ‘Development, Policy and 
Impacts of Genetically Modified Crops in China: A Comprehensive Review of China’s Agricultural Biotechnology Sector’. 
Paper presented at the workshop held at Villa Bellagio, Bellagio, Italy, June 2005, Science, Technology and Globalization 
Project. The Committee now consists 64 experts and serve three‐year terms, according to the interview with the 
vice‐minister Taolin Zhang on October 8, 2015 http://www.agrogene.cn/info‐2855.shtml (accessed on October 10, 2015) 
84  See 2001 State Council Regulation, Art. 9 to Art.12. 
85  Ibid, Art.13 to Art.18. 
86  Ibid, Art. 19 to Art. 25 
87  Ibid, Art. 26 to Art. 30 
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It seems that the MOA is the single and lead agency responsible for all activities of agricultural 
GMOs in China. Different ministries or agencies still collaborate on the issue of GMOs, but the 
MOA could be seen as the most important role being responsible for regulating agricultural 
GMOs. 
 
The Ministry of Science and Technology (MOST) 
Although the MOST was the first government ministry that initiated the regulation of GMOs in 
China in 1993, it is playing a more indirect role now. According to the 1993 MOST GE 
Measures, a National Safety Commission on Genetic Engineering was established within the 
MOST for the overall supervision and coordination of the safety of genetic engineering.89 
What is noteworthy is that the 2001 State Council Regulation does not make any reference to 
this Commission. Since the early stage of the biosafety management regime was set up in 
1990s, whether the MOST or the MOA shall take the dominant position has been a consistent 
debate. Based on the current situation and the administrative system, Huang pointed out that it 
is very unlikely that the MOST will be dominate in the biotechnology management unless the 
government structure be reformed, which is unlikely to be happen in the short term.90 At 
present, the MOA is responsible for all activities regarding agricultural GMOs, including 
imports and exports. Thus, in practice, the MOA has taken over much of the regulating 
competence of the MOST. The MOST used to in charge of managing and distributing funds 
from central government to research institutes and universities for the research and 
development of agricultural transgenic crops, however, since major part of the researches are 
about the agricultural biotechnology, the MOA has now in charge. It seems like that the MOST 
has only one role left in GMO regulation, namely to participate in the MOA dominated 
Inter-Ministerial Joint Meeting and the Agricultural GMO Biosafety Committee.  
 
The Ministry of Ecology and Environment (MEE)  
Currently there is no legislation or administrative measure promulgated by the Ministry of 
                                                                                                                                                        
88  Ibid, Art. 31 to Art. 38 
89  1993 MOST GE Measure, Art 4. 
90  Jikun Huang and Qingfang wang, supra note 4. 12. 
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Ecology and Environment (which is used to be named as the Ministry of Environmental 
Protection) regarding to the agricultural biosafety issues. It was designated by Chinese 
government to be the leading authority for the negotiation and implementation of the 1992 
Biodiversity Convention and the 2000 Biosafety Protocol. The main responsibility of the MEP 
is environmental administration, however, regarding to the area of biodiversity and biosafety, 
the role of the MEP is not clearly defined by law. Originally, the MEP was mainly responsible 
with the matter of pollution, but for the past few years with the increasing environmental 
awareness, the scope of competence of the MEP has expanded. The 2001 State Council 
Regulation provides that experts of MEP participate in the Inter-Ministerial Joint Conference 
for Biosafety of Agricultural GMOs led by the MOA. In the area of testing of biotechnology 
products, the MEE and its affiliated testing institutes are in charge of testing for environmental 
safety assessment and developing national and industry standards for biotech testing.91 The 
MEE clearly should be responsible for regulating the environmental implication of agricultural 
GMOs, but with the regulation of almost all activities related to agricultural GMOs in the hands 
of MOA, there is little left for the MEE.  
 
However, the picture is not yet totally fixed for the MEE or the MOA. It was reported in 2011 
that the MEE and the MOST are refining details of a new draft of law on GMOs biosafety 
including the GMOs food safety to be promulgated by the National People’s Congress, which 
belongs to the second rank.92 The aim and purpose of this draft law is to ensure the overall 
biosafety in a wide range of issue areas: agriculture, medicines, trade, and the environment. It is 
expected that the MEP will have a more significant role in GMOs biosafety management. 
 
The General Administration of Quality Supervision, Inspection and Quarantine 
(AQSIQ) 
The AQSIQ set up inspection and quarantine offices nationwide and those offices are directly 
responsible to the AQSIQ. The main function of the AQSIQ and those offices is to examine and 
                                                 
91  For example, the Ministry of Environmental Protection issued the ‘Guideline for eco‐environmental biosafety assessment 
of Insect‐resistant transgenic plants’ (HJ 625—2011), become effective on January 1st, 2012. 
92  See < http://scitech.people.com.cn/GB/13653570.html> (accessed on 10 Oct, 2015) 
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quarantine all the GM products when they entry and exit the Chinese territory. In accordance 
with the 2001 State Council Regulation, the AQSIQ has issued the ‘Administrative Measures 
on the Inspection and Quarantine of Imports and Exports of GM products’93, which entered into 
force on May 24, 2004. This measure regulates the procedure should be taken by the customs 
when carried out the examination and quarantine of importing and exporting biotech goods. 
 
In general, the job of testing the biotechnology products is jointly carried out by the affiliated 
testing institutes of the MOA, the AQSIQ and the MEP. The AQSIQ does not testing all the GM 
products but only the products and foods imported or exported. To be specific, the AQSIQ 
examines imported products to prevent unapproved biotechnology events, the MOA supervised 
and conducts the domestic crops assessment and their safety assessment experiments, and the 
MEP carries out the environmental safety assessments in general. All of the MOA, the AQSIQ 
and the MEP have developed biotech testing standards both for national testing and industry 
production testing and the methods adopted in testing is the polymerase chain reaction (PCR) 
testing methodologies.94 
 
The National Health Commission (NHC) (formerly the Ministry of Health, MOH) 
The NHC is responsible for the hygiene of food in general. In 1995, the National People’s 
Congress promulgated the “Law of the People’s Republic of China on Food Hygiene” (it has 
been now replaced by the Law of the People’s Republic of China on Food Safety in 2009, 
hereinafter the Food Safety Law95). This law conferred the competence of supervision and 
administration of food hygiene in general to the NHC. Other relevant ministries or agencies are 
responsible for the administration of food hygiene in as far as this is within their competence.96 
 
The role of NHC in GMO food safety administration has changed dramatically in the past 
decade. First of all, in April 2002 the former MOH issued the ‘Administrative Measures on the 
                                                 
93  ‘Administrative Measures on the Inspection and Quarantine of the Import and Export of GMO Products’ Adopted at the 
meeting of the General Administration of Quality Supervision, Inspection and Quarantine of the People’s Republic of China 
on September 5, 2001, promulgated by Decree No. 62 of the Director‐General on May 24, 2004 
94  < http://www.china‐cas.org/#>   
95  Supra note 51 
96  Ibid. Art.4 
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GM Food Hygiene’ in accordance with the 1995 “Food Hygiene Law” and the 2001 State 
Council Regulation. These measures was not the only regulation regarding to the GMO 
foodstuffs promulgated by the former MOH at the time, but also it defined the leading role of 
MOH in administration on the GMO food safety and its risk assessment. However it was soon 
abolished in 2007 when the new ‘Administrative Measures on New Resource Food’97 issued 
by former MOH took effect. The GMO food was catalogued as a kind of new resource food in 
these new measures yet the words like “genetically modified organisms food’ were not appear 
anywhere in the measures, it may cause confusion whether the former MOH was still in charge 
of the GMO food administration. Till the year of 2013, the reformed NHC issued 
‘Administrative Measures for the Safety Review of New Food Raw Materials’98, the Article 23 
clearly stated that the new food raw materials do not include the genetically modified food.99 
Currently, there is no specific legislation regulating GMO food products and the NHFPC has no 
more administrative competence with regard to the GMOs. 
 
2.4 Substantive Regulations on Agricultural Biotechnology 
The following section is a summary of the relevant substantive rules, standards and procedural 
requirements of agricultural GMOs in China. 
 
2.4.1 Regulations on research activities 
The 2001 State Council Regulation provides the legal framework for regulation of GMOs in 
China. The 2002 MOA Assessment Measures provide detailed procedural and substantive rules 
for the implementation of the 2001 State Council Regulation with regard to research.  
 
The Regulation covers all the activities of research, field experiment, production, processing, 
                                                 
97  ‘Administrative Measures on New Resource Food’, Decree No.56 (2007) of the National Health and Commission, issued on 
1 December 2007 
98  ‘Administrative Measures for the Safety Review of New Food Raw Materials’, Decree No. 1 (2013) of the National Health 
and Family Planning Commission, issued and come into force on October 1, 2013 
99  Ibid. Art.23 
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sales, imports and exports of agricultural GMOs within the territory of China.100 With regard to 
research, it applies to the research activities conducted by Chinese entities, joint entities and 
foreign entities101. According to the Regulation, in order to ensure the GMOs safety during the 
process of GMOs research and testing all units engaged in the relevant work GMOs are 
required to have competent facilities and safety measures commensurate with the safety classes. 
Furthermore, each unit should establish biosafety groups which will be responsible for the 
research and testing 102  The biosafety measures should be adequate to deal with the 
corresponding risk category (explained below) approved by the authority. Before a joint entity 
and a foreign entity conduct their research and field trial activities in China, they should obtain 
the approval for their research from the MOA.103 For research activities in the risk Categories 
III and IV (medium risk and high risk), the approval from the MOA is required before the 
beginning of the research work.104 
 
On the aspect of risk assessment, a 4-category system was initially provided in the 1993 MOST 
GE Measures and this system was adopted in the 2001 State Council Regulation. The Measures 
identified four categories of risk to human beings, animals, plants, microorganism and the 
ecological environment: Category I - no risk, Category II - low risk, Category III - medium risk 
and Category IV - high risk.105 Each ministry or agency should set up its own detailed technical 
standards and environmental standards for these four categories and submit them to the 
National Safety Commission of the MOST for its records. Only the research, intermediate trial 
and industrial production, environmental release and utilization of GMOs falling into Category 
IV (high risk) were subject to the examination and approval of the National Safety 
Commission.106 If the research and intermediate trial created risks of Category III, and risks of 
industrial production, environmental release and utilization of GMOs would fall into 
Categories of I to III, they were subject to examination and approval by relevant ministries and 
                                                 
100  The 2001 State Council Regulation, Art 2. 
101  Ibid, Art 18. 
102  Ibid, Art. 11 
103  Ibid, Art. 18 
104  Ibid, Art. 12 
105  1993 MOST GE Measures, Art. 6 
106  Ibid, Art. 14, Art. 15 and Art. 16. 
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agencies at the national level. If the risks of the research and intermediate trial would fall in 
Category I or II, the executive chief of the research entity (for example, a biotechnology 
institute) was responsible for the examination and approval (in practice this means that if the 
executive chief of the research unit is the researcher himself or herself, he or she has the 
authority to approve his/her own work). The 1993 MOST GE Measures itself did not provide 
any detailed standard on how to assess the risks. In other words, only the highest risks were 
subject to the National Safety Commission for approval.  
 
The 1993 MOST GE Measures did not provide tight controls on GMOs. This might be because 
in 1993, GMO related activities were mainly at their early stage of research and development 
(public programs such as the “863 Program” were only launched in the late 1980s) and issues 
involving GM products did not cause direct challenges to the governmental regulation. Another 
reason for this situation may because that the scope of the overall competence of former the 
State Science and Technology Commission (now the MOST), responsible for these rules, was 
to regulate the scientific and technological aspect of GMOs, not the intended use of this science 
and technology. Sales, imports and exports of GMOs were clearly not within the competence of 
the Commission and were not mentioned at all in the 1993 MOST GE Measures. Another 
reason is that imported GMOs and GM products, for example, GM soybeans, did not cause 
serious concerns at that time; import and export of soybeans were more or less balanced before 
1995.  
 
In response to the above concern, the State Council decreed the 2001 State Council Regulation 
to replace the early 1993 MOST GE Measures. It still uses the four categories of risk 
assessment created in the 1993 MOST GE Measures, but all agricultural GMO related activities 
(including sales, imports and exports) of all risk categories are now regulated by the MOA. The 
2001 State Council Regulation, however, does not refer to or even mention the 1993 MOST GE 
Measures or the National Safety Commission established with 1993 Measures. Instead, a 
Biosafety Committee is established which is responsible for safety evaluation of agricultural 
GMOs, including Category IV risk of GMOs.  
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The 2001 State Council Regulation divides up field trials in 3 stages: the intermediate trial, the 
environmental release and the production trial.107 After the research activity is completed in 
the laboratory and moves on to the stage of field trials, the research entity should report to the 
MOA108. When moving on to the next stages of trial, an application should be sent to the MOA 
that will decide whether or not to approve. After the final stage of field trial (production trial) is 
completed, the unit engaged in trail may apply for a Biosafety Certificate of Agricultural 
GMOs from the MOA. According to the 2002 MOA Assessment Measures, the MOA will 
organize assessment for such certification twice a year. The two deadlines for application are 
March 31 and September 30. Within two months after receipt of the application, the MOA will 
decide whether to accept the application or not. Within three months after the acceptance of the 
application, the MOA shall notify the applicant about the result of the assessment.109 From 
2008, the MOA published an announcement stated that the National Agricultural 
Biotechnology Committee will conduct appraisal three times a year, the three deadlines for 
submission of safety evaluation documents respectively are in March, June and November. The 
Committee will make reply within 45 days after receiving the application. 
 
2.4.2 Regulation on production and processing 
The production and processing of agricultural GMOs is regulated in the third sector of the 2001 
Regulation. A production permit or a production license measure has been introduced.110 It 
requires all units or individuals producing GM seeds, GM breeding stock or GM aquatic fry 
should apply for a Production Permit from the MOA, and fulfill the conditions laid down by 
other relevant laws and administrative regulations.111 In addition, according to the Article 19, 
any production unit or person who apply for the production license of genetically modified 
seeds, breeding livestock and poultry, and aquatic fry and seeds shall meet the following 
                                                 
107  2001 State Council Regulation, Art.13. 
108  Ibid, Art.14 
109  2002 MOA Assessment Measures, Art.16. 
110  2001 State Council Regulation, Art 19‐Art.25. 
111  Ibid, Art.19 and Art.21. 
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conditions:  
a. having obtained a safety certificate of agricultural genetically modified organisms and 
passed variety examination;  
b. planting or breeding in the designated areas;  
c. having adopted appropriate safety administration and precautionary measures and other 
conditions provided for by the competent agricultural administrative department of the State 
Council.112  
They should also establish and keep production documents which include the information of 
production location, genes and their sources, methods of genetic modification and the 
whereabouts of the GM seeds, GM breeding stocks and GM aquatic fry.113  
 
In addition, any production units or individuals conducting the production or processing of all 
other kinds of agricultural GMOs should obtain the approval from the MOA or the competent 
agricultural administrative department at the provincial level.114 The detailed rules for the 
application of the approval shall be made by the MOA in due course. After they get the 
approval, they should periodically report to the local agricultural agencies at the county level 
the information on production, processing, safety administration and the destination of the 
product.115  
 
2.4.3 Regulation on marketing 
Pursuant to the 2001 State Council Regulation, units or individuals intending to market GM 
seeds, GM breeding stock and GM aquatic fry should apply for a Marketing License from the 
MOA, and fulfill the requirements laid down by other relevant laws and administrative 
regulations.116 They should also establish and keep files that contain the information on the 
                                                 
112  Ibid, Art 19. 
113  Ibid, Art 20. 
114  Ibid, Art.21. 
115  Ibid, Art.23. 
116  Ibid, Art 26. 
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sources, storage, transportation and sales of the seeds, breeding stock and aquatic fry.117  
 
2.4.4 Regulation on GMOs Labelling 
The 2001 State Council Regulation provides that it is prohibited to import or sell any 
agricultural GM products listed in the inventory of the 2002 Administrative Measures on the 
Labeling of Agricultural GMOs without a proper label. The GM label should be made by the 
unit or individual responsible for the production and packaging.118 The label should clearly 
indicate the names of the main raw materials containing GMO ingredients in the product. If 
there is any special requirement on the scope of sale, the specific scope shall be identified and 
the product should be sold within that identified scope.119 Any advertisements of agricultural 
GMOs should be examined and approved by the MOA before they can be published, 
broadcasted, set and posted to the public.120 
 
More detailed requirements of GMOs labelling are provided by the 2002 MOA Labelling 
Measures. The Measures require all the approved agricultural GMOs products should be 
correctly labelled and aiming to prevent unlabeled or mislabeled GMOs products be imported 
or sale in the territory of China. It also provides that the agricultural agency at or above the 
county level is responsible for the supervision and administration of the GMOs labelling. The 
AQSIQ is responsible to check the GM labelling at the port of import.121 If the labelling on the 
package is difficult (for example, at the fast food restaurant or retail business), the labelling 
may be made by special identification on price tag, separate GM tag, or special identification at 
the outside of the container.122 The GM labelling should be in Chinese language and the GM 
labelling of imported agricultural GMOs should be sent to the MOA for approval and to the 
AQSIQ and Ministry of Commerce for record before it can be used. The time limit for the 
                                                 
117  Ibid, Art 27. 
118  Ibid, Art.28. 
119  Ibid, Art.29. 
120  Ibid, Art.30. 
121  2002 MOA Labelling Measures, Art.4. 
122  Ibid, Art.8 
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examination for GM labelling is 30 days.123 
 
Unlike the European Union, Chinese law has not yet provided technical means or standards for 
GMO detection or a threshold for GM labelling. If any GM content is found by the agricultural 
agency at or above county level, a label needs to be used. The 2002 MOA Labelling Measures 
provides three kinds of labels for intentional release to environment. The first way is labelling 
GMOs and the products containing GMOs ingredient as ‘genetically modified XX’. Secondly, 
the directly processed product of agricultural GMOs should be labeled as ‘processed GM XX 
product’ or ‘processed from GM XX material’. Finally, if a product if processed from GM 
material however the GM ingredient of the product is no longer contained or detectable, it 
should be labeled as ‘processed product from agricultural GMOs but the relevant GMOs may 
not be contained’. Labelling is not the only way available to put the GM products under control, 
but it is a common way for this kind of product in many countries. For example, both in the EU 
countries and China adopted mandatory labelling requirements. It is increasingly used by the 
government for reasons of administration and protection of consumer interests regarding to not 
only GM products but also to many other agricultural and industrial products in China. In the 
inventory annexed to the 2002 MOA Labelling Measures, 5 groups of GM products must be 
labelled before sale and most of them are major agricultural imports. The 5 groups of products 
which are subject to the mandatory labelling requirement include: Group 1: soybean seeds, 
soybeans, soybean powder, soybean oil and soybean meal; Group 2, corn seeds, corn, corn oil 
and corn flour; Group 3, rapeseed for planting, rape seeds, rapeseed oil, rapeseed meal; Group 4, 
cottonseed; and Group 5, tomato seed, fresh tomato, tomato sauce. This list since it was 
published in 2002 has not been updated since.  
 
In October 2015, the newly implemented Law on Food Safety (promulgated by the National 
People’s Congress Standing Committee) will incorporated existing regulations on 
biotechnology labelling into law and it also makes legally mandate GMOs labelling instead of 
referring to relevant regulations as discussed above. In other words, the 2002 MOA Labelling 
                                                 
123  Ibid, Art 10, 11, and 12. 
  
 
4
Measures requires the labelling of approved agricultural biotech products and prohibit the 
importation and sale of any unlabelled or mislabeled products. The 2015 Food Safety Law 
codifies into law existing biotechnology labelling regulations. For example, Article 69 states 
that producers will pay the penalty if GMOs products are not properly labeled.124 
 
In addition to these new labelling requirements, the misleading advertisement have also 
recently become the subject of controlling measures. In January 2015, the Ministry of the 
Agriculture released the Notice Concerning Guidance for GMO-related Advertisements, which 
required the competent agricultural authorities at the provincial level to work with the local 
commerce authorities as well as the food and drug authorities to strengthen the supervision 
over advertisements related to GMOs. The Notice explicitly “prohibits the use of ‘non-GMO’ 
in advertisements of products made of crops where no genetically modified version has been 
approved for sale in China or where no genetically modified version exists.”125 Non-GMO 
labels can be used for products for which genetically modified versions are available, but the 
labelling must be accurate and cannot use misleading words such as ‘healthier’ or ‘safer’.126 
 
2.4.5 Regulations on imports and exports of agricultural GMOs  
The rules laid down in the 2001 State Council Regulation are applicable to both agricultural 
GMOs developed in China and abroad. The MOA is responsible for the GMO regulation while 
the decision on specific import and export of GMOs is made by the Ministry of Commerce 
(formerly the Ministry of Foreign Trade and Economic Cooperation, MOFTEC). 127  In 
comparison with the domestic GMOs developed in China, the imported GMOs are subject to a 
separate and more stringent regulation, mainly provided by the 2002 MOA Import Measures.  
 
                                                 
124  Law of Food Safety, Art. 69. 
125  Global Agricultural Information Network (GAIN), Report No.CH15032, Agricultural Biotechnology Annual—China 
Considering Major Revisions to Biotechnology Regulations (USDA Foreign Agricultural Service, 21 December 2015) 
126  Notice Concerning Guidance for GMO‐related Advertisements 
http://www.moa.gov.cn/ztzl/zjyqwgz/zcfg/201501/t20150122_4346780.htm last accessed 10 December 2016 
127  Zhou Yu (ed.), The Management Mode and the Regulations on Genetically Modified Food in Worldwide (Beijing Military 
Medical Science Press, 2012) 66 
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For the purpose of research and field trials, the importing entity should apply to the MOA for 
approval.128 The unit should possess the application qualification provided by the MOA, the 
prior corresponding research and field trial already conducted overseas and relevant safety 
administration and prevention measures. If the overseas companies export GM seeds, breeding 
stock, aquatic fry, agricultural pesticides, veterinary medicine, fertilizer and additives produced 
by agricultural GM technology or containing agricultural GM composition to China for the 
purpose of field trials, they should apply to the MOA for approval. In the application, they 
should provide information that:  
- the proposed use and marketing has been approved by the exporting state or territory;  
- scientific experiments in the exporting state or territory show that no harm has been caused 
to human, animal, micro-organism and eco-system;  
- there are relevant safety administration and preventive measures.  
 
After a successful completion of the production trial and safety evaluation, an agricultural 
GMO Biosafety Certificate will be issued.129 With the GMO Biosafety Certificate and other 
relevant approvals, the importing entity or the overseas entity may go on with other procedures 
of evaluation, registration, quarantine and customs.130 The time limit for the MOA and the 
AQSIQ to approve or reject the application for the Biosafety Certificate is 270 days.131 
 
According to the 2002 MOA Import Measures, the Measures apply to any one of the three uses 
of agricultural GMOs, namely research, field trails, and production and processing.132 For the 
purpose of research, the importing entity should apply to the MOA for approval with a list of 
documents. If the import is for the purpose of environmental release and production trial, the 
GMO Biosafety Certificate is required and the application should be sent to the MOA.133 
Production mainly refers to the import of seeds, breeding stock and aquatic fry for purpose of 
the production of GMO crops, stocks and fish in China. Before the production starts, the GMO 
                                                 
128  2001 State Council Regulation, Art.31. 
129  Ibid, Art.32. 
130  Ibid, Art 32, 33 and 34. 
131  Ibid, Art 36. 
132  2002 MOA Import Measures, Art.4. 
133  Ibid, Art.5 to Art 8. 
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Biosafety Certificate is required and other relevant administrative rules also apply.134 For the 
purpose of processing, the overseas exporting company should also first apply for the GMO 
Biosafety Certificate from the MOA.135 If the imported processing GMO materials contain 
living GMOs, they should be segregated from other materials and guaranteed that all necessary 
measures are taken to assure that there is no release into the environment.136 For the purposes 
of production and processing, the relevant import contract should only be signed after the GMO 
Biosafety Certificate is issued. 
 
In comparison with domestic GMOs, the imported GMOs are subject to more stringent control 
from the stage of research. For the domestic GMOs, the research of below Risk Category III, no 
report to the MOA is necessary. For research at or above Risk Category III, only report to the 
MOA is necessary. But for the imported GMOs of whatever risk category, the importing entity 
should apply to the MOA for import approval. At the stage of field trials, for the domestic 
GMOs, report to the MOA is necessary when turning to the intermediate trial from the research 
stage. When turning from intermediate trial to environmental release or production trial, an 
application for approval from the MOA is required. While for the imported GMOs, no matter of 
what risk category, an application for approval from the MOA is required. Moreover, an 
application for approval from the MOA is required when turning from each stage of filed trials 
to the next stage. At the stage of production, if the overseas companies export GM seeds, 
breeding stock, aquatic fry, or seeds, or breeding stock, aquatic fry, agricultural pesticides, 
veterinary medicine, fertilizer and additives produced by agricultural GM technology or 
containing agricultural GM composition to China for the purpose of production, they should 
also apply to the MOA for approval. Besides, going through all stages of field trials in China 
and the Biosafety Certificate are required. For the importing GMOs used as processing 
materials, the oversea companies should apply for the Biosafety Certificate from the MOA and 
go through the safety evaluation procedure. If the same oversea company already holding the 
Biosafety Certificate for the same agricultural GMO, the application for a new Certificate in the 
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future is simplified. With the importing safety management registration form, a copy of the first 
Biosafety Certificate and a safety measure plan to be adopted by the oversea company in China, 
the oversea company may apply for the second Biosafety Certificate. 
 
Export of Chinese agricultural GMOs is not as strictly regulated as import. Only at the request 
of an importing State, the AQSIQ will examine the products and issue a GMO-Free 
Certificate. 137  A GMO Biosafety Certificate is not compulsory for exporting Chinese 
agricultural GMOs.  
 
2.4.6 Regulations of liability and law enforcement  
The 2001 State Council Regulation delegates the enforcement authority to the MOA and local 
agricultural agencies at or above the county level. In case of violation of the above procedural 
and substantive rules, the enforcement measures include inquiry, an order for cessation of the 
wrongful act, sealing up, detainment, withdrawal of Biosafety Certificate, destruction of the 
dangerous agricultural GMOs and imposing fines. Most of the penalty provisions are targeting 
the violation of the administrative procedures, for example, failure to report to the MOA of 
Categories III and IV field trials. 
 
Article 45 of the 2001 State Council Regulation provides that in the case of illegal production 
and application of agricultural GMOs without the approval after the production trial, the MOA 
shall order an immediate stop of the production and impose a fine of no less than RMB 20,000 
(about 2,000 GBP ) but no more than RMB 100,000 (about 10,000 GBP).138 Article 50 
provides that in case of import of agricultural GMOs without the approval of MOA, the MOA 
shall order to stop the import and confiscate the imported products and the income gained with 
the illegal activities. If the illegal income is over RMB 100,000, the MOA shall impose a fine of 
one to five times of the illegal income. If the illegal income is less than RMB 100,000, the 
MOA shall impose a fine of no less than RMB 100,000 but no more than RMB 100,000. On the 
                                                 
137  2001 State Council Regulation, Art. 37. 
138  The current exchange rate of RMB to GBP is about 10:1, last checked on Nov 2015. 
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aspect of damage to the environment or to non-GM crops caused by the release of GMOs, 
nothing is provided. It seems that the MOA administration, backed by penalties provisions, has 
the highest priority. Biosafety is not given the same amount of attention and is not backed by 
any provisions in the 2001 State Council Regulation. The logic might be that if all the 
agricultural GMO procedural requirements are met, biosafety is automatically secured.  
 
In general, the agricultural GMO regulatory system seems complete, containing both 
substantive and institutional norms, and incorporating international regulatory approaches and 
techniques, but the real challenge to such a regulatory system is firstly whether China, the 
largest developing country has the capacity to implement and enforce the rules. Taking into the 
consideration the highly decentralized and fragmented character of public administration in 
China, limited administrative resources (both human and financial resources) and strong local 
protectionism by local governments and other elements, it is not surprising that incidents such 
as the illegal plantation of GMOs took place. According to the report by Greenpeace, 93 
percent of samples taken in 2015 from corn fields in five counties in Liaoning province, part of 
China's breadbasket, tested positive for GMO contamination. 139  However, there is no 
genetically modified corn variety has been approved for domestic commercial cultivation in 
China. The Information Office of MOA claimed on news conference earlier this year that 
illegal planting of GM crops did happen in some cities, however, the severity was not as bad as 
above report claimed.140 China is definitely shall improve the regulatory system and achieve 
one mode which is suitable and practical to the specific political, economic, social and cultural 
environment of the regulatory state. 
 
2.5 International Aspect of the GMOs Regulations 
Since the late 1970s, China started to participate in international efforts for the protection of 
environment. China has participated in some most important multilateral environmental 
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treaties and bilateral agreement. For example, in 1996 China participated in the Vienna 
Convention on Nuclear Safety; in 2002, joined the Kyoto Protocol; and in 2009 participated in 
Copenhagen Accord and so forth. China’s domestic environmental lawmaking was actually 
triggered by its participation in international efforts. The following part of this paper will focus 
on the international aspect of the China’s regulation of agricultural GMOs. 
 
2.5.1 General overview of China and international treaties 
The relationship between international environmental treaties and domestic law is a matter of 
constitutional law. There are two major issues involved in this aspect. The first is the 
incorporation of international treaties into Chinese law. The second is the supremacy of the 
international treaties. The 1982 Constitution and the 2000 Legislation Law are both silent on 
these issues.  
 
On the issue of incorporation of international norms into domestic legal system, at least three 
approaches may be identified. The first one is that an international treaty is directly applicable 
in China without any subsequent domestic legislative act by the legislature, for example the 
1984 UN Convention against Torture. The second is that a subsequent domestic legislative act 
is made in order to transform international norms into domestic law, for example the 1970 
Hague Convention on Hijacking. The third approach, which is most widely adopted recently, 
especially after the WTO membership, is the revision or annulment of existing domestic laws 
in order to be in line with China’s international legal obligation.  
 
On the issue of supremacy of international law, reference can only be found in national laws. A 
typical example is Article 46 of the “Environmental Protection Law” (1989), which provides 
that if an international treaty regarding environmental protection concluded or acceded to by 
China contains provisions differing from those contained in the laws of China, the provisions of 
the international treaty shall apply, unless the provisions are those to which China has 
announced reservations. Therefore, one could conclude that the supremacy of international 
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treaties is recognized by Chinese law. 
 
2.5.2 Convention on biological diversity and biosafety protocol 
1992 Convention on Biological Diversity 
China signed the Convention on Biological Diversity (CBD) in 1992. In January 1993, the 
Standing Committee of the National People’s Congress ratified the Convention. The CBD 
entered into force for China on December 29 of 1993. The SEPA was designated as the lead 
agency for the implementation of the CBD in China. Other ministries and agencies participated 
in the implementation efforts. On June 13 1994, the China Action Plan for the Protection of 
Biodiversity was published. In February 1998, the China Research Report of the State of 
Biodiversity was made public. Later China also published the following documents on 
biodiversity:  
- the Administration of China Natural Reserve,  
- China Protection of Biodiversity and Sustainable Use of Wetlands,  
- State Report of Convention Implementation,  
- China State Framework of Biosafety, etc. 
  
In February 2014, the Coordination Office of the CBD Implementation (belongs to the MEP) 
published its 5th National report of the implementation progress of the CBD in China. 
According to the Coordination Office, China made tremendous efforts for the protection of 
biodiversity. The progress includes the following: establishment of the state coordination 
framework for the implementation of the CBD, led by the MEP; improvement of the regulatory 
and enforcement framework; strengthening of the protection of the habitats; improvement of 
public education and public awareness; and more active collaboration with the international 
community. On the aspect of challenges, the review identified the following: continuing 
degradation of the habitats and distinction of species; invasion of alien species; inadequate 
administrative framework of biosafety; inadequate protection and management of the genetic 
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resources; urgent need for protection of the biodiversity in the western provinces in China.141   
 
2000 Biosafety Protocol 
The 2000 Biosafety Protocol was adopted on January 29, 2000 in Montreal of Canada and 
entered into force on September 11, 2003. On August 8, 2000, China signed the Protocol and on 
April 27, 2005 has approved the Protocol.142 The second COP-MOP143 was held between in 
2005 in Montreal, Canada. China participated in this COP-MOP. 
 
After signing the Protocol, it took China about 5 years to ratify. This long delay caused 
concerns in the National People’s Congress and the Political Consultative Conference. The 
Protocol, in their view, played a positive role in protecting China’s biosafety and human health, 
stabilizing the agricultural production, promoting agricultural exports, ensuring the social 
stability and improving the living standard of the agricultural community in China. Moreover, 
the Protocol would help China to build and strengthen its administrative capacity. Therefore, it 
was in the interest of the country to approve the Protocol. The reason of the failure to ratify the 
Protocol was the coordination problem among ministries or agencies. However, the 
Coordination Office emphasized that this should not have become an obstacle to the final 
approval. National interests were more important than the interests and administration 
authority of individual ministries or agencies.  
 
It seems that there has been institutional tension between the MOA and the MEE. As it was 
reviewed earlier in this paper, the current GMO regulatory framework delegated the regulatory 
authority on agricultural GMOs to the MOA, and as a result, the MEE is marginalized. But the 
designated agency responsible for the implementation of the CBD in China is the MEP. 
Therefore, the MEE logically believed that it should be able to regulate all the matters falling 
within the scope of the CBD, including all matters involving GMOs. As to the current 
regulatory framework, the MEP considered that it lacked the supervision on relevant basic 
                                                 
141  The 5th National Report of the Implementation of CBD in China, the Ministry of Environmental Protection, 2014 February. 
https://www.cbd.int/doc/world/cn/cn‐nr‐05‐zh.pdf (last accessed on December 2, 2015) 
142  Dayuan Xue (ed.), Biosafety and Regulation for Genetically Modified Organisms (Beijing Science Press, 2009) 163 
143  COP‐MOP stands for the Conference of the Parties serving as the meeting of the Parties to the Protocol. 
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research work and environmental release of GMOs. It claimed that the regulatory framework is 
not complete and has obvious gaps and is far from being a unified and coherent national 
supervision and management mechanism. Another argument was that the MOA cannot be both 
the player and referee at the same time. There is a conflict of interest in the current GMO 
regulation. 
 
This is neither the first nor the last time that institutional tension affected the effectiveness of 
policy and law in China. And the regulation of GMOs is not an isolated problem in China, 
either. It has to be admitted that the regulation of GMOs demands to bring several ministries or 
agencies in. The complicated issues of GMO regulation (e.g. science, technology, human 
health, environment, economic, social, and etc.) easily go beyond the scope of competence of a 
single ministry or agency. Therefore, a workable and efficient regulatory framework has to deal 
with coordination issues first. It is strongly demanded that the MEE, together with the MOST in 
particular and other relevant ministries, would draft a new GMO Safety Law to be promulgated 
by the National People’s Congress, which is superior to the State Council regulation.  
 
a. China’s overall view of the Protocol 
China participated in the negotiation of the Protocol but the position of China was not clearly 
recorded in the negotiation documents of the Protocol. In general, China shared the position of 
the ‘like-minded group of countries’ and supported a strong Protocol.144 According to the 
officials of the MEP, the present provisions of the Protocol more or less reflected the position of 
China, and they claim that early ratification would benefit the protection of biodiversity, 
eco-system and human health; and would prevent the potential risks caused by the import of 
GM products and environmental release and commercialization of living modified organisms 
or LMOs145 in China. Other advantages of the Protocol are the legitimacy and justification of 
establishing a GMO regulatory framework in China and the support for capacity building of 
strengthening of the regulatory framework.  
                                                 
144  Coordination  Office  (MEP),  Brief  Report  on  the  Protection  of  Biodiversity  and  the  Implementation  of  the  CBD,  < 
http://www.biodiv.gov.cn/lygz/lyjb/index.htm> (last accessed December 2, 2015) 
145  the term used in the Protocol for this group of GMOs, Cartagena Protocol on Biosafety to the Convention on Biological 
Diversity 
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The 2001 Regulation of the State Council was issued one year later on May 23 of 2001. The 
following will show that on certain substantive aspects there are clear connections between 
these two legal documents.  
 
b. Precautionary approach 
The precautionary approach is the cornerstone of the protocol. It inherited the Art 15 of the Rio 
Declaration on Environment and Development, ‘…In order to protect the environment, the 
precautionary approach shall be widely applied by States according to their capabilities. Where 
there are threats of serious or irreversible damage, lack of full scientific certainty shall not be 
used as a reason for postponing cost-effective measures to prevent environmental 
degradation’.146 In other substantive and procedural provisions, the precautionary approach is 
specified.  
 
As it was mentioned earlier in this paper, the objective of the 2001 State Council Regulation 
was mainly focused on three aspects: to strengthen the safety management of the agricultural 
GMOs; to ensure the safety of human health, animal, plant and micro-organism and eco-system; 
and to promote the research of agricultural GMO technology.147 
 
In general, GMO related activities are not banned in China, but the GM seeds, GM crops and 
GM food are regulated and treated substantially different from the conventionally produced 
seeds, crops and food. This differentiated treatment (not prohibited by the Biosafety Protocol) 
is not based on the evidence of actual harm but on the potential uncertainty and risks associated 
with GMOs. There are several regulatory tools, including safety assessment, Biosafety 
Certificate, compulsory labeling, import and export control and relevant liability scheme 
provided by the law. Basically, China adopted the precautionary approach. 
 
                                                 
146  The United Nations Conference on Environment and Development, Rio Declaration on Environment and Development. 
Having met at Rio de Janeiro from 3 to 14 June 1992. Art. 15 
 
147  2001 State Council Regulation, Art.1. 
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c. Advanced Informed Agreement (AIA) 
The Protocol created an important procedural requirement for the exporters of LMOs, which is, 
to seek consent from the importing country (public authority) before the first shipment of 
LMOs which are meant to be introduced into the environment or for direct use as food or feed 
for processing. This is the so-called the Advance Informed Agreement (AIA). 148  The 
importing country (public authority) has 270 days to make a decision on the import request. 
The decision should be made available to both the exporter and to the Biosafety 
Clearing-House established under the Protocol.149  
 
The 2001 State Council Regulation and the 2002 MOA Import Measures incorporated the same 
requirements,150 but the scope of such consent is broader than what was provided in the 
Protocol. They cover the import of agricultural GMOs for research and experiment, for 
environmental release or production (e.g. seeds, etc.) and for materials for being processed. The 
application for export to China shall be made to the MOA and the AQSIQ, which shall, within 
270 days of the receipt of the application, make a decision on whether to approve or to reject 
the application.151 But before that, the exporter should apply to the MOA for the agricultural 
GMO Biosafety Certificate and other relevant documents issued by the MOA.152  
 
d. Documentation 
The Protocol requires bulk shipments of LMO commodities, such as GM corn or GM soybeans 
that are intended to be used as food, feed for processing, to be accompanied by documentation 
stating that such shipments “may contain” living modified organisms and are “not intended for 
intentional introduction into the environment”.153   
 
As described above, the 2002 MOA Labeling Measures provides three kinds of labels for 
intentional release to environment. The difference with the Protocol is that the Measures do not 
                                                 
148  Cartagena Protocol on Biosafety to the Convention on Biological Diversity, Art.7‐Art.11. 
149  Ibid, Art.12 
150  Chapter 5 of the 2001 State Council Regulation. 
151  2002 MOA Import Measures, Art.18.   
152  Ibid, Art. 12 
153  Cartagena Protocol, Art.18 
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use the term “may contain”, but a clear ‘contain’ label. 
 
e. Risk assessment 
According to the Protocol, the importer may make the risk assessment or require the exporter to 
make such assessment.154 
 
The MOA issued the Assessment Measures in 2002. The requirement of a risk assessment is 
not only applied to imported GMOs, but also to domestic GMOs. From what was provided by 
the Measures, the assessment is to be made on a scientific basis. However it has to be noted that 
neither the Protocol nor the Measures provided criteria (e.g. GMO threshold) or methods (e.g. 
PCR or ELISA) used for assessment. 
 
f. Liability 
The issue of dispute settlement and liability was not resolved when the protocol was signed. It 
was left for later the first COP-MOP.155 By the time when the fist COP-MOP was held in Kuala 
Lumpur, China has already promulgated one 2001 State Council and three Administrative 
Measures. The 2001 State Council Regulation and relevant Measures all provided liability and 
penalty provisions in the form of fines and criminal penalties in case of forged documentation. 
As it was mentioned earlier, the liability provisions in the Regulation and Measures are targeted 
to strengthening the GMO administration, however not on the biosafety. 
 
2.6 Conclusion 
This chapter gave a general introduction of the regulation of agricultural GMOs in China. As 
the chapter shows, China embraced agricultural GMO technology with enthusiasm since the 
middle of 1980s, mainly out of economic and political reasons. Considerable public funds have 
been invested in this area. As a result, China has become the among the six largest agricultural 
GMO producers. Based on the consideration of the possible impact that the biotech products 
                                                 
154  Cartagena Protocol, Article 15 and Annex III 
155  Ibid, Art.27. 
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might bring to the environment and human health, China, as many other countries and regions 
in the worldwide pays high attention to the biosafety management, especially on the 
agricultural sector. In summary, the legislative framework of agricultural biosafety is mainly 
constituted by the relevant regulations in the Environmental Law, specialized agricultural 
biosafety regulation, relevant legislation as well as technology norms. Among the others, the 
core content of the specialized agricultural biosafety includes: the Administrative Regulation 
on the Biosafety of Agricultural GMOs (2001), the Administrative Measures on the Safety 
Assessment of Agricultural GMOs (2002), the Administrative Measures on Safety of Import of 
Agricultural GMOs (2002), the Administrative Measures on Labelling of Agricultural GMOs 
(2002), the Administrative Measures on the Inspection and Quarantine of the Import and 
Export of GMOs Products and the Administrative Measures on Examination and Approval of 
Agricultural GMOs Processing (2006). This series of legislations provided the legal basis to the 
risk assessment, administrative system, labelling requirements, report system, licensing system, 
supervision and examination system. Furthermore, the scale of legislative framework also 
extends to the forestry, food safety, products inspection and quarantine related to the GMOs. In 
the past decades, this framework has a positive effect on enhancing the biosafety management, 
regulating import and export order of agricultural transgenic products and supporting the 
research and development of biotechnology. However, the current situation of the 
biotechnology development and the national conditions of China has greatly changed and is 
very different from the time when the biosafety legislative framework was established. The 
legislative framework is urgently needed improvement to cope with the challenges. 
 
Nowadays Chinese government pay high attention on domestic biotechnology research and 
development as the recent national policy repeatedly emphasis that biotechnology is a strategic 
emerging industry. On the other hands, the commercialization of GMOs has been held back   
and till now there have been no licences for commercial planting transgenic staple crops 
granted. And Chinese government is also more cautious on importing transgenic crops. For 
example, in 2014, the MOA announced to delay the approval of one soybean varieties 
application for the reason of the public concerns. This is the first time the MOA refuses to 
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approve an import application based on non-scientific reason.156 Furthermore, the biosafety 
certificates of Chinese domestically developed biotech rice and corn expired in August 2014 
and the MOA did not complete the final approval for commercialization. All the actions taken 
by the government might look contradictory that supports and invests the biotechnology 
research strongly yet stalls the approval for commercialization of the domestically developed 
GM varieties and import of foreign imported GM crops. A comment by the President Xi in 
September 2015 might explain this confusing situation. He commented that ‘…Biotech is a 
new technology, and a new industry with bright prospect. As a novel issue, biotechnology 
attracts social disputes and doubts, which is normal.  For this issue, I want to emphasize two 
aspects, one is guaranteeing safety and the second is indigenous innovation. That is, we shall 
be bold in research, but cautious in commercialization. The industrialization and 
commercialization of genetically modified crops shall strictly follow the technical procedures 
provided by Chinese regulations; the industrialization and commercialization of genetically 
modified crops shall be steady and make sure no problem occurs, and all safety-related factors 
shall be considered.  The research and innovation shall be bold, so we can take the 
commanding heights in biotechnology, and not let large foreign companies dominate the 
agricultural biotechnology product market.’157 
 
This is remarks made publicly for the first time by President Xi on biotechnology. These 
comments affirmed the official support for biotechnology research but with a cautious attitude 
on the commercialization. In the future, China will continue to pursue the development of 
agricultural GMOs because such technology is expected to ultimately become the solution to 
many existing problems of the Chinese agricultural sector, including production efficiency, 
food security, food safety and environmental protection.  
 
The development of the Chinese regulatory framework for agricultural GMOs was triggered by 
many considerations, including domestic and international ones. Many competing interests are 
                                                 
156  USDA Gain Report No. CH14032, p2 
157  Xi Jinping’s speech on the Central Conference on Rural Work on December 23, 2013, released  in September 2014, the 
English translation was cited from the USDA Gain Report, 2014 p.3 
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involved, both internationally and domestically. Internationally speaking, the EU and the US 
stand for two opposing sides on the regulation of the agricultural GMOs. The EU’s 
precautionary approach is more influential in the design of the whole regulatory framework in 
China. The US is more influential in forcing China to remove the regulatory obstacles to 
American GM products into Chinese market. An obvious reason why China chose the EU 
model is that China, like the EU, is not a major exporter of GM products, but an importer. As an 
importer, the issues of biosafety and food safety all are currently existing and challenging. If 
the international rules (the Biosafety Protocol) and foreign rules (the EU model) provide ready 
and useful models for this purpose, China shall learn the lessons. Domestically speaking, the 
interests of the biotechnologists, GM crop farmers and the MOA, etc. are prevailing. The 
interests of other agricultural scientists, non-GM crop farmers and the MEP are neglected. The 
issue of biosafety is not given the importance it should have. The lawmaker of GM 
technologies does not seem to pay enough attention on the protection of non-GM crop farmers 
and taking precautionary measures to reduce the risk of gene pollution, for example. The issue 
of biosafety is expected to be given proper attention in the future GMO safety law. 
 
As to the characteristics of the GMO regulation in China, the following features may be 
identified. Firstly, China used legal binding regulations, rather than the voluntary guidelines. 
Instead of revising the existing regulation, a new regulatory mechanism was created, limited to 
agricultural GMOs. Secondly, China took a multi-ministry approach so several ministries and 
agencies are involved in the regulatory framework. Thirdly, with China’s accession to the WTO, 
the decision-making has become more transparent than before; relevant documents and 
information have been published on official websites. Fourthly, the MOA plays the leading role 
in this regulatory framework. In theory, biosafety and environmental considerations are 
considered, but the priority of the MOA is agricultural production. Therefore, a more active 
role of the MEE is definitely necessary in the GMO regulation. The relevant issues of 
agricultural GMOs are not only agricultural or economic issues, GMOs should be addressed 
and regulated in broader context and in the more neutral way. 
 
  
 
5
From the above study on the Chinese governance of GM technology and agricultural GMOs 
products, it is fair to say that, after decades of efforts, China has established a comparatively 
thorough legal system on the GMO management from the laboratory research to marketing 
the final products of this technology. However, in order to streamline the regulatory process 
of agricultural biotechnology and bring the governance of GM technology into a higher level, 
further improvement is still needed. The aspects of the Chinese governance regime on GMOs 
which need to be improved and their shortcomings could be summarized as follows.  
 
(i) First of all, among the current scattered regulations and administrative measures, a 
comprehensive law on GMOs biosafety is missing from the legal framework which 
could have made the legal system logically clearer. In order to largely enhanced the 
legal enforcement, the policy makers might need to consider to simplify the legal 
organization of the relevant laws, clarify the administrative responsibilities of the 
different governmental and public agencies involved in het development, licensing 
and commercialization of GM crops, and thereby made the enforcement of the 
relevant provisions more straightforward and effective. Moreover, as the development 
of research on GM technology is rapid and the utility of its products is increasing, the 
current dominating regulation on GMOs which is the 2001 Regulation on Biosafety of 
Agricultural Genetically Modified Organisms158 could be considered as out of date. 
In respect of effective law enforcement and management, there are gaps and defects 
exist in the legal framework, for example, the comprehensive traceability measure, the 
co-existence measures and emergency management measure are absent.  
 
(ii) Secondly, although with the accession to the WTO, the decision-making process on the 
GMOs issues has become more transparent than before; relevant documents and 
information could be found on official websites. However, the public participation 
mechanism is still absent from current Chinese legislation. The current regulations on 
                                                 
158  Regulation on the Biosafety of Agricultural Genetically Modified Organisms, adopted at the 38th Meeting of the State 
Council on May 9, 2001, promulgated by the Decree No. 304 of the State Council of the People’s Republic of China of 2001 
on May 21, 2001, and effective as of the date of promulgation.   
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GMOs management do not have stipulations or articles relating to public participation 
in the decision-making process of GMO authorisations or the GMOs safety 
management. The regulation of biosafety and/or GMOs might be considered as 
scientific issues which require professional scientific knowledge to understand and 
evaluate the technical scientific issues to which they give rise. However, it is important 
that the rights of ordinary citizens to participate in decision making on GM technology 
are not neglected.  
 
(iii) Finally, the establishment of a regime for establishing liability for damage caused by GM 
cultivation and appropriate remedies is necessary for protecting and promoting 
biosafety. This has been ignored in the current GMOs biosafety management system. 
Environmental liability - and the establishment of remedies – should be one of the 
most important elements in building a future Chinese system for the governance of 
biosafety law and GM technology. 
 
These issues will be discussed in more detail in the following chapters, and options for reform 
considered in the Conclusion.  
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Chapter 3 Regulatory Regime for Genetically Modified Organisms in the 
European Union1 
3.1 Introduction 
In the European Union, governments, the media, non-governmental organizations, consumers, 
and industry associations remain conflicted about the use of agricultural biotechnology. The 
controversies surrounding the use and cultivation of GMOs in the European Union concern the 
uncertainty of the safety, possible risks to human health and the environment, and the necessity 
of it to the society. Acceptance varies widely across countries. The EU produces very few 
genetically modified (GM) plants, however, with the increasing acceptance of biotechnology 
around the world by leading agricultural producers, the EU imports millions of tons of GM 
soybeans and corn products every year, mainly used as a feed ingredient in the livestock and 
poultry sector.2 The most recent developments of GMOs legislation include a new directive3 
that allows Member States to ban cultivation of GM crops in their territories for non-scientific 
reasons and a legislative proposal on allowing Member States to prohibit or restrict the use of 
GM food and feed on part or all of their territory.4  
 
Until the 1990’s, the European Union was a leader in research and development of biotech 
plants. Nowadays, the EU is still active in agricultural biotechnology research however the 
                                                 
1  This chapter is an updated and largely expanded vision based on the writer’s LL.M dissertation, ‘A Study on the EU Policy 
and Regulation of Genetically Modified food and its reference to China’, submitted in Sep 2012. The idea and structure is 
from the work. Some of the references used in the LL.M dissertation have also been quoted in this thesis with updated 
information and adjustment. 
2  Global Agricultural  Information Network  (GAIN), EU‐28 Agricultural Biotechnology Annual 2016, GAIN Report Number: 
FR1624  (  USDA  Foreign  Agricultural  Service  ,  12  June  2016) 
https://gain.fas.usda.gov/Recent%20GAIN%20Publications/Agricultural%20Biotechnology%20Annual_Paris_EU‐28_12‐6‐20
16.pdf accessed 10 May 2017 p10 
3  Directive (EU) 2015/412 of the European Parliament and of the Council of 11 March 2015 amending Directive 2001/18/EC 
as  regards  the possibility  for  the Member  State  to  restrict  or  prohibit  the  cultivation  of  genetically modified  organisms 
(GMOs) in their territory. [2015] OJ L68/1 
4  Proposal  for  a Regulation of  the  European Parliament  and of  the Council  amending Regulation  (EC) No  1829/2003  as 
regards the possibility for the Member States to restrict or prohibit the use of genetically modified food and feed on their 
territory (COM(2015) 177 final). 
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research is not likely to leas to commercialization of GM crops in the near future. The EU has 
multi-level governance arrangements allocating responsibility for decision making on different 
aspects between the Member States and EU institutions. The effect of this has in practice been 
to restrict development. As a result of strong regulatory constrains, the commercial cultivation 
of GM crops is very limited in the EU. The only GM plant cultivated on a large scale 
commercially is GM corn/maize which is grown on around 130,000 hectares, mostly in Spain, 
where accounts for 30 percent of the corn area.5 The EU does not export any GM products but 
is a major importer of soybeans (around 30 million metric tons per year on average) and corn 
products (around 7 million metric tons per year on average), mainly used as animal feed in the 
livestock and poultry sectors. The proportion of GM products in total imports is estimated at 
around 90 percent for soybeans and less than 25 percent for corn.6 With the growing adoption 
of biotechnology around the globe by leading agricultural producers, the EU is getting 
increasingly isolated internationally, and it is more and more difficult and expensive for EU 
companies to source non-biotech products.  
 
In the worldwide, the regulatory approaches on the biotechnology research and the use of 
GMOs that the European Union has applied could be regarded as on an advanced and 
sophisticated level. 7  However, despite its advanced management regime and the rapid 
development of the transgenic technology, the general attitude of policy makers and general 
public to GMOs is still complicated and with a hint of refusal. The reason behind the advanced 
regulatory approaches and cautious attitude to the GMOs is actually deeply connected to the 
historical events and the social causes. The following section will introduce the background of 
the EU regarding to it legislative framework to the GMOs.  
 
                                                 
5  GAIN Report Number: FR1624, p11.   
6  Ibid. 
7  Bernd van der Meulen, ‘The EU Regulatory Approach to GM Foods’ (2007) 16 Kansas Journal of Law and Public Policy 286 
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3.2 The Moratorium on Authorisation of GMOs in the EU8 
The cautious attitude on the use of transgenic technology in the agricultural production and 
food production started almost as the same time as this new technology had been applied and 
this skepticism intensively increased throughout the period of time from the 1980s to the 1990s. 
Subsequently, this attitude has soon caused intense political awareness and interest around the 
issue. Discussions and debates emerged not only about the necessity and safety of the 
utilization of new technology in foods production and processing as well as their incorporation 
into the market from the scientific perspective, but also about the role of politics, science, and 
public concerns and participation in GMOs debate from the social perspective. The GMOs 
issue could not be simply sorted as merely a scientific issue or merely a social issue, it covers 
both. The motivation for formulating a legislative framework governing the GMOs in the EU is 
mainly driven by two factors: the scientific uncertainties of the GMOs based on its nature and 
the public concerns around the safety issue.9 
 
3.2.1 Previous food safety crises 
The food safety within the European Union is a long-running issue. Nowadays, the European 
Union enjoys the high reputation regarding to its strict management of food safety management, 
protection of public health and customer right. However, these achievements were not 
accomplished in an action. The food safety crises happened in the past and had seriously 
threatened the public health and the government reputation.10  The Bovine Spongiform 
Encephalopathy (BSE) crisis could be seen as the most representative case which caused a 
reconstruction in the legal and regulatory approaches of the European Union’s food law.11  
 
                                                 
8  For more detailed literature discussing the moratorium on authorization of GMOs in the EU, please see for example, Maria 
Lee, EU Regulation of GMOs: Law and Decision Making for a New Technology (Edward Elgar Publishing Limited, 2008), p.2 
‘Introduction‐The EU’s moratorium on authorization of GMOs’ 
9  D. R. Anderson, “Biotechnology Risk Management:  the Case of Genetically Modified Organisms  (GMOs),”  (2001) 54  (4) 
CPCU Journal 219 
10  Bernd van der Meulen, P297. 
11  Ibid.  In  this article  it also mentioned other  food safety crisis which happened  in  the past, however,  the BSE crisis was 
considered by the author as ‘a catalyst for the recent developments in the field of EU food legislation’. Also see Community 
Legislation on BSE, available at http://ec.europa.eulfoodlfs/bselbseI5_en.pdf Last accessed in Jan 2017   
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At the early stage when the BSE crises outbroke, the government tried eliminate public 
concerns by suggesting that the problem was exaggerated by media and the scientific 
significant was little.12 For instance, in order to ensure the safety of British beef to the public, 
the British Minister of Agriculture of the day feed his daughter a hamburger on television to 
reassure consumers.13 However, as the fatalities of livestock caused by the BSE increased 
rapidly and the spread of the disease to human beings, the European citizens lost their trust on 
the government, the food industry and the scientific data published by the officials. The 
influence of the BSE crises was not only about risking public’s health and caused damages and 
hazards but also it caused the collapse of EU citizens’ confidence to the government with the 
way that the government and food industries handled of the disease. Just as it was stated in the 
Phillips Report of the (BSE) crises: ‘…When on 20 March 1996 the Government announced 
that BSE had probably been transmitted to humans, the public felt that they had been betrayed. 
Confidence in government pronouncements about risk was a further casualty of BSE.’14  
 
As a consequence of government authorities’ failure in handling of the BSE crises, many 
European citizens and customers lost their trust in reassurance by the government especially in 
the case of relating to the public health.15 Therefore, when the biotechnology was used in the 
agricultural planting and food production, there was no surprise that the European citizens kept 
skeptical to this new biotechnology and its products—GMO food, ‘Frankenstein Food’ as 
branded by the media, as well as the scientific assurances and risk assessment results.16 In this 
way, it appears that the strict management regime for the GMOs was a defensive strategy took 
by the European Union authorities to re-obtain public’s trust and re-build the government 
credibility of the government for the time.17  
 
                                                 
12  Ibid. 
13  To convince the population that there was nothing wrong with British beef, the Minister of Agriculture, John Gummer, fed 
his  young  daughter  a  hamburger  on  TV  (May  16,  1990  BBC).  Text,  picture  and  video  available  at:  < 
http://news.bbc.co.uk/onthisday/hi/dates/stories/may/16/newsid_2913000/2913807.stm> last accessed in Jan 2017 
14  G. Little, ‘BSE and the Regulation of Risk’ (2001) 64 Modern Law Review 730 
15  Bernd van der Meulen, p300 
16   It  is  a  dramatic  interpretation  of  GM  food,  see  e.g.  Fields  of  Gold  shown  by  the  BBC  on  8‐9  June  2002 
(www.bbc.co.uk/fieldsofgold). Quoted from the article Michael Cardwell, ‘The release of genetically modified organisms into 
the environment: public concerns and regulatory responses’ (2002) 4 (3) Environmental Law Review156 
17  Bernd van der Meulen, p297 
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3.2.2 The scientific uncertainty of GMOs 
The development and exploitation of GMOs might promise a variety of potential benefits, but 
also causes possible serious social, economic, and environmental concerns at national, 
international and global levels.18 Except the public concerns and fears of the risks involved, the 
EU regulatory framework on GMOs is also influenced by the scientific uncertainty of GMOs. 
The public concerns and fears not only caused by the scientific uncertainty of GMOs and the 
possible risk to human health and the environment, but also caused by media reports with 
skeptical and nervous atmosphere regarding to implication of GMOs products on the market in 
the European Union. 
 
However, the risks involved regarding to the GMOs are different from those of food crises 
which happened in the past because the nature of the GMOs and the former food crises are 
different. Specifically, the former kind of food risk, for example, the risk of the BSE is 
“grounded in identifiable and ultimately established risk”19 which is practically identifiable 
and preventable. Also, the evaluation of the risk is not really a scientific issue. On the other 
hand, the risk involved within the GMOs are far more complex and potentially far reaching. 
Furthermore, the use of transgenic technology in agricultural production and its final products 
or products are much more uncertain than normal ones. The utilization of GMOs in human 
history started only a few decades ago however, the certain answer to the safety issue takes 
experience learned from long-term research and assessment in cultivation and production 
which might cost time from generation to generation. Despite the British Plain English 
Campaign awarded Mr. Donald Rumsfeld the prize for the most nonsensical remark made by a 
public figure to it, his quote actually provided a great explanation of modern society’s general 
concerns to GMOs’ risk. He said, “…as we know, there are know knows; there are things we 
know we know. We also know there are know unknowns; that is to say we know there are some 
things we do not know. But there are also unknown unknows—the ones we don’t know we 
                                                 
18  M Rosso Grossman, ‘Genetically modified crops in the United States: Federal Regulation and State tort liability’ (2003) 5 
Environmental Law Review 86 
19  Lisa Carson and Robert Lee,  ‘Consumer  sovereignty and  the  regulatory history of  the European market  for genetically 
modified foods’ (2005) 7 (3) Environmental Law Review 173 
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don’t know.”20 
 
From the scientific perspective, the methods used to identify a certain risk include multiple 
elements: the selected variables, the measures, the samples, the models and causal 
relationships.21 The issue of the GMOs is more complex and the identification of its potential 
risks cannot only rely on short-term observations and a few variables. To what extent the GM 
technology and its products might impact the human society and the environment is still unclear 
based on the current scientific knowledge due to the complex nature of the GMOs. Therefore, 
there is no surprising that the arguments and debates around the issue of scientific uncertainty 
of GMOs has been ongoing. Furthermore, based on the consideration of the uncertain, 
unquantifiable and unpredictable nature of GMOs risks, it is reasonable that the Precautionary 
Principle was designed as the guiding principle of the EU’s regulatory framework and 
penetrates into the whole management regime of GM technology and its products.22  
 
3.3 The Regulation Regime of Agricultural GMOs in the EU 
The history of regulation on GMOs in the European Union is not long.23 The regulatory 
framework of agricultural GMOs in the EU in its initial stage was governed under the 
governance of the EU’s General Food Law24, and its core content include the Council Directive 
90/219/EEC on the contained use of GMOs25 and Council Directive 90/220/EEC on the 
deliberate release of GMOs into the environment26. The regulatory framework changed its 
focus from the previous predominantly market-oriented approach to consumer protection by 
                                                 
20   Donald  Rumsdeld:  quoted  in  Rum  Remark  wins  Rumsfeld  and  Award,  2  December  2003.  Source:  < 
http://news.bbc.co.uk/1/hi/3254852.stm > last accessed 24th April, 2017 
21  Karen Morrow, ‘Genetically Modified Organisms and Risk’, in Luc Bodiguel and Michael Cardwell (eds), The Regulatory of 
Genetically Modified Organisms—Comparative Approaches (Oxford, 2010) p54 
22  Miguel A. Recuerda, ‘Administrative Authorizations, Risk and Biotechnology’ (2009) 4 EFFL 251. P.252 
23  Michael Cardwell, The European Model of Agriculture (OUP, 2004) p.285 
24  Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general 
principles and  requirements of  food  law, establishing  the European Food Safety Authority and  laying down procedures  in 
matters of food safety OJ L31/1 
25  Directive 90/219/EEC of 23 April 1990 on the contained use of genetically modified micro‐organisms [1999] OJ L117/ 1 
26  Directive 90/220/EEC of 23 April 1990 on the deliberate release into the environment of genetically modified organisms 
[1990] OJ L 117/15 
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the trigger of the previous food safety crises,27 This transformation was clearly stated in the 
Communication Life Sciences and Biotechnology—a Strategy for Europe28 of the European 
Commission. In the first paragraph, the European Union Commission expressed its opinion that 
the EU’s approaches to GMOs should be: 
 
“[r]ather than passively accepting the advent of the new technology, it was preferable to 
develop proactive policies to exploit them in a responsible manner, consistent with the 
European values and standards.”29  
 
In the process of revising and improving the regulatory framework since 1990s, it could be seen 
that the European Union is trying to achieve the balance between the interest environmental 
protection as well as the human health and the valuable benefits to the social and economic 
development brought by the new technology. It has been concluded that, the purpose of the 
legislation is to safeguard the protection of health, the transparency of information to the public, 
and the protection of the environment, all shall not be achieved by sacrificing the chance of 
development the modern biotechnology sector could offer to the society.30 Shortly after the 
release of the Communication, both of the 90/219/EEC Directive and 90/220/EEC were 
replaced,31 a series of regulations were formulated and enacted which focused on the GM food 
and feed safety were adopted and enacted.32 The Precautionary Principle of EU environmental 
law is a corner stone of the regulatory approach adopted through these instruments.33 
 
                                                 
27  Bernd van der Meulen, ‘Regulating GM food: three levels, three issues’ in Han Somsen (ed), The Regulatory Challenge of 
Biotechnology—Human Genetics, Food and Patents (Edward Elgar Publishing Limited 2007) p.139 
28  European Commission, Communication from the Commission to the European Parliament, the Council, the Economic and 
Social Committee and the Committee of the Regions: Life Sciences and Biotechnology—a Strategy for Europe COM (2002) 27 
[2002] OJ C55/3 
29  Ibid, para.1 
30  Marine  Friant‐Perrot,  ‘The  European  Union  Regulatory  for  Genetically  Modified  Organisms  and  its  Integration  into 
Community  Food  Law  and  Policy’  in  Luc  Bodiguel  and  Michael  Cardwell  (eds),  The  Regulatory  of  Genetically  Modified 
Organisms—Comparative Approaches (Oxford, 2010) p.80 
31  To be specific, the Directive 90/219/EEC was replaced by the Directive 2009/41; the Directive 90/220/EEC was replaced by 
the Directive 2001/18/EC. 
32  Specifically,  the  Regulation  1829/2003  of  the  European  Parliament  and  of  the  Council  of  22  September  2003  on 
Genetically Modified Food and Feed [2003] OJ L 268/1; and the Regulation No. 1830/2003 of the European Parliament and of 
the Council of 22  September 2003 Concerning  the Traceability and  Labelling of Genetically Modified Organisms and  the 
Traceability of Food and Feed Products Produced from Genetically Modified Organisms and Amending Directive 2001/18/EC 
[2003] OJ L 268/24 
33  Directive 2001/18/EC on the Deliberate Release into the Environment of Genetically Modified Organisms, Preamble(8) 
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The current EU regulatory framework follows a ‘step-by-step’ approach which was explicitly 
stated in the 2001 Directive: “…that the containment of GMOs is reduced and the scale of 
release increased gradually, step by step, but only if evaluation of the earlier steps in terms of 
protection of human health and the environment indicates that the next step can be taken.”34 
There are three steps composing the EU regulatory framework which are the contained use of 
GMOs, the deliberate release of GMOs into the environment and placing the GMOs on the 
market including the cultivation and the use of GMOs in food and feed production.35 Therefore, 
in order to have a thorough understanding on the system of current EU regulatory framework 
for GMOs, the following content will firstly study on the guiding principle—the Precautionary 
Principle and then respectively study on the regulatory regime for each step in the legal 
framework. 
 
3.3.1 The precautionary principle in the EU 
The Precautionary Principle, which famously acknowledges the place of scientific uncertainties 
at the center of decision making procedure, is also an important opportunity to open up space 
for broader perspectives on the regulation. The precautionary principle provides, at its most 
basic, that scientific uncertainty does not in itself preclude regulatory action. Depending on the 
approach which precautionary principle chosen, that regulatory action could be constrained by, 
for example, the severity or irreversibility of the risk, or by a cost-benefit analysis of regulatory 
action.36 The precaution principle is the subject to vastly different interpretations and roles, 
also it is an important principle of EU law and hence of the regulation on GMOs. 
 
The precautionary principle applies broadly in the EU, to the regulation of environmental 
protection, human health and safety.37 The European Court of Justice (ECJ) and the Court of 
                                                 
34  Ibid, Recital 24. 
35  Hans‐Georg Dederer, ‘The Challenge of Regulating Genetically Modified Organisms in the European Union: Trends and 
Issues’ in Yumiko Nakanishi (ed.) Contemporary Issues in Environmental Law: The EU and Japan (Springer, 2015) p143 
36  See  for  example  Rio Declaration  on  Environment  and Development  (United Nations  Conference  on  Environment  and 
Development,  1992);  and  European  Commission,  Communication  on  the  Precautionary  Principle  COM  (2000)  1  final; 
Regulation 178/2002 Laying Down the General Principles and Requirements of Food Law OJ 2002 L31/1. 
37  Article  191  (ex  Article  174  TEC)  of  the  Treaty  on  the  Functioning  of  the  European Union,  applies  the  precautionary 
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First Instance (CFI) have both had a number of opportunities on which to consider the 
precautionary principle, and the Commission has published an important Communication on 
the subject.38 
 
In the 1970s, the origin of Precautionary Principle was primarily proposed when the West 
Germany by the time set up the principle of Vorsorgeprinzip, which could also be referred as the 
principle of ‘foreseeability’. 39  In 1992, the Rio Declaration provided the landmark 
specification for the principle in Principle 15:  
“Where there are threats of serious or irreversible damage, lack of full scientific certainty shall 
not be used as a reason for postponing cost-effective measures to prevent environmental 
degradation.”40 
 
In the following year, the concept of the Precautionary Principle was introduced for the first 
time by the Maastricht Treaty into European Union law. It was provided in the Article 191(2) 
TFEU (ex 174(2) EC) that: 
 
“Union policy on the environment shall aim at a high level of protection taking into account 
the diversity of situations in the various regions of the Union. It shall be based on the 
precautionary principle and on the principles that preventive action should be taken, that 
environmental damage should as a priority be rectified at source and that the polluter should 
pay…”41  
 
The Precautionary Principle then has been gradually adopted into the EU environmental law 
and regarded as the guidance principle after the Maastricht Treaty. The status of the  
Precautionary Principle was consolidated by the Communication on the Precautionary 
Principle released by the EU Commission and in the Communication the Precautionary 
                                                                                                                                                        
principle to the environmental title of the Treaty.   
38  See European Commission, Communication on the Precautionary Principle COM (2000) 1 final 
39  Stuart Bell and Donald McGillivray, Environmental Law (7th edn, OUP 2008) p. 64 
40  Rio Declaration on Environment and Development (1992) 31 ILM 874, Principle.15 
41  The Treaty on the Functioning of the European Union Article 191(2) 
  
 
6
Principle was designed as a “central plank” of Community policy in 2000.42 Furthermore, the 
Court of First Instance described the Precautionary Principle in the subsequent Artegodan 
Judgment as a “general principle of Community law”.43 There is no doubt that in order to 
prevent the emergence of unpredictable and uncertain risks, the Precautionary Principle is a 
“safer option” to the policy makers.44 
 
In addition to the environmental law in general, the EU General Food Law is a representative 
example of the Precautionary Principle applied in the EU legislative framework. Article 7 of the 
General Food Law lays down the Precautionary Principle as one of the general principles of the 
General food law: “…In specific circumstances where, following an assessment of available 
information, the possibility of harmful effects on health is identified but scientific uncertainty 
persists, provisional risk management measures necessary to ensure the high level of health 
protection chosen in the Community may be adopted, pending further scientific information for 
a more comprehensive risk assessment.” 45  Moreover, the EU General Food Law has 
established the risk analysis system to safeguard on human health, including objective risk 
assessment and risk management. The risk assessment is based on the existing scientific 
evidence and knowledge, while the risk management is based on the result of risk assessment 
and other factors.46 Due to the accomplishment of comprehensive and thorough protection on 
public health, the General Food Law explicitly invokes Precautionary Principle:  
 
“…following an assessment of available information, the possibility of harmful effects on 
health is identified but scientific uncertainty persists, provisional risk management 
measures necessary to ensure the high level of health protection chosen in the Community 
may be adopted, pending further scientific information for a more comprehensive risk 
                                                 
42  Veerle Heyvaert,  ‘Facing  the  consequences of  the precautionary principle  in European Community  Law’  [2006] 31  (2) 
European  Law Review 185. P. 186.  Joined  cases: Case C‐180/96, United Kingdom v Commission[1998] E.C.R.  I‐2265; Case 
T‐199/96, Laboratoires pharmaceutiques Bergaderm SA & Jean‐Jacques Goupil v Commission[1998] E.C.R. II‐2805; for more 
recent case, Case C‐165/08, Commission of the European Communities v Republic of Poland [2008] ECLI:EU:C:2009:473. 
43  Case T‐74/00 R Artegodan GmbH v Commission[2002] E.C.R. II‐4945, para. 184 
44  Miguel A. Recuerda, ‘Administrative Authorizations, Risk and Biotechnology’ (2009) 4 EFFL 251 
45  Regulation (EC) No 178/2002, Article 7 
46  Helle Tegner Anker and Margaret Rosso Grossman,  ‘Authorization of Genetically Modified Organisms: Precaution  in US 
and EC Law’ (2009) 1 EFFL 3 p8 
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assessment”.47 
 
The application of the Precautionary Principle have different effects on the EU’ approaches 
applied for the contained use of GMOs and for the deliberate release GMOs into the 
environment.48 The precautionary principle mainly applies to the administrative procedure of 
the approval of GMOs, the labelling of GMOs and the safeguard clause.49 The Directive 
2001/18 on the deliberate release of GMOs and Regulation 1830/2003 on Traceability and 
Labelling are also guided under the Precautionary Principle. The Article 1 of Directive 2001/18 
on the Deliberate Release of GMOs stated “in accordance with the Precautionary Principle”50 
and Article 4 also stated “…Member States shall, in accordance with the precautionary 
principle, ensure that all appropriate measures are taken to avoid adverse effects on human 
health and the environment which might arise from the deliberate release or placing on the 
market of GMOs.”51 
 
It was pointed out by Michael Cardwell that the application of the Precautionary Principle in the 
Directive 2001/18 could be seen as an illustration of the Communication on the Precautionary 
Principle52 which released in the year of 2000.53 He summarized it as “…establishing a 
common understanding of the factors which would justify the invocation of the precautionary 
principle and of establishing guidelines for its application based on reasoned and coherent 
principles.”54 In addition, the Communication also suggested that the Precautionary Principle 
should play a fundamental role in regulating the food law in the EU.55  
 
                                                 
47  Regulation No.178/2002 of  the European Parliament and of  the Council of 28  January 2002  Laying Down  the General 
Principles and Requirements of Food Law, Establishing the European Food Safety Authority and Laying Down Procedures in 
Matters of Food Safety, [2002] OJ L 31/1. Article 7(1) 
48  Marine Friant‐Perrot, p.81 
49  in respect of ‘safeguard clauses’, EU directives and regulations often contain safeguard clauses, allowing Member States 
to  take action  to  respond  to problems emerging after authorization. The  safeguard  clasues used  in  the  field of GMOs  is 
headed in the Deliberate Release Directive and will be discussed in the next section. 
50  Directive 2001/18 Article 1. 
51  Ibid. Article 4 
52  Commission of  the European Communities, Communication From  the Commission on  the Precautionary Principle COM 
(2000) 1 Brussels, 2000 
53  Michael Cardwell,p.146 
54  Ibid. 
55  Ibid. 
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3.3.2 The EU legislation for the contained use of GMOs  
Under the process approach of the EU, there is a horizontal approach applied to the contained 
use of GMOs and deliberate release the GMOs into the environmental, which means all types 
of GMOs are covered and regulated by two EU directives at their contained use and deliberate 
release stage. The contained use of GMOs is regulated by the Contained Use Directive 
(Directive 2009/41) while the deliberate use of GMOs is governed under the Deliberate 
Release Directive (Directive 2001/18).56 
 
The risks exist in each stage related to the operation of GMOs from the laboratory research to 
use of transgenic technology in food production. One of major risks concerns policy makers is 
that “micro-organisms, if released into the environment in one Member State in the course of 
their contained use, may reproduce and spread, crossing national frontiers and thereby affecting 
other Member States.”57 Therefore the Directive on the contained use of GMOs is the first 
barrier provided by the EU regulatory framework regarding to the GMOs safety and to prohibit 
or minimize the chance of risk happening. 
 
The origin of regulating the contained use of GMOs was the Directive 90/21958 on the 
contained use of genetically modified micro-organisms which was subsequently amended by 
Directive 98/8159 in 1998. The current concept of contained use of GMOs is defined in the 
Article 2(c) of Directive 2009/41, as “any activity in which micro-organisms are genetically 
modified or in which such GMMs are cultured, stored, used, transported, destroyed, disposed of 
or used in any other way, and for which specific containment measures are used to limit their 
contact with, and to provide a high level of safety for, the general population and the 
environment.”60 
 
                                                 
56  See note 33,p144 
57  Directive 2009/41/EC of the European Parliament and of the Council of 6 May 2009 on the contained use of genetically 
modified micro‐organisms [2009] OJ L125/75 Preamble (17) 
58  Council Directive 90/219/EEC 
59  Directive  98/81/EC  of  26 October  1998  amending Directive  90/219/EEC  on  the  contained  use  of  genetically modified 
micro‐organisms[1998] OJ L330/13 
60  Directive 2009/41/EC, Article 2(c) 
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The Directive 2009/41 provided detailed requirements and procedures for proceeding the risk 
assessments on contained use of genetically modified micro-organisms which in the contained 
use facilities, for example, the laboratories or greenhouses, based on the perceived level of 
hazards of the genetically modified micro-organisms.61  
 
Specifically, at the first stage of preventing the possible adverse impact of contained used of 
GMOs to human health and the environment, it is compulsory for the user to proceed the risk 
assessment.62 This procedure of the assessment needs be recorded and kept in file and sent to 
the competent authority in an appropriate form as a part of the notification procedure or by 
request.63 The risk level of the genetically modified micro-organisms will be divided into 4 
classifications based result of the risk assessment. The 4 classifications a respectively are: Class 
1—activities of no or negligible risk; Class 2—activities of low risk; Class 3—activities of 
moderate risk; and Class 4—activities of high risk.64 Furthermore, the Annex IV explicitly lays 
down the different purposed for utilization of genetically modified micro-organisms in 
difference risk classification could imposed on.65 
 
In addition, according to the Directive 2009/41, the unit or person who carries out the 
genetically modified micro-organisms research for the first time, need to notify the competent 
authority in advance by submitting a formal notification or application.66 The competent 
authority will process the application differently depending on the classification of the 
genetically modified micro-organisms use belongs to. Specifically speaking, for the research on 
the Class 1 genetically modified micro-organisms, the unit or person only need to submit a 
summary of the risk assessment. Neither the prior consent from the competent authority nor the 
further notification of the research process is necessary.67 As the risk of the use of genetically 
modified micro-organisms increase, the requirement and procedure of notification becomes 
                                                 
61  Marine Friant‐Perrot, p.82 
62  Directive 2009/41/EC. Article 4 (2) 
63  ibid. Article 4 (6) 
64  ibid. Article 4 (3) 
65  ibid. Annex IV 
66  Ibid. Article 6. 
67  Ibid. Article 7 and Annex V, Part A. 
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more complex and strict accordingly.68 The strictest requirement and management applies to 
Class 3 and Class 4 uses of GM micro-organisms. According to the Article 17, each Member 
State is required to submit an annual summary report to the European Commission on the 
research programmes carried out on Class 3 and Class 4 use of genetically modified 
micro-organisms and in every three years, Member States should also submit a summary report 
on their experience with the Directive.69  
 
Therefore, the European Union establishes its safety management procedure on the contained 
use of GMOs in the research facilities. Since the research activity of the contained used of 
GMOs is carried out in the laboratory and the risks are considered as controllable, the approval 
procedure relatively simplified compare to the authorization regime applied to the deliberate 
release of GMOs into the environment. 70  The following section will study on the EU 
approaches on managing the deliberate release of GMOs. 
 
3.3.3 The deliberate release of GMOs into the environment 
 
The Council Directive 90/220/EC was the first directive on the deliberate release of GMOs in 
the EU and was replaced by the Directive 2001/18/EC on deliberate release of GMOs (hereafter, 
the Deliberate Release Directive) which was considered as more ‘rigorous’ and 
‘comprehensive’.71 Based on the Precautionary Principle, the Deliberate Release Directive 
requires an environmental risk assessment of GMOs to be proceeded before the application for 
authorization. The explicit reference to the precautionary principle is one of the major changes 
in this new directive. The Precautionary Principle was invoked in the Article 1 of the Deliberate 
Release Directive: 
 
“…[i]n accordance with the precautionary principle, the objective of this Directive is to 
                                                 
68  Marine Friant‐Perrot, p.83 
69  Directive 2009/41/EC. Article 17 (1)(2)(3) 
70  Marine Friant‐Perrot, P83 
71  Michael Cardwell, p.286 
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approximate the laws, regulations and administrative provisions of the Member States and 
to protect human health and the environment.”72  
 
The precautionary principle implies that absence of full scientific proof of harm cannot be used 
to obstruct measures intended to prevent harm.73 It could be disputable of the way to interpret 
this in real situations, yet in the Deliberate Release Directive, the precautionary approach is 
interpreted in the case-by-case approach stated in Article 4: 
 
‘Member States and where appropriate the Commission shall ensure that potential adverse 
effects on human health and the environment, which may occur directly or indirectly 
through gene transfer from GMOs to other organisms, are accurately assessed on a 
case-by-case basis. This assessment shall be conducted in accordance with Annex II taking 
into account the environmental impact according to the nature of the organism introduced 
and the receiving environment.’74 
 
Moreover, this Deliberate Release Directive sets up a new administrative management regime 
for both the deliberate release GMOs into the environment and the placing GMOs on the market, 
as it is stated at Preamble: “no GMOs, as or in products, intended for deliberate release are to be 
considered for placing on the market without first having been subjected to satisfactory field 
testing at the research and development stage in ecosystems which could be affected by their 
use.”75 The two subjects should both follow the step-by-step procedure yet the procedure 
provided to two subjects are different and respectively stated in the Part B and Part C of the 
Directive.76 It also requires each Member State of the European Union to establish appropriate 
measures on coexistence on the national level to prevent accidental presence of GMOs in other 
crops and products.77 
                                                 
72  Directive 2001/18/EC Article 1   
73  1992 Rio Declaration, Principle 15 
74  Directive 2001/18/EC Article 4 
75  Directive 2001/18/EC Preamble 25 
76  Michael Cardwell, p.145 
77   Christopher  Rodgers,  ‘DEFRA's  Coexistence  Proposals  for  GM  Crops:  A  Recipe  for  Confrontation?’(2008)  10  (1) 
Environmental Law Review 1 p1 
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In Part B of the directive there are articles about the deliberate release of GMOs for any purpose 
other than for placing on the market, and it extends beyond just research and development. This 
part covers experimental release, namely field trails, of GMOs which are used in order to study 
their performance, behaviour and interaction with outside environmental factors before 
applying for a market release of GMOs. The Part B also set out an authorization procedure 
specifically for the transgenic varieties of maize, oilseed rape, and potatoes.78 
 
The authorization procedure will be started by the submission of a notification by the applicate 
which should include the technical information indicated in Annex III of the Deliberate Release 
Directive and an environmental risk assessment report to the competent authority of the 
Member State. According to the Annex III, the technical information should cover interactions 
between the GMOs and the environment, and plans for monitoring, control, waste treatment, 
and emergency.79 The competent authorities must make a reply either to authorize or reject the 
application within 90 days after examine the application.80 The result of risk assessment 
submitted by the applicate must clearly states any risk to human health or the environment to 
the competent authority.81 In accordance to the Precautionary Principle, in case that there are 
any modifications or unintended changes of the GMOs which could have adverse consequences 
and risks to human health and the environment or new information and scientific knowledge 
becomes available on certain risks, the applicate must, the applicate should immediately 
measure those risks and revise the measures, even the notification has been examined by the 
competent authority of a Member State or has received the written consent for that authority.82 
In addition, Member States must make the information of all Part B releases in their territory 
available to the public, also the European Commission is responsible to inform the public about 
the information contained in the system of exchange.83 Therefore, the Member States are 
                                                 
78  Marine Friant‐Perrot, P83 
79  Ibid. In particular, Annex IIIA, paras IV and V 
80  In  the  stage of examining,  the  consideration of  any observations  from other Member  States  should  also be  included 
under the exchange of information procedure established by the Article 11. See Directive 2001/18/EC Article 11 and Article 
6(5) 
81  Ibid. Article 10 
82  Ibid. Article 8 
83  Ibid. Article 9 and 11 
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conferred more considerable powers under the Part B of the Deliberate Release Directive in 
order to enhance the environmental protection in the territory of the Union. 
 
Part C generally covers articles for marketing authorizations of GMOs to be used on a 
commercial scale but also GMOs that are imported from non-EU countries and that will be used 
in the food or feed industries. Part C provides a procedure at the Community level for 
authorization of GMOs.84 As Macmaoláin pointed out that, “it is clear from the outset that 
Directive 2001/18 is largely moulded by a vastly increased consideration for consumer 
concerns, an input that was largely missing from the provisions of Directive 1990/220.”85 
Furthermore, the Part C constitutes the a most rigorous administrated procedural stage with 
preventive approaches to the application of the GMOs to be placed on the markets and public 
participation system with high degree.86  
 
There are several amendments and improvements between the Directive 90/220 and the current 
Deliberate Release Directive. First of all, the most significant amendment might be the object of 
the risk assessment is expanded by the new Directive.87 According to the Annex II of the 
Directive, the formerly stated “potential harmful effects” is expanded to include “indirect 
effects” and “delayed effects”.88 Therefore, the reasonable consideration on the risks and 
consequences to the economy and society brought by the deliberate release of GMOs into the 
environment need to be include to the risk assessment.89 Specifically, the “indirect effects” 
means “effects on human health or the environment occurring through a causal chain of events, 
through mechanisms such as interaction with other organisms transfer of genetic material, or 
changes in use or management”; and “delayed effects” is explained as “effects on human health 
or the environmental which may not be observed during the period of release of the GMO, but 
become apparent as a direct or indirect effect either at a later stage or after the termination of the 
                                                 
84  Marine Friant‐Perrot, p.85 
85  C Macmaoláin, EU Food Law: Protecting Consumers and Health in a Common Market (Hart Publishing 2007) p.246 
86  Marine Friant‐Perrot, p.85 
87  Michael Cardwell, p.147 
88  Directive 2001/18/EC Annex II 
89  Michael Cardwell, p.147 
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release”.90 Secondly, the Deliberate Release Directive requires the notifier to submit the 
monitoring reports and any new information on risks to the competent authorities of the 
Member State and the European Commission.91 Under the transparency policy, the competent 
authorities of the Member State and the European Commission must make sure that the results 
of the monitoring to be available to the public,92 while under the precautionary principle, the 
notifier must immediately take the protective measures and report to the competent authority, 
with further provisions for onward circulation of this information to the European Commission 
if there is any new information emerges which could have adverse effects to the environment 
and human health.93 
 
Another significant amendment is that the Deliberate Release Directive strengthened the 
requirements relating to the approval procedure of placing imported GMOs products on the 
market. To be specific, in case of a GMO product is to be placed on the market for the first time, 
any importer or manufacture who intends to place an imported GMO on the European Union 
market must submit a notification to the competent authority of the Member State.94 Within 90 
days of the notification, the competent authority must prepare an assessment report which 
indicates whether or not the GMO in question should be placed on the market. 95  The 
assessment report must be then sent to the European Commission and to be forwarded to other 
competent authorities of Member States. If the prepared report prepared by the competent 
authority indicates to place the GMO on the market, the European Commission and other 
Member States have a period of 60 days to make reasoned objections; otherwise, the 
manufacture and importer will obtain a consent with a maximum duration of 10 years.96 This 
10-years consent was firstly proposed by the Deliberate Release Directive, 97 and the consent 
could be renewed after the first 10-years consent expires. The renewed consent should not 
exceed 10 years term in general and in specific cases it could be shortened or extended 
                                                 
90  Directive 2001/18/EC Annex II 
91  Directive 2001/18/EC, Article 20 
92  Ibid. Article 20(4) 
93  Ibid, Article 20 
94  Ibid, Article 13(1) 
95  Ibid. Article 14(3) 
96  Ibid. Article 15 
97  Michael Cardwell, p.147 
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accordingly.98  
 
In summary, release applications received are of two types depending on their intended purpose. 
Applications under Part B of the Deliberate Release Directive, for research and development 
trials, are submitted within the Member State and consent is given at a national level. 
Applications under Part C are for placing a GMO on the European Union market. Part C 
applications are initially assessed by one (lead) Member State in Europe which then forwards a 
summary to the Commission and other Member States for assessment.  
 
To illustrate how this procedure works, let us take the Advisory Committee on Release to the 
Environment (ACRE) of the UK as an example. The ACRE is an advisory non-departmental 
public body composed of leading scientists, sponsored by the Department for Environment, 
Food & Rural Affairs. The Department for Environment, Food & Rural Affairs (Defra) is 
responsible for the control of the deliberate release of genetically modified agricultural 
products and for national, EU and international policy on the environmental safety of such 
products.99 Defra is the competent authority that implements and enforces the Deliberate 
Release Directive. Defra provides the secretariat for the Advisory Committee on Releases to the 
Environment (ACRE).  
 
The ACRE undertakes critical reviews of applications to release GMOs under the UK and 
European regulatory framework. The main function of ACRE is to give advice to ministers on 
the risks to human health and the environment from the release of GMOs and on the release of 
certain non-GM species of plants and animals that are not native to Great Britain. If government 
grants consent, the committee will also look at any monitoring outcomes and make further 
assessments if required. To be more specific, the responsibilities of the ACRE are providing 
advice to government on: issuing consents to release or market GMOs; limitations of consents 
issued, limitations of consents issued, including monitoring and any amendments needed; 
                                                 
98  Directive 2001/18/EC Article 17(6) 
99   For  further  and  the  latest  information,  please  see  the  official  website  of  ACRE  < 
https://www.gov.uk/government/organisations/advisory‐committee‐on‐releases‐to‐the‐environment>,  last  accessed  on 
August 7, 2018 
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issuing feed and costs of enforcing consents; evaluating new research findings and any 
science-based GM matter; research into risks of GMOs; releasing non-native animals and 
plants into the environment and regulations for releasing and marketing of GMOs.100 In 
reviewing applications, the ACRE gives advice on whether or not the proposed release 
activities of the application present a significant risk to human health and the environment. The 
ACRE particularly pays attention to the environmental risk assessment and any risk 
management and monitoring conditions attached to proposed releases. If these are not sufficient, 
we indicate what is required to ensure adequate risk management. Further information or 
clarification on particular points is often requested from applicants.101 
 
In the situation that there is an objection raised by a competent authority of Member State or the 
Commission as regarding the risks of GMOs to human health or to the environment, the 
Commission should consult with the relevant Scientific Committee(s)102 which is composed of 
representatives of the Member States. After the official consultation, the Commission will 
subsequently submit a draft decision to a Scientific Committee. The procedure for the 
objections to the placing GMOs and the GMOs products which need to carried out by the 
Community is provided in the Articles 18 and 30(2).103  
 
Thirdly, the Article 23(1), headed ‘Safeguard clause’, of the Deliberate Release Directive 
provides that:  
 
“Where a Member State, as a result of new or additional information made available 
since the date of the consent and affecting the environmental risk assessment or 
reassessment of existing information on the basis of new or additional scientific 
                                                 
100   Source  https://www.gov.uk/government/organisations/advisory‐committee‐on‐releases‐to‐the‐environment  last 
accessed in May 2017 
101   The  Advisory  Committee  on  Release  to  the  Environment  Annual  Report  2015  < 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/561272/acre‐annual‐report‐2015.pdf>  p14 
last accessed in May 2017 
102  Directive 2001/18/EC Preambles(53), ‘Provision should be made for consultation of the relevant Scientific Committee(s) 
established by Commission Decision 97/579/EC(7) on matters which are likely to have an impact on human health and/or the 
environment’; 97/579/EC Commission Decision of 23  July 1997  setting up Scientific Committees  in  the  field of  consumer 
health and food safety ; Directive 2001/18/EC, Article 15 
103  ibid Article 18, 30(2) 
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knowledge, has detailed grounds for considering that a GMO as or in a product which 
has been properly notified and has received written consent under this Directive 
constitutes a risk to human health or the environment, that Member State may 
provisionally restrict or prohibit the use and/or sale of that GMO as or in a product on its 
territory.”104  
 
Therefore, the safeguard clause of the authorized consent was limited to the Member States 
regarding to the new available information emerging in relation to the risks to public health and 
the environment. Even if the Commission has granted the authorized consent to a GMO product 
which has been properly notified, any individual Member State still has the right to temporarily 
prohibited, restrict or impede this GMO product in its territory based on the reasonable 
consideration according to the safeguard clause.105 However, at the meantime Article 23 states 
that “Member States may not prohibit, restrict or impede the placing on the market of GMOs, as 
or in products, which comply with the requirements of this Directive”.106 If such a decision 
made by an individual Member State, it must immediately inform the Commission and the 
Commission will make a final decision of whether to continue to permit this prohibition.107 As 
Michael Cardwell summarized that the consequences of establishing the new procedure does 
not only improve the information collected by the European Parliament, it rather seemed to 
address concerns at the powerful decision-making role of the European Commission which was 
expressed in the case of Association Greenpeace France v. Minitère de l’Agriculture et de la 
Pêche108. 
 
Finally, the Deliberate Release Directive provided tightened labelling requirements. According 
to the Deliberate Release Directive, all GMOs placed on the market as or in products must be 
properly labelled. To be specific, Article 12(2) provides that the notification should contain a 
proposal for labelling which complied with the detailed standard stated in Annex IV. The 
                                                 
104  Ibid, Article 23 
105  Raymond O’Rourke, European Food Law (3rd end, Sweet&Maxwell 2005) p.178; see also Directive 2001/18/EC Article 23 
106  Directive 2001/18/EC Article 23 
107  Ibid. 
108  Michael Cardwell, p.147; Case C‐6/99 Association Greenpeace France v. Minitère de  l’Agriculture et de  la Pêche  [2000] 
ECR I‐1651 
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Directive also requires that “the words ‘his product contains genetically modified organisms’ 
shall appear either on the label or in an accompanying document”.109 This clause could be seen 
as an interim step for the later regulation regarding to the labelling requirement. The later 
Regulation 1830/2003 concerning traceability and labelling of GMOs and traceability of food 
and feed products from GMOs has fully developed and improved the labelling management. In 
addition, the Regulation 1830/2003 made an exception to the labelling requirement by 
providing minimal threshold approach which exempt the labelling of products with GMO 
ingredients lower than 0.9 percent110 in the case of adventitious or technically unavoidable 
traces of authorized GMOs. The products which fit the requirement could be placed on the 
market without labelling.111 More detailed regulations on GMOs labelling will be discussed 
later in this chapter. 
 
It is out of doubt that the Deliberate Release Directive greatly augmented the regulatory 
framework for GMOs in the EU. The Commissioner Byrne appraised the Deliberate Release 
Directive as “…an important point of departure’ to be complemented by “a legislative 
package”.112 Therefore, the horizontal approach took by the EU in accordance with its process 
approach governs contained use and deliberate release of GMOs is completed by the Contained 
Use Directive and the Deliberate Release Directive. The authorization procedure and 
management regime of the GMOs foods and feeds are not provided in specific by the Deliberate 
Release Directive,113 the full legislative package is completed by the Regulation 1829/2003 on 
Genetically Modified Food and Feed and the Regulation 1830/2003 on Traceability and 
Labelling. 
3.4 The Regulation on GM Food and Feed 
In order to protect consumer safety and facilitate customers’ choice, the EU legislature 
established a regulatory framework specifically for GM food and feed which places heavy 
                                                 
109  Directive 2001/18/EC.Article 12 
110  Ibid, Article 21(3), as amended by Regulation 1830/2003 
111  Ibid, Article 21 
112  MEMO/01/42, Commission Welcomes the Adopting of New Rules for GMOs, Brussels, 16 February 2001 
113  Marine Friant‐Perrot, p.87 
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administrative burdens on both food business operators who deal with GM foods and those who 
do not.114  
 
The first regulation on GMOs in human food and animal feed was the Council Directive 
90/220.115 In order to specifically govern the use of GMOs in food production, the Regulation 
258/97 of the European Parliament and of the Council concerning novel foods and novel food 
ingredients116 was enacted in 1997. Subsequently, the European Commission White Paper on 
Food Safety was issued one proposal of it suggested the regulatory framework should adopt 
legislations on risk assessment, authorization, and labelling regarding to the novel foods with 
particular reference to GM food and feed and to enhance the authorization procedure provided 
by the Regulation 258/97.117 Therefore two new regulations which were the Food and Feed 
Regulation and Regulation 1830/2003 on traceability and labelling were issued in 2003.  
 
The Regulation on Food and Feed and the Regulation 1830/2003 on labelling and traceability 
together with the Deliberate Release Directive have contributed to the regulatory framework of 
the European Union in two main aspects: firstly, a single authorization procedure is provided 
and secondly the traceability and labelling regime is strengthened. The year of 2003 could be 
seen as the milestone of the development on regulating the use of GMOs in food and feed 
production. Thus, the pre-2003 legislative framework and post-2003 legislative framework will 
be studied separately below.  
 
3.4.1 The legislative framework before 2003 
The Regulation (EU) No. 258/97 concerning novel foods and novel foods ingredients regulates 
                                                 
114  Bernd van der Meulen, p.153; 
115  Directive 90/220/EEC on the deliberate release into the environment of genetically modified organisms 
116  Regulation No. 258/97 of the European Parliament and of the Council of 27 January 1997 Concerning Novel Foods and 
Novel Food Ingredients [1997] OJ L 43/1; please note that the Regulation (EC) 258/97 has now been repealed by Regulation 
(EU) 2015/2283 of the European Parliament and of the Council of 25 November 2015 on novel foods, amending Regulation 
(EU)  1169/2011  of  the  European  Parliament  and  of  the  Council  and  repealing  Regulation  (EC)  258/97  of  the  European 
Parliament and of the Council and Commission Regulation (EC) No. 1852/2011 [2015] OJ L327/1 
117  European Commission, White Paper on Food Safety COM(1999) 719 final, Brussels 12 January 2000. Annex—Action Plan 
on Food Safety: Actions 6,50,51 and 52 
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the GM food while GM feed was partially regulated under the Deliberate Release Directive 
before the year of 2003. GM food and feed will be discussed separately in the following 
sections. 
 
Within the meaning of GMOs indicated by Directive 90/220/EC,118 the Regulation (EC) 
No.258/97 divided the GM food into two categories. The first category covers food, and food 
ingredients products from, but no longer containing GMOs; and the second category covers 
food and food ingredients containing or consisting of GMOs. Generally speaking, food 
containing GMOs or food produced from GMOs had to fulfill the requirements for all novel 
foods, which required not present any danger to the consumers; not mislead the consumers; 
furthermore, the GMO products shall not be differed from the products they intend to replaced, 
they should be substantially equivalent regarding to the nutrition of the products.119 
 
There are different authorization procedures applied to the two categories of GM food. Two 
possible approaches were provided in the case of food produced from, but not containing 
GMOs. The first approach is that, under Regulation (EC) No 258/97, the applicant could notify 
the European Commission of the placing on the market of the product while the product was 
substantially equivalent to its traditional counterpart120, then the European Commission was 
responsible to forward the notification to Member States within 60 days.121 The substantial 
equivalence could be established based on either generally recognised scientific evidence and 
existing scientific knowledge, or on an opinion provided by food assessment institute of a 
Member State122. Secondly, the applicant had to submit a request to the competent authority of 
the Member State in which the product was to be placed on the market and also the applicant 
needed to forward a copy of this request to the European Commission. This was also the 
approach to foods and food ingredients which contain GMOs. In the request, information which 
                                                 
118  According  to Directive 90/220/EC,  “a  'genetically modified organism  (GMO)' means an organism  in which  the genetic 
material has been altered in a way that does not occur naturally by mating and/or natural recombination”. 
119  Regulation (EC) 258/97, Article 3. 
120  Ibid, Article 3(2).  Equivalence of  the novel  food  in  comparison  to  its  tradition  counterpart  in  terms of:  composition, 
nutritional value, metabolism, intended use, level of undesirable substances contained. 
121  Ibid, Article 5. 
122  Regulation (EC) 258/97, Article 3(4). 
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demonstrate the product had fulfilled the general criteria had to be included. The general 
criteria requested the products shall not present a danger to the consumer; mislead the consumer; 
or, differ from foods or ingredients it intended to replace to the extent that normal consumption 
would be nutritionally disadvantageous for the consumer.123 
 
The submitted notification shall also conclude a summary of detailed labelling rules and 
complete file of information. After receiving the request from the notifier, the Member State 
shall ensure a risk assessment to be carried out. It could be done by its competent food 
assessment institute which needed to be informed to the European Commission, or the Member 
State could ask the European Commission to designate a competent body of another Member 
State to carry out the assessment. The responsibility of the European Commission was to 
provide necessary recommendations from the scientific perspective in order to support the 
application and preparation of the risk assessment report.124 
 
There was a period of three months for the initial risk assessment report to be completed. The 
report had to indicate whether an additional assessment would be necessary.125 Then the report 
would be sent to other Member States through the European. Each Member State had the right 
to make comments or objection on the report within 60 days and the comments or objections 
would be circulated to other Member States within this period.126 
 
After completing the above procedure, if there was no additional assessment was required and 
no objections from the Member States were received, the applicant would be informed and 
receive the consent that the product could be placed on the market. In case that the addition 
assessment was considered as necessary or any Member State objected the proposal, a further 
authorization decision would be necessary. Under this situation, the Standing Committee for 
                                                 
123  Ibid, Article 3(1) 
124  Commission Recommendation of 29  July 1997  concerning  the  scientific  aspects  and  the presentation of  information 
necessary  to  support  applications  for  the  placing  on  the  market  of  novel  foods  and  novel  food  ingredients  and  the 
preparation of  initial assessment reports under Regulation  (EC) No 258/97 of  the European Parliament and of  the Council 
(Text with EEA relevance) (97/618/EC) [1997] OJ L253/1 
125  Regulation(EC) 258/97, Article 6 
126  Regulation (EC) 258/97, Article 5. 
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Foodstuffs was designed to make the further authorization decision. If no opinion was reached 
by the Standing Committee for Foodstuff, the European Council would make an authorization 
decision. The scope pf the authorization needed to be defined in the authorization decision, and 
the should establish: “1) the conditions of use of the food or ingredient; 2) the designation of the 
food or ingredient and its specification; and, 3) any specific labelling requirements.”127 
Moreover, the authorization decision should also in accordance to the environmental safety 
requirements for GMOs which provided in Article 10 of Directive 90/220. The applicant would 
then be informed by the European Commission of the result. Throughout the process, the 
European Commission had to consult with the Scientific Committee on Foodstuffs regarding to 
any matter which could possibly bring adverse impact to human health.128 
 
According to the labelling requirements, the labels of the GMO product shall indicate the 
presence of a GM organism and any characteristic which caused the product no longer 
equivalent to its counterpart product, for example the composition, nutritional value or effects 
and use of the food. The notification and method must be indicated in the label in the case of 
such a change in characteristics.129 
 
Regulation (EC) No 49/2000130 provided a labelling threshold of 1% for adventitious presence 
of GMOs in the product, while Regulation (EC) No 50/2000131 extended the labelling scope to 
include additives and flavourings containing GMOs. 
 
The Deliberate Release Directive replaced the Directive 90/220 and regulate all the activities 
related to the placing products containing or consisting of GMOs on the market. The Deliberate 
Release Directive does not provide provisions specifically for GM feed therefore the GM feed 
                                                 
127  Ibid, Article 7. 
128  Ibid, Article 11. 
129  Ibid, Article 8. 
130  Commission Regulation (EC) No 49/2000 of 10 January 2000 amending Council Regulation (EC) No 1139/98 concerning 
the compulsory indication on the labelling of certain foodstuffs produced from genetically modified organisms of particulars 
other than those provided for in Directive 79/112/EEC [2000] OJ L6/13 
131  Commission  Regulation  (EC)  No  50/2000  of  10  January  2000  on  the  labelling  of  foodstuffs  and  food  ingredients 
containing additives and flavourings that have been genetically modified or have been produced from genetically modified 
organisms [2000] OJ L6/15 
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was only partially regulated under the Directive. To be specific, if the GMOs are used directly 
as animal feed they are covered under the Directive and the Directive is applicable to all GMOs; 
while the animal feed which are proceed from GMO product are not regulated by the Deliberate 
Release Directive. Before 2003, the specialized authorization procedure for GM feed was 
absent.132 
 
Moreover, a general notification procedure for GMOs being placed on the market has been 
establish the Deliberate Release Directive. According to the Article 13, the notification must 
attached with a list of documents including: 1) information required in Annexes III and IV of 
the Directive; 2) the environmental risk assessment and report; 3) conditions for the placing on 
the market of the GMO; 4) a proposed period for consent which shall not be exceed 10 years; 5) 
a monitoring plan; 6) a labelling proposal which must comply with labelling requirements; 7) a 
proposal of packaging; and, (8) a summary of the complete dossier.133 This notification must be 
submitted to the competent authority of the Member State where the GMO is about to be placed 
on the market for the first time. 
 
Within 90 days after receiving the notification, the competent authority must prepare an 
assessment report indicating a permission or objection on placing the GMOs in question on the 
market. The assessment report will be sent to other Member States and the European 
Commission; and other Member State and the European Commission have 60 days to make 
comments or objections. In case of outstanding issues, there was a period of 105 days permitted 
to resolve the issues.134 
 
3.4.2 The legislative framework after 2003 
As it has been discussed above, before the year of 2003 GM food products were generally 
                                                 
132  European Commission Evaluation of the EU legislative framework in the field of GM food and feed (2010) DG SANCO 
Evaluation Framework Contract Lot3 (Food Chain) p. 8 
<https://ec.europa.eu/food/sites/food/files/plant/docs/gmo_rep‐stud_2010_report_eval‐gm.pdf > last accessed in May 
2017 
133  Ibid. Art. 13(2). 
134  Ibid. Art. 14(2). 
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regulated as novel foods under Regulation No 258/97. There was no specific authorisation 
procedure provided for GM animal feeds except the GMOs which directly used as animal feed 
were covered under the Deliberate Release Directive 2001/18/EC since the Directive is 
applicable to all GMOs. In order to achieve the ultimate goal of high level of protection of the 
public health and welfare, the environment and customers’ benefits in relation to GM foods and 
feeds as well as the effective function of the internal market, 135  two regulations were 
formulated and enacted to specifically deal with the GM foods and feeds in 2003. The first of 
these, Regulation 1829/2003136 (also known as the Food and Feed Regulation) provides the 
general framework for GM food and feed regulations, while the second legislation is the 
Regulation 1830/2003 (hereafter referred as the Labelling and Traceability Regulation), 
regulates traceability and labelling137. These two regulations replaced and expended the GM 
provisions laid out in Regulation 258/1997 with the main objectives to achieve higher levels of 
protection of human and animal health; to encourage the free movement of feed and food in the 
internal market; and to eliminate differences between authorities in the assessment of GM food 
and feed to prevent distorted competition.138  
 
In general, the Food and Feed Regulation introduced a centralized risk assessment procedure 
which is arranged by European Food Safety Authority (EFSA), rather than individual Member 
States; and it operates together with the Labelling and Traceability Regulation which regulates 
the traceability and labelling of products containing GMOs and their products. The Food and 
Feed Regulation identifies two categories of GMO products. The first one is GM food and food 
which contains or consists of GMOs, food produced from or containing ingredients which 
produced from GMOs and GMOs for food use)139; the second category is GM feed and GMOs 
feed use, feed containing or consisting of GMOs, feed produced from GMOs and GMOs for 
                                                 
135  Regulation (EC) 1829/2003, preamble (3). 
136  Regulation  (EC) No  1829/2003  of  the  European  Parliament  and  of  the  Council  of  22  September  2003  on  genetically 
modified food and feed (Text with EEA relevance) [2003] OJ L268/1 
137  Regulation  (EC) No 1830/2003 of  the European Parliament and of  the Council of 22 September 2003  concerning  the 
traceability and  labelling of genetically modified organisms and the traceability of  food and  feed products produced  from 
genetically modified organisms and amending Directive 2001/18/EC 
138  Regulation (EC) 1829/2003, Article 1. 
139  Ibid, Article 3. 
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feed use140. In addition, in accordance with previous legislation, GM food has to be examined 
as safe, not misleading and must not be different from its counterpart origin products to the 
extent that their normal consumption would be disadvantageous to the consumer.141 The GM 
feed is regulated under the same principles. Regarding to the environmental safety, products 
containing or consisting of GMOs have to be in accordance with the requirements of Deliberate 
Release Directive. 
 
3.4.3 The risk assessment 
The regulatory approvals process and risk assessment for GM food and feed comprise a number 
of steps. An application for authorising a GMO for food or feed uses must be submitted to a 
national authority. The application under the Food and Feed Regulation must also comply with 
the requirements set out in Commission Implementing Regulation 503/2013 on applications for 
authorisation of genetically modified food and feed.142 It must include: purpose and scope; all 
relevant data, studies and analysis of the results; monitoring plan; labelling proposal; detection 
method; and, indication of confidential information. The national authority acknowledges 
receipt of the application within 14 days. It then sends the application to the EFSA for a risk 
assessment. EFSA makes the application summary available to the public.143  
 
The EFSA core task is to independently assess any possible risks of GM plants to human beings 
and animal health and the environment. EFSA does not authorize GM products; its role is 
limited to giving scientific advice. EFSA’s panel provides independent scientific advice on the 
safety of GM plants on the basis of Deliberate Release Directive and derived food or feed on the 
basis of Food and Feed Regulation. There is a guidance document published by the EFSA and 
its Panel to provide guidance for the preparation and presentation of applications submitted 
                                                 
140  Ibid, Article 15 
141  Ibid, Article 4 
142  Commission Implementing Regulation (EU) No 503/2013 of 3 April 2013 on applications for authorisation of genetically 
modified  food and  feed  in accordance with Regulation  (EC) No 1829/2003 of the European Parliament and of the Council 
and amending Commission Regulations (EC) No 641/2004 and (EC) No 1981/2006 (1) 
143  If  the  application  also  covers  cultivation,  EFSA delegates  the environmental  risk  assessment  to  an  EU Member  State 
which sends EFSA its Environmental Risk Assessment (ERA) report. 
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within the framework of the Food and Feed Regulation and the Deliberate Release Directive. 
This document therefore covers the full risk assessment of GM plants and derived food and 
feed.144  
 
According to the Food and Feed Regulation, GM food and feed can only be placed on the 
market after the authorisation. To obtain the authorization, an application must be sent to a 
competent authority of the Member State which the applicants choose, the application should 
generally include the following documents: 1) name and address of the applicant; 2) the 
designation of the food and its specification (including events used); 3) information to 
demonstrate compliance with Annex I of the Cartagena Protocol; 4) a detailed description of the 
method of production and manufacturing; 5) copies of studies which demonstrate safety, that 
the product does not mislead the consumer and does not differ from food it is intended to 
replace; 6) either analysis supported by data to show that the characteristics of the product are 
not different from its non-GM counterpart, or a proposal for labelling; 7) either a reasoned 
statement that the food does not give rise to any ethical or religious concerns, or a suitable 
proposal for labelling; 8) the conditions for placing the product on the market; 9) methods for 
the detection, sampling and identification of the GM event; 10) positive and negative control 
samples of the food to be used for control purposes, plus information as to where the reference 
material can be accessed; 11) a proposal for post-market monitoring regarding the use of the 
food for human consumption (where appropriate); 12) a summary of the dossier.145 In case of 
the GMOs and food containing or consisting of GMOs, the following documents should also be 
submitted accompanied to the application: a complete technical dossier related to the release 
into the environment of GMOs (as laid down in Annexes III and IV of the Deliberate Release 
Directive); and a monitoring plan for environmental effects (as provided in Annex VII of the 
Deliberate Release Directive).146 
 
                                                 
144  EFSA Guidance  document  for  the  risk  assessment  of  genetically modified  plants  and  derived  food  and  feed  by  the 
Scientific Panel on Genetically Modified Organisms (2006) < http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2006.99/epdf> 
last accessed in May 2017 
145  Regulation (EC) No. 1829/2003 Article 5(3) The documents listed here relate to food, those for feed are similar. 
146  Regulation (EC) No. 1829/2003 Art.5(5) 
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The national competent authority must forward the application to EFSA after receiving, and the 
EFSA must forward the application to the European Commission and Member States in turn. 
Within 6 months, the EFSA shall provide an opinion based on the assessment to the 
completeness of the dossier if it is considered as valid.147 The EFSA could reasonably extend 
the time line if the supplementary information which shall be prepared and provided by the 
applicant is considered as necessary.148  
 
The Food and Feed law provided a series of processes for the EFSA to take while it prepares 
the opinion. EFSA should firstly examine whether the submitted documents are in accordance 
with the guidance document provided by the EFSA for the risk assessment of GM plants and 
derived food and feed, and it should fulfill the general requirements for GM food. Secondly, 
during a three-months period, the EFSA shall ask the Member States for their voluntary 
comments on the dossier. Thirdly, the EFSA may designate a food assessment body of a 
Member State to carry out a safety assessment. Following this, the EFSA may ask a competent 
authority of a Member State to provide an environmental risk assessment. In case of the 
applications for GMOs cultivation, this process is compulsory. Moreover, the EFSA must send 
to the relevant community reference laboratories the samples and methods for detection to have 
a further assessment. Finally, the EFSA is obliged to examine the scientific data in order to 
ensure the GMOs food and its conventional non-GM counterpart is characteristically same.149 
 
The final opinion shall in accordance with Articles 6 and Article 18 of the Food and Feed 
Regulation and a number of annexes and it must when complete be sent to the European 
Commission, the Member States and the applicant. In accordance to the public participation, 
the EFSA will publish the opinion on its official website and the specific arrangements for the 
public to comments on will be provided on the European Commission website. The public 
                                                 
147  Ibid, Article 6 
148  European Commission Evaluation of  the EU  legislative  framework  in  the  field of GM  food and  feed  (2010) DG SANCO 
Evaluation  Framework  Contract  Lot3  (Food  Chain)   
<https://ec.europa.eu/food/sites/food/files/plant/docs/gmo_rep‐stud_2010_report_eval‐gm.pdf > p12 last accessed in May 
2017 
149  Regulation (EC) No. 1829/2003 Article 6(3) 
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comments and responses will be collected during a 30-days period.150 Moreover, according to 
the Food and Feed Regulation, the applicant could ask the European Commission to delete the 
confidential information in relation to the intellectual property and personal data from the 
publicly published opinion for appropriate justification, for example, if the data is disclosed to 
the public, the competitivity of the applicant will be seriously harmed.151 
 
3.4.4 The single authorization procedure 
The single authorization procedure is one of the great contributions provided by the Food and 
Feed Regulation. The procedure is applicable to all genetically modified food and feed, 
including the food and feed produced from GMOs and consisting of GMOs.152 The single 
authorization procedure conducted under the so-called ‘one door—one key’ principle at the 
European Union level which is applicable to both the GM food and GM food for industrial 
uses.153 Furthermore, for the GMOs and GM products which are not intended to enter the food 
chain, the applicant can do the application on the basis of Part C of the Deliberate Release 
Directive; for GMOs and GM products are the food uses the application is made on basis of the 
Food and Feed Regulation.154 
 
Before the GM food to be placed on the market, the applicant must submit an application to the 
competent authority of the Member State where the product is expected to be placed on the 
market.155 Once they receive the application, the competent authority at the national level is 
obliged to forward the application together with the supplementary information provided by the 
applicant to the EFSA156. The food and feed must be examined and proved to not have adverse 
effects on human health, animal health, or the environment 157 . The EFSA shall then 
                                                 
150  Ibid, Article 6(6) 
151  Ibid, Article 6(7) 
152  Regulation 1829/2003 Article 3 
153  Bernd van der Meulen, 2007 p142 
154  Marine Friant‐Perrot p.90 
155  Regulation 1829/2003 Article 5 
156  The  required  information being  set out  in Article 5  (3) of  the Food and Feed Regulation  in  the case of GM  food and 
Article 17(3) in the case of GM feed 
157  Regulation 1829/2003 Article 4(1)(a) and 16(1)(a) 
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immediately forward the application and any supplementary information to the European 
Commission and other Member States, and a summary of the application must be made 
available for public comments.158 The Deliberate Release Directive also requires a compulsory 
risk assessment regarding environmental protection.159  
 
The European Commission needs to submit an initial decision to the Standing Committee on 
the Food Chain and Animal Health within three months of receiving the complete opinion 
prepared by the EFSA. This initial decision shall be in accordance with the opinion of EFSA, 
provisions in the EU law and any other legitimate factors. The European Commission shall 
apply an explanation in case the draft decision differs from EFSA’s opinion. The Standing 
Committee on the Food Chain and Animal Health will the prepare an opinion on the initial draft 
of the European Commission indicating whether or not propose the authorisation. The 
European Commission will adopt the draft decision in case that qualified majority in favour is 
achieved; otherwise, the draft decision must be sent to the Council by the European 
Commission and the European Parliament shall be informed. Within three months, the Council 
shall response by qualified majority. If the qualified majority of Council opposes the decision, 
the European Commission could response by resubmitting the original draft decision; 
submitting an amended draft decision; or providing a legislative proposal. In case of no 
qualified majority in favour or object is obtained (including the case where the Council has not 
acted within three months), the decision must be adopted by the European Commission 
according to the Article 5(6) of the comitology decision process160. 
 
After any GMOs food and feed to be placed on the market, the authorization holder should fulfil 
the obligation as one of the condition of the authorization which is to submit the monitoring 
reports to the European Commission and if there is any new scientific evidence or information 
which could impact the original risk assessment on the use of GMOs in food and feed 
                                                 
158  Ibid. Article 5(2)(b) and 17(2)(b) 
159  Ibid. Article 6(4) and 18(4) 
160  The comitology procedure  is a horizontal decision making tool set out  in Council Decision 1999/468/EC as amended by 
Council Decision 2006/512/EC; European Commission Evaluation of the EU legislative framework in the field of GM food and 
feed (2010) DG SANCO Evaluation Framework Contract Lot3 (Food Chain) p.14 
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production, authorization holder must alter the European Commission.161 In case when the 
authorized GMOs products is proved by scientific evidence to be risky to human and animal 
health, or the environment safety, the Member State could take interim protective measures 
autonomously if the European Commission fails to take actions on time after being officially 
informed.162 In addition,  the period of the validity for the authorisation is 10 years which is 
renewable as appropriate. The application for renewal must be made no later than one year 
before the initial authorisation expires. The documents need to be submitted for the renewal 
must include: a copy of the original authorisation; a report on the results of monitoring (if 
specified in the original authorisation); any other new information relating to the evaluation of 
safety and risks to the consumer and environment; and, a proposal for amending or 
complementing the conditions of the original authorisation (where appropriate). Except the 
required documents are different, the decision procedure and timeline are identical as the origin 
authorisations.163 
 
The Regulation on Food and Feed also enhanced the transparency of information and protection 
of customers’ interests by informing and consulting the public. Therefore, the public is able to 
reach the information including the applications, supplementary information provided by the 
applicant, the EFSA’s opinion, monitoring reports.164 Nevertheless, the customers’ right to 
know and right to choose is more directly protection and more effectively assured by the 
Regulation 1830/2003 on Traceability and Labelling.165  
 
3.4.5 Traceability and labelling regime 
The function of the traceability and labelling regime could be concluded as “to allow consumers 
to be informed of the history of the food concerned (such as the ingredients and additives used) 
                                                 
161  Ibid. Article 9 and 21 
162  See Regulation No.178/2000 Article 53 and 54 
163  European Commission Evaluation of the EU legislative framework in the field of GM food and feed (2010) DG SANCO 
Evaluation Framework Contract Lot3 (Food Chain) p.14 
164  Ibid. Article 6(7), 18(7) and 29 
165  Marine Friant‐Perrot, p.89 
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and, thereby, to follow their preferences when choosing what to eat.”166 The Traceability and 
Labelling Regulation contributed great improvement to the management system of GMOs and 
also consolidated and extended the regulatory framework in the European Union. 167  It 
established a harmonised framework at the Union level for tracing and identifying GMOs, 
GMO food products and feed and covered all stages of through the production and distribution 
chains.168 The Regulation is applicable to all GMOs placed on the market including: products 
consisting of, or containing GMOs, placed on the market in accordance with the Union 
legislation; food produced from GMOs, placed on the market in accordance with the Union 
legislation; and animal feed produced from GMOs, placed on the market in accordance with the 
Union legislation.169 
 
Traceability 
The general requirements of the traceability regulated under the General Food Law170 that all 
food, animal feed, food-producing animals, and any other substance intended or expected to be 
incorporated into a food or feed shall be traceable at all stages of production, processing and 
distribution.171 In other words, any person who supply food, feed, food-producing animal, or 
any substance intended or expected to be incorporated into a food or feed and the business 
operator who has been supplied to, must identify each other. The system and procedures shall 
be recorded and the related information shall be available to the competent authorities. The 
Traceability and Labelling Regulation provided more specific provision for the GMO food and 
feed to be placed on the market. 
 
The Traceability and Labelling Regulation defines its objectives in the Article 1 as: “facilitating 
accurate labelling; monitoring the effects on the environment and, where appropriate, on health; 
                                                 
166  ibid 
167  Michael Cardwell, The European Model of Agriculture (OUP, 2004) p.150 
168  Lisa Carson and Robert Lee,  ‘Consumer sovereignty and  the regulatory history of  the European market  for genetically 
modified foods’ (2005) 7 (3) Environmental Law Review 173 p.180 
169  Directive 1830/2003 Preamble (11) 
170  Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general 
principles and  requirements of  food  law, establishing  the European Food Safety Authority and  laying down procedures  in 
matters of food safety 
171  Regulation (EC) No 178/2002, Art. 18 
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and implementing appropriate risk management measures including, if necessary, withdrawal 
of products. ”172 It defines traceability of GMOs as “the ability to trace GMOs and products 
produced from GMOs at all stages of their placing on the market though the production and 
distribution chains.”173 This traceability regime is also generally called as ‘from farm to fork’ 
regime. The Traceability and Labelling Regulation also requires a paper trail for each GM food 
and feed to ensure traceability internally. 
 
At the first stage of placing a product consisting of or containing GMOs on the market, the 
business operators who supply the GMO product must record in file of information which 
indicate that the product contains or consists of GMOs and provide the unique indentifier(s) 
assigned to those GMOs products. The file will be sent to the operator receiving the product. At 
every following stage, the same information must be passed on.174  
 
In 2004, the European Commission devised a system of unique identifiers to be assigned to 
each GMOs and promulgated the Regulation (EC) No 65/2004 to establish this new system.175 
The Annex of this regulation prescribes the format of the identifier. The function of the unique 
identifier is that in any stage of the GMO product to be placed on the market from production to 
distribution, the information of the former supplier of the product and the next operator of the 
product (on step up and one step down) could be tracked through the information recorded in 
identifier. To the GMOs, the format of unique identifier is created by the Organization for 
Economic Cooperation and Development and it has been used for its Bio-Track product 
database and the Biosafety Clearing House.176 The European Commission requires a document 
accompanied to each GMOs food and feed or GMOs for processing to indicate each GMOs 
ingredient the product concerns.177 The Cartagena Protocol on Biosafety to the Convention on 
Biological Diversity in Article 18(2) provides specific requirements for those accompanied 
                                                 
172  Regulation (EC) No. 1830/2003 
173  Regulation (EC) No. 1830/2003, Art.3 
174  Ibid. Art. 4(1) and 4(2) 
175  Commission Regulation (EC) No 65/2004 of 14 January 2004 establishing a system for the development and assignment 
of unique identifiers for genetically modified organisms [2004] OJ L10/5   
176  Regulation (EC) 65/2004, Preamble. 
177  Ibid, Art. 2. 
  
 
9
document of GMOs food and feed.178 
 
The Commission requires the applicant must develop the unique identifier for each GMO food 
and feed as the condition in the authorization decision179 and it shall be recorded in the relevant 
register.180 The Commission shall ensure the unique identifier and relevant information to be 
forwarded to the Biosafety Clearing-House as soon as possible.181 
 
As noted above, the unique identifier system was introduced in 2004 by the Regulation 65/2004, 
therefore for the GMOs product was granted to entry into the market before the Regulation 
65/2004 would not have the unique identifier. Under this situation, the consent holders or the 
competent authority is obliged to consult with the Organization for Economic Cooperation and 
Development BioTrack product database and the Biosafety Clearing-House to affirm if a 
unique identifier has been created for that GMO product. 182 In case that GMO product has a 
unique identifier, the information shall be notified to the European Commission; for the GMO 
product has no unique identifier, the consent holder of the origin application and competent 
authority shall must develop one for that GMO. And the consent hold must inform the 
Commission about the details of the identifier within 90 days after the Regulation 65/2004 took 
effect.183 
 
Labelling 
The informed choice in one of the principles of European General Food Law and has been 
prescribed in the Article 8 that “…food law shall aim at the protection of the interests of 
consumers and shall provide a basis for consumers to make informed choices in relation to the 
foods they consumer. It shall aim at the prevention of: (a) fraudulent or deceptive practices; (b) 
the adulteration of food; and (c) any other practices which may mislead the consumer”.184 
                                                 
178  Dayuan Xue (ed.), Biosafety and Regulation for Genetically Modified Organisms (Beijing Science Press, 2009) p.140 
179  Ibid, Art 3(a) 
180  Ibid, Art 3(c), 5(3) 
181  Ibid, Art 5(4) 
182  Ibid, Art 4. 
183  Ibid, Art 6. 
184  General Food Law, Regulation 178/2002, Art. 8 
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The Traceability and Labelling Regulation follows a similar authorization procedure applied to 
the food labelling only limits the objective to the scope of food and food ingredients consisting 
of, or produced from, GMOs. The Traceability and Labelling states that the labelling section 
shall apply to “foods which are to be delivered as such to the final consumer or mass caterers in 
the Community and which (a) contain or consist of GMOs; or (b) are produced from or contain 
the ingredients produced from GMOs.”185 Labels do not have to conclude of information on the 
use of GM processing aids and for the animal products, whether or not the animal was fed by 
GM feed does not need to be mentioned on the label.186 
 
Regarding to the GM food, the customers will be able to be informed through the labels that the 
use of GMOs in the production of the food products they purchase in accordance with the 
principle of informed choice. Therefore, the Article 13 of the Food and Feed Regulation 
regulated that “the words ‘genetically modified’ or ‘produced from genetically modified [name 
of the ingredient]” shall appear in the list of ingredients’.187 These requirements have been 
further developed in Article 4 of the Traceability and Labelling Regulation that operators shall 
ensure that: “ a)for pre-package products consisting of, or containing GMOs, the words ‘This 
product contains genetically modified organisms’ or ‘This product contains genetically 
modified (name of organisms)’ shall appear on a label; b) for non-pre-packaged products 
offered to the final consumer the words ‘This product contains genetically modified organisms’ 
or ‘This product contains genetically modified (name of organisms(s))’ shall appear on, or in 
connection with, the display of the product.”188 
 
These labelling requirements apply to all products produced from GMOs including highly 
refined products with a few exceptions. The labeling requirement does not apply GMOs foods 
or feeds containing material which contains, consists of, or is produced from GMOs in a 
                                                 
185  Regulation (EC) No. 1830/2003, Art. 12(1) 
186  Or generally speaking, processing aids do not need to be labeled. See Directive 2000/13/EC of the European Parliament 
and of  the Council of 20 March 2000 on  the approximation of  the  laws of  the Member  States  relating  to  the  labelling, 
presentation and advertising of foodstuffs [2000] OJ L109/32 at Art. 6(4) 
187  Regulation (EC) No. 1829/2003, Art 13 
188  Regulation (EC) No. 1830/2003, Art 4 
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proportion no higher than 0.9% of the food ingredients considered individually or food 
consisting of a single ingredient, provided that this presence is adventitious or technically 
unavoidable.189 The burden of proof is on industry regarding to “establish that the presence of 
this material is adventitious or technically unavoidable, operators must be in position to supply 
evidence to satisfy the competent authorities that they have taken appropriate steps to avoid the 
presence of such material.”190 It means in the whole production chain, the GM food production 
must be completely segregated from the conventional food production. 
 
3.4.6 The main changes between pre-2003 and post-2003 legislative framework 
The year of 2003 could be seen as milestone in the development of EU’s legislation on GM food 
and feed. There are great changes and improvement contributed by the two regulations enacted 
in 2003. To start with, the GM food and feed were regulated in a single and specialized 
regulatory framework. Before 2003 the GM food was regulated as novel food, the feed which 
consist of or contains GMOs was generally regulated under the Deliberate Release Directive 
while the feed directly produced from GMOs was not covered by the legislation for GMOs.191 
Secondly, EU completed the centralized authorization procedure for GM food and feed which 
under the former system the EU was only partly involved in the procedure. If the result of the 
assessment which was carried out by one competent authority of one Member State granted the 
GM food and feed to be placed on the market, and within certain period of time there was no 
comments received from the European Commission or other Member States, the application 
would be approved. However, based on the centralized authorization procedure, the European 
Commission is involved in the whole process of every single case.192 Moreover, the role of the 
EFSA in the assessment and evaluation was greatly enhanced. Before 2003, the competent 
authority of one Member State was in charge of processing the scientific evaluation. In case the 
                                                 
189  Regulation (EC) No 1829/2003, Art 12(2) and Art 24(2). In case of a GMO that has not yet been authorized, a presence of 
5% maximum  is  considered  not  to  constitute  an  infringement provided  that  this GMO  has benefited  from  a  favourable 
opinion from the Community Scientific Committee or the European Food Safety Authority before the date of application of 
Regulation (EC) 1829/2003, Art 47. 
190  Regulation (EC) No 1829/2003, Art 12(3). 
191  European Commission Evaluation of  the EU  legislative  framework  in  the  field of GM  food and  feed  (2010) DG SANCO 
Evaluation Framework Contract Lot3 (Food Chain) p.15 
192  Ibid. 
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Member States objected, the scientific evaluation would have to be carried out by the Scientific 
Committee for Food of the European Union. After 2003 the EFSA was designed to 
independently complete all the scientific assessments.193 
 
Furthermore, the labelling requirements of GM food product was used to be provided by the 
Regulation (EC) No 1139/98 194  and Regulation (EC) No 49/2000 195  while labelling 
requirement for GM feed or for food and feed produced from GMOs was absent.196 The fourth 
main development after 2003 is that the labelling requirements have been systematized and 
applicable to all food and feed consisting, containing of or produced from GMOs. and a 
tolerance threshold was introduced into the system allowing unintended and technically 
unavoidable presence of GMOs. and finally, before the year of 2003 there was no requirement 
for the submission and validation of detection method included in the legal regulation at the 
EU level. After the Regulation No 641/2004197 and Regulation No 1981/2006198 came into 
force, applications for authorization should include the detection methods and identification of 
transformation event and control samples of the food and animal feed which must be validated 
by the Community Reference Laboratory before the authorization.199  
3.5 Multi-Level Governance of GMOs in the EU  
It is increasingly difficult to identify clear lines dividing national from European Union 
competences.200 The EU has always been characterized by its multi-level governance, in which 
                                                 
193  Ibid. 
194  Council Regulation  (EC) No 1139/98 of 26 May 1998  concerning  the  compulsory  indication of  the  labelling of  certain 
foodstuffs produces from genetically modified organism of particulars other than those provided for in Directive 79/112/EEC. 
195  Commission Regulation (EC) No 49/2000 of 10 January 2000 amending Council Regulation (EC) No 1139/98 concerning 
the compulsory indication on the labelling of certain foodstuffs produced form genetically modified organisms of particulars 
other than those provided for in Directive 79/112/EEC. 
196  European Commission Evaluation of  the EU  legislative  framework  in  the  field of GM  food and  feed  (2010) DG SANCO 
Evaluation Framework Contract Lot3 (Food Chain) p.15 
197  Commission Regulation (EC) No 641/2004 of 4 April 2004 on detailed rules for the implementation of Regulation (EC) No 
1829/2003 of the European Parliament and of the Council as regards the application for the authorization of new genetically 
modified  food  and  feed,  the  notification  of  existing  products  and  adventitious  or  technically  unavoidable  presense  of 
genetically modified material which has benefited from a favourable risk evaluation. 
198  Commission Regulation (EC) No 1981/2006 of 22 December 2006 on detailed rules for the implementation of Article 32 
of  Regulation  (EC)  No  1829/2003  of  the  European  Parliament  and  of  the  Council  as  regards  the  Community  reference 
laboratory for genetically modified organisms. 
199  European Commission Evaluation of the EU legislative framework in the field of GM food and feed (2010) DG SANCO 
Evaluation Framework Contract Lot3 (Food Chain) p.15 
200Maria Lee, ‘Multi‐level Governance of Genetically Modified Organisms in the European Union: Ambiguity and Hierarchy’ 
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authority is not allocated in a straightforward way to either the EU or the Member States. 
Instead, authority is dispersed along a spectrum of more or less national-centralized control. 
Multi-level governance calls on institutions that enable collaboration, learning, and discussion 
in order to escape the limited solutions or deadlocks that occur when using harder-edged 
techniques of law and government.201 Multi-level governance is not straightforward in respect 
of GMOs, however, the classic mechanisms of multi-level governance are present in the 
regulatory framework for GMOs. The regulation of GMOs provides plenty of opportunities for 
different levels of governance to intervene in decision-making, and the legislative framework 
generally avoids recourse to single levels of authority, as well as building in opportunities for 
early discussion. For example, the centralization implies by the role of the European Food 
Safety Authority (EFSA) in assessing risk is mediated by obligations of networking and 
consultation with national authorities, and special obligations of transparency in respect of 
disagreement.  
 
The above sections introduced the comprehensive legal framework in the EU regarding to the 
authorization, traceability and labelling of GMOs. The Food and Feed Regulation provided 
legal basis for regulating the food, food ingredients, and containing, consisting of or produced 
from GMOs and it also regulates GMOs used as source material for food and feed production, 
for example the cultivation. The Deliberate Release Directive regulates all kinds of GMOs, in 
comparing to the GM food and feed, the Directive focus more on the cultivation of GM plants. 
The aim of the authorization procedure set out by both pieces of acts is to the products in 
questions placed on the market would not have adverse effect on human and animal health as 
well as the environment. From this perspective, the center of the authorization is the risk 
assessment based on the scientific evidence that every authorization should be justified on the 
ground of scientific assessment.202 The EFSA plays a crucial role as it is designated by the 
                                                                                                                                                        
in Luc Bodiguel and Michael Cardwell  (eds), The Regulation of Genetically Modified Organisms: Comparative Approaches 
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201  Governance  also  generally  implies  the  involvement  of  civil  society  beyond  ‘government’  although  the  focus  here  is 
particularly on  the  legal  arrangement of  EU  and national  contributions  to decisions. Multi‐level  governance  should  also 
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legislation to cooperate with competent authorities of Member States to process the scientific 
risk assessment.  
 
According to the examination procedure provided in EU Regulation No 182/2011203, the 
decision making on authorization of GMOs shall follow the form of implanting acts adopted by 
the Commission. Therefore, the authorization process is very much centralized to the European 
Union level while the Member State also plays a crucial role in the process. There are two 
stages the Member States involved in which could influence the decision making: the Member 
States could vote on the draft decisions provided by the Commission in the Standing Committee 
and in case the decision is unable to be reached at the Standing Committee level, the Member 
States could vote in the Appeal Committee. The decision can be made either based on the 
qualified majority in favour of or against to. The qualified majority in defined in the as “…votes 
representing at least 55 percent of the 28 Member States, and at least 65 percent of the EU 
population. Where there is no qualified majority in favour of or against the draft decision in the 
Appeal Committee, the result is “no opinion”.204 
 
The rules governing this procedure205 provide that where “no opinion” is issued by the Appeal 
Committee, “the Commission may adopt the draft implementing act.”206 This wording in 
certain extent gives the Commission the discretion. While regarding to the decision making of 
GMOs cases, the Deliberate Release Directive, the Food and Feed Regulation together with the 
Traceability and Labelling Regulation reduced the “margin for manoeuvre” of the Commission 
significantly.207  
 
The process for authorizing GMOs broke down at the end of the 1990s, in the face of 
                                                 
203  Regulation (EU) No 182/2011 of the European Parliament and of the Council of 16 February 2011 laying down the rules 
and general principles concerning mechanisms for control by Member States of the Commission’s exercise of implementing 
powers. 
204  European Commission, Communication From  the Commission  to  the European Parliament,  the Council,  the European 
Economic and Social Committee and the Committee of the Regions—Reviewing the decision‐making process on genetically 
modified organisms (GMOs), COM(2015) 176 final, Brussels, 22.4.2015. 
205  Regulation (EU) No 182/2011 
206  Article 6(3) of Regulation (EU) No 182/2011. 
207  European Commission Evaluation of the EU legislative framework in the field of GM food and feed (2010) DG SANCO 
Evaluation Framework Contract Lot3 (Food Chain) 
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widespread public rejection of GM food and agriculture, and there were no authorizations 
between 1998 and 2004. The EU institutions and Member States ceased to apply the old 
legislation, and instead negotiated a new regulatory framework, composed of two key pieces of 
legislation, the Deliberate Release Directive and the Food and Feed Regulation. Since the entry 
into force of the Food and Feed Regulation in 2003, the Member States have not obtained a 
qualified majority in favour of or against a draft decision made by Commission on authorizing 
GMOs, including GMOs for cultivation or for GM food and feed. The result has always been 
“no opinion”. This situation has consistently happened at all stages of the authorization 
procedure both in the Standing Committee and in the Appeal Committee, under the current 
rules, and in the Council in the past.208 
 
The authorization process is complicated, varying according to the level of agreement or 
disagreement between the Member States, and according to the uses for which the GMO is to be 
authorized, in particular, according to whether the GMO (including a seed or other plant 
propagating material) is ultimately for food or feed use or not. The key steps are a risk 
assessment by the EFSA, on the basis of information submitted by the applicant, and a decision 
on authorization by the Commission and Member States through the examination procedure set 
out by the Regulation (EU) 182/2011.209  
 
3.6 Public Participation in the EU Authorisation Procedures for GMOs 
In 1972, the United Nations Conference on the Human Environment in Stockholm210 (which 
gathered representatives from 113 countries (as well as numbers of international organisations 
and non-governmental organisations) laid down new principles of international environmental 
law and governance, including important recommendations regarding public participation in 
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decision making. They have had an important impact on the governance of GMOs in the EU 
and elsewhere. In its closing meeting, the Declaration of the United Nations Conference on 
the Human Environment was adopted and the very first principle of the Declaration stated that, 
‘[M]an has the fundamental right to freedom, equality and adequate conditions of life, in an 
environment of a quality that permits a life of dignity and well-being, and he bears a solemn 
responsibility to protect and improve the environment for present and future generations.’211 
The Declaration showed the commitment of the world community to solve global 
environmental problems and gave the rise to the enacting of international environmental 
agreements and national laws as well as stimulated the development of the environmental 
protection organization system.  
 
If the Stockholm Conference brought the environmental protection issues to the attention of 
human society, the United Nations Conference on Environment and Development which was 
held twenty years later in Rio de Janeiro further appealed that the public should be 
empowered to participate in decision making and have a right to access information, as well 
as a right to environmental justice. The 10th principle of the Declaration on Environment and 
Development proclaims The Rio Declaration proclaims in principle 10 that: ‘[E]nvironmental 
issues are best handled with participation of all concerned citizens, at the relevant level. At the 
national level, each individual shall have appropriate access to information concerning the 
environment that is held by public authorities, including information on hazardous materials 
and activities in their communities, and the opportunity to participate in decision-making 
processes. States shall facilitate and encourage public awareness and participation by making 
information widely available. Effective access to judicial and administrative proceedings, 
including redress and remedy, shall be provided.’ 212  The Rio Declaration has great 
significance because it appealed on countries and authorities to provide conditions for the 
public to access the information and justice as well as to participate into the decision-making 
process on environmental issues as they are the crucial links of basic human rights.  
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3.6.1 The Convention on Biological Diversity and the Cartagena Protocol213 
While at the same year, the Convention on Biological Diversity (CBD) took one step further 
which provide the public participation into the biosafety issues. The Article 13 of the 
Convention requires the Contracting Parties shall ‘…(a) Promote and encourage 
understanding of the importance of, and the measures required for, the conservation of 
biological diversity, as well as its propagation through media, and the inclusion of these topics 
in educational programmes; and (b) Cooperate, as appropriate, with other States and 
international organizations in developing educational and public awareness programmes, with 
respect to conservation and sustainable use of biological diversity.’214 It has also mentioned 
in its Article 14 that ‘(the Contracting Parties) shall introduce appropriate procedures 
requiring environmental impact assessment of its proposed projects that are likely to have 
significant adverse effect and, where appropriate, allow for public participation in such 
procedure.’215  
 
Under the CBD, the Cartagena Protocol on Biosafety reinforced this obligation of the 
Contracting Parties with specific reference to the genetically modified organisms. The 
Cartagena Protocol specifically listed the ‘Public Awareness and Participation’ as its Article 
23, that the Parties shall: ‘(a) Promote and facilitate public awareness, education and 
participation concerning the safe transfer, handling and use of living modified organisms in 
relation to the conservation and sustainable use of biological diversity, taking also into 
account risks to human health. In doing so, the Parties shall cooperate, as appropriate, with 
other States and international bodies; (b) Endeavour to ensure that public awareness and 
education encompass access to information on living modified organisms identified in 
                                                 
213  The back ground information and further study of the UN Convention on Biological Diversity please see S. Jodoin & M. 
Cordonier Segger (Eds.), Sustainable Development, International Criminal Justice, and Treaty Implementation (Cambridge: 
Cambridge University Press,2013); for general idea of the Cartagena Protocol is inspired by Professor. Christopher Rodgers, 
“Environmental Risk, Environmental Liability and the Regulation of Biotechnology: Mediating Law and Biology?” Chapter 7 
pp.95‐115 in (Hocking ed.) The Nexus of Law and Biology: New Ethical Challenges (Ashgate, 2009) 
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accordance with this Protocol that may be imported.’ Also, the Article 23(2) provides that the 
Parties shall, ‘in accordance with their respective laws and regulations, consult the public in 
the decision-making process regarding living modified organisms and shall make the results 
of such decisions available to the public’.216  
 
3.6.2 The Aarhus Convention 
It might need be addressed that neither the Declaration of the Stockholm Conference or the 
Rio Declaration has legally binding. There was no international document with legally 
binding specifically on public participation produced in the past until the Aarhus Convention 
on Access to Information, Public Participation in Decision-making and Access to Justice in 
Environmental Matters were concluded in the 1998.217 The Aarhus Convention was an 
important step taken by the international society to honor its commitment to protect the 
environment by enhancing the public awareness, promoting pubic participation and 
empowering the public the right access to justice in environmental matters.218 Moreover, the 
Arhus Convention especially mention the agricultural biotechnology in its Preamble, where 
require the Contracting Parties to recognize ‘the concern of the public about the deliberate 
release of genetically modified organisms into the environment and the need for increased 
transparency and greater public participation in the decision-making in this field.’219 Later 
under the Almaty amendment in 2005, the legislations on GMOs was separated as a single 
area where the provision of the regulation were developed further.220 The implementation of 
the Aarhus Convention started from October 2001 yet it was not ratified by the European 
Union until 2005.221 Parties of the Aarhus Convention are mainly European countries, and till 
                                                 
216  The Cartagena Protocol on Biosafety, see < http://bch.cbd.int/protocol/text/> (last accessed on 22 May, 2018) 
217  The  Aarhus  Convention  on  Access  to  Information,  Public  Participation  in  Decision‐making  and  Access  to  Justice  in 
Environmental  Matter  (the  Aarhus  Convention),  1998.  See  < 
http://www.unece.org/fileadmin/DAM/env/pp/documents/cep43e.pdf> (last accessed on 1 June, 2018) 
218  Dayuan Xue (ed.), Biosafety and Regulation for Genetically Modified Organisms (Beijing Science Press, 2009), p.320 
219  Ibid. The Preamble. 
220  Michael Cardwell, ‘Public Participation in the Regulation of Genetically Modified Organisms: A Matter of Substance of 
Form?’ (2010) 12 Environmental Law Review 12 p.14 
221  Council Decision 2005/370/EC on the conclusion, on behalf of the European Community, of the Convention on Access to 
Information, Public Participation in Decision‐making and Access to Justice in Environmental Matters (OJ L124/1, 2005). Also 
see Michael Cardwell,  ‘Public Participation  in the Regulation of Genetically Modified Organisms: A Matter of Substance of 
  
 
1
the present days no Asian countries joint the Convention. 
 
There are three pillars under the Aarhus Convention which are the access to information, 
access to justice and the public participation. According to the Aarhus Convention, the public 
participation should be involved in: firstly, the ‘decisions on specific activities’;222 secondly, 
‘plans, programmes and policies relating to the environment’;223 and thirdly, ‘the preparation 
of executive regulations and/or generally applicable legally binding normative 
instruments’.224  
 
3.6.3 Public participation in authorisation for GMOs in the EU 
The promotion of agricultural biotechnology and the GMO products in the European Union 
have encountered resistance from the European public since their introduction.225 According 
to an analysis report, the reason behind this resistance from the European public to the GMOs 
was more because of social and cultural reasons than of lack of scientific knowledge and 
education or the negative publicity from the media.226 On the other hand, the Public 
Participation in the legal framework and governance of the European Union plays an 
important role. The 2001 European Governance—a White Paper227 could be seen as an 
evidence. It this document, the participation is identified as one of the principles of good 
governance, not only because ‘the quality, relevance and effectiveness of EU policies depend 
on ensuring wide participation throughout the policy chain—from conception to 
implementation’, but also that improvements in this area are ‘likely to create more confidence 
in the end result and in the institutions which deliver policies’.228 Later, in accordance to the 
Aarhus Convention, the European Union enacted the Regulation (EC) 1367/2006 to the make 
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sure that the publics’ right on access to the information, public participation in 
decision-making process as well as access to justice in environmental matters be fulfilled.229 
 
Regarding to the authorisations for GMOs, there are two directives governing the activities 
related to the GMOs which are the Deliberate Release Directive (Directive 90/220/EEC, later 
was replaced Directive 2001/18/EC) and the GM Food and Feed Regulation (Regulation 
1829/2003/EC), they constructed two slightly different procedures for GMOs authorization 
and both of them provided provisions for public participation.230 The early Council Directive 
90/220/EEC on the Deliberate Release into the Environment of Genetically Modified 
Organisms231 stated in its Preamble that ‘it may be considered appropriate in certain cases to 
consul the public on the deliberate release of GMOs into the environment’.232 The Article 7 
especially required the Member State may provide that ‘groups or the public shall be 
consulted on any aspect of the proposed deliberate release’.233 Although this Directive was 
replaced by the Directive 2001/18/EC234, the public participation were further emphasized and 
enhanced which allowed wider access to the regulatory process. Article 9 required the 
Member States shall ‘consult the public and, where appropriate, groups’, and they must ‘lay 
down arrangements for this consultation, including a reasonable time period, in order to give 
the public or groups the opportunity to express an opinion’, and ‘comments by the public 
should be taken into consideration in the drafts of measures submitted to the Regulatory 
Committee.’235 In Part C of this Directive which governs the GMOs which are about to be 
placed on the market, the Article 24 stipulates that the public may make comments on the 
summery and the assessment report submitted by the Commission and the Commission shall 
immediately forward the comments to the competent authorities in case of placing a GMO 
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product on the market.236 In the GM Food and Feed Regulation237 also have similar 
stipulation. 
 
It could be concluded from the above instruction that the importance of public participation in 
the environmental matters are generally recognized from the international level and the 
national level. Moreover, along with the rapid development of modern network, the channels 
for the public accessing the information are numerous, therefore to guarantee the pubic have 
greater right of participating in the decision-making and legislative process is an irreversible 
trend. The provision regarding to the public participation in authorisations for GMOs in the 
European Union legal system are comparatively detailed. The public participation is not only 
necessary but also sustaining, sufficient period of time is provided for the public to express 
their comments which are guaranteed to be involved into the decision-making access.  
 
Although development strategies on agricultural biotechnology are various from country to 
country, the practices of European Union in encouraging the public participation in 
environmental matters especially the GMOs matters have in certain degree proved its 
practicability and therefore could be studied and used for reference by Chinese policy makers 
in this area. The specific proposal for China to establish its public participation system in 
GMOs authorization will be discussed in the final chapter. 
 
3.7 Co-existence Measures in the EU238 
Agricultural production systems can be described in three categories: conventional, 
conventional using genetically modified crops, and organic. Conventional systems often use 
fertilizers and pesticides. Genetically modified systems use crops that have been genetically 
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engineered to resist pests or disease or to tolerate herbicides. Organic systems, by contrast, do 
not usually use chemical fertilizers or pesticides, nor do they use GM materials in the 
production process.239 These three types of agricultural production may occur in the same 
geographic region. When they do, producers who grow organic or conventional crops often 
want to avoid the adventitious presence of GM material in their crops.  
 
Genetically modified crops make up an ever-larger proportion of the world’s maize and 
soybeans, and the coexistence of these crops with other, more traditional varieties is a matter of 
increasing concern, especially in the European Union. In the EU, where GM crops have been 
viewed with suspicion, the goal of avoiding adventitious presence is particularly important. Of 
course, farmers in other nations often share the same concern.  
 
According to the European Commission, the term ‘coexistence’ refers to “the ability of farmers 
to make a practical choice between conventional, organic and GM crop production, in 
compliance with the legal obligations for labelling and/or purity standards.”240 The European 
Association for Bio-industries (including ‘green’ or agricultural biotechnology) offered a more 
expansive definition: ‘coexistence is about how crops intended for different markers can be 
grown in the same vicinity without becoming commingled and thereby possibly compromising 
the economic value of each other. Coexistence is based on the premise that farmers should be 
free to cultivate the crops of their choice using the production system they prefer, whether they 
are GM, conventional or organic’.241 
 
Article 26a of the Deliberate Release Directive provides that: ‘Member State may take 
appropriate measures to avoid the unintended presence of GMOs in other product’. This 
‘co-existence’ provision in principle allows considerable flexibility in the Member States, with 
different approaches to respond to their diverse conditions, for example as to the size of farms, 
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different levels of commitment to organic farming and varied geographical and ecological 
conditions. Measures to ensure the co-existence of different forms of agriculture include 
staggered sowing, weed management and careful cleaning and maintenance of equipment. At 
the more interventionist end, separation distance or buffer zones between crops might amount 
to GM free zones on various scales. 
 
Coexistence rules of genetically modified plants with conventional and organic crops are not 
set by EU authorities but by national authorities of Member States. At EU level, the European 
Coexistence Bureau organizes the exchange of technical and scientific information on best 
agricultural management practices for coexistence. On this basis, in July 2003, the European 
Commission issued its Recommendation242 on guidelines for the development of national 
strategies and best practices to ensure the coexistence of genetically modified crops with 
conventional and organic farming.243 
 
Countries which produce GM crops have enacted specific legislation on coexistence, except 
Spain where coexistence is managed by following the good agricultural practices defined by the 
National Association of Seed Breeders. In some parts of the EU such as Southern Belgium and 
Hungary, coexistence rules are very restrictive and strongly limit the cultivation of GM crops. 
Some countries are preparing coexistence rules. In Poland, the drafted legislation is expected to 
enter into force not earlier than in 2016. In the United Kingdom, rules will be implemented 
‘when GE crops are grown.’ In France, several regulations are in place but the rules governing 
distances between GM crops and other fields have not been defined yet.244 
 
3.8 Environmental Liability Regime in the EU 
When the risks of GMOs research and development and other activities related to the GMOs, 
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for example, the production, transportation, environmental release, storage and marketing 
activities, turn into actual harm and damage, the problems of compensating the injured party 
as well as undertaking the corresponding legal liability for the damage to the biological 
environment are involved. ‘Legal liability’ under the biosafety law means legal consequences 
to the offender who violates biosafety law or breaks their contractual obligation while the 
‘redress’ is the way or method to remedy the liability.245 Damages are one of the most 
important parts in the biosafety legal system which are also comparatively controversial in the 
existing international biosafety legal system. 
 
The European Union has started to consider to establish an EU community-wide 
environmental liability regime since 1993.246 In April 2000, the European Commission 
published the ‘White Paper on Environmental Liability’247, and the Deliberate Release 
Directive explicitly refers to liability in its Recital.248 The provisions provided by the 
Deliberate Release Directive shall not only be ‘without prejudice to Member States’ national 
legislation in the field of environmental liability’, but also the ‘Community legislations in this 
field needs to be complemented by rules covering liability for different types of 
environmental damage in all areas of the European Union.’249 Moreover, the Deliberate 
Release Directive also anticipated the Commission to ‘bring forward a legislative proposal on 
environmental liability’ which will cover damage from GMOs.’250 In 2004, a pubic liability 
mechanism at the Community level is provided by the EU’s Environmental Liability 
Directive.251  
 
The 2004 Environmental Liability Directive aims to prevent and remedy environmental 
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2008), p.127 
249  Directive 2001/18, Recital 16. 
250  Ibid. 
251  Directive of the European Parliament and of the Council of 21 April 2004 on environmental  liability with regard to the 
prevention and remedying of environmental damage [OJ L 143 of 30.04.2004]. 
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damage and therefore establishes a framework based on the polluter pays principle. The 
polluter pays principle is set out in the Treaty on the Functioning of the European Union.252 
The provisions of the Directive apply for the remediation of pure ecological damage which is 
the ‘environmental damage’ and ‘biological damage’, therefore the Directive is based on the 
powers and duties of public authorities, which is different from the civil liability system for 
the economic loss and other commercial losses or property damage and they are not in the 
range of the remediation offered by the Directive.253  
 
Before we can understand the liability regime provided by the Environmental Liability 
Directive, it is important to know the way the Directive defines the ‘environmental damage’ 
and ‘operator’. There are three categories of environmental damage covered under the 
Directive. First of all, there is ‘damage to protected species and natural habitats’, which is any 
damage that has significant adverse effects on reaching or maintain the favourable 
conservation status of such habitats or species.254 Secondly, there is ‘water damage’, which is 
any damage that significantly adversely affects the ecological, chemical and/or quantitative 
status and/or ecological potential, as defined in the Water Framework Directive 2000/60255, of 
the waters concerned;256 and finally, there is ‘land damage’, which is any land contamination 
that creates a significant risk of human health being adversely affected as a result of the direct 
or indirect introduction, in, on or under land, of substances, preparations, organisms or 
                                                 
252  TFEU, Article 191(2) 
253  Christopher Rodgers, “Environmental Risk, Environmental Liability and the Regulation of Biotechnology: Mediating Law 
and Biology?” Chapter 7 pp.95‐115 in (Hocking ed.) The Nexus of Law and Biology: New Ethical Challenges (Ashgate, 2009) 
254  2004 Environmental Liability Directive, Article 2 (1)a. In addition, the ‘favourable conservation status of a natural habitat’ 
and  ‘the  favourable  conservation  status  of  a  species’  have  legal  definition  given  in  the  Council  Directive  92/43/EEC  on 
conservation on natural habitats and of wild fauna and flora (1992). See Article 1(e), ’… The conservative status of a natural 
habitat will be taken as "favourable" when: its natural range and areas it covers within that range are stable or increasing, 
and the specific structure and functions which are necessary for its long‐term maintenance exist and are likely to continue 
to exist  for  the  foreseeable  future, and  the  conservation  status of  its  typical  species  is  favourable as defined  in  (i);’ and 
Article 1(i), ‘ conservation status of a species…will be taken as "favourable" when: population dynamics data on the species 
concerned  indicate that  it  is maintaining  itself on a  long‐term basis as a viable component of  its natural habitats, and the 
natural range of the species is neither being reduced nor is likely to be reduced for the foreseeable future, and there is, and 
will probably continue to be, a sufficiently large habitat to maintain its populations on a long‐term basis’. For detailed study 
and  discussion  on  the  nature  conservation  law,  please  see  Christopher  Rodgers,  The  Law  of Nature  Conservation  (OUP 
2013). 
255  Directive 2000/60/EC of the European Parliament and of the Council of 23 October 2000 establishing a  framework  for 
Community action in the field of water policy [2000] OJ L327/1 
256  2004 Environmental Liability Directive, Article 2 (1)b 
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micro-organisms.257 
 
In order to provide for effective liability, the establishment of a causal link between the 
activity and the damage is always required. Therefore, the Directive provides two different 
but complementary liability regimes which respectively applies for two different categories of 
damage. Firstly, the strict liability applies for the environmental damage caused by any of the 
dangerous activities (listed in Annex III) carried out by operators.258 These activities include, 
among others, industrial and agricultural activities requiring permits under the 1996 
Integrated Pollution Prevention and Control Directive, waste management operations, the 
release of pollutants into water or into the air, the production, storage, use and release of 
dangerous chemicals, and the transport, use and release of genetically modified organisms.259 
These activities are assumed to be high risk and therefore engage liability without proof of 
fault. Secondly, operators carrying out occupational activities other than those listed in Annex 
III are liable for fault-based damage to protected species or natural habitats (biodiversity 
damage)260, which means an operator would only be held liable if the operator was at fault or 
negligent and if he has caused damage to species and natural habitats protected at EU level 
under the 1992 Habitats Directive261 and 1979 Birds Directives.262 
 
Under the liability regime provided by the Environmental Liability Directive, the public 
authorities play an important role since it is their responsibility to identify liable operators and 
to ensure them to undertake necessary preventive provisions or remedying measures 
stipulated by the Directive. Before the damage has actually occurred but there is an imminent 
threat of such damage, the operator shall immediately take necessary preventive action and 
inform the competent authority of all relevant aspects in certain cases.263 While there is actual 
environmental damage has occurred, the operator shall, without delay, inform the competent 
                                                 
257  Ibid, Article 2(1)c 
258  Ibid, Article 3(1)a. 
259  Ibid, Annex III. 
260  Directive 2004/35/EC, Article 3(1)b. 
261  Council Directive 92/43/EEC of 21 May 1992 in the conservation of natural habitats and of wild fauna and flora [1992] OJ 
L206/7 
262  Council Directive 79/409/EEC of 2 April 1979 on the conservation of wild birds [1979] OJ L103/1 
263  Directive 2004/35/EC, Article 5. 
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authority of all relevant aspects of the situation and take: (a) all practicable steps to 
immediately control, contain, remove or otherwise manage the relevant contaminants and/or 
any other damage factors in order to limit or to prevent further environmental damage and 
adverse effects on human health or further impairment of services, and (b) the necessary 
remedial measures, in accordance with the relevant provisions of the Environmental Liability 
Directive (particularly in accordance with its Annex II).264 In addition, public interest groups, 
for example the NGOs, will be able to require public authorities to act when necessary. The 
Directive also offers an additional safeguard when the decisions of the public authorities are 
deemed illegal, the public interested groups are able to challenge their decisions before the 
courts. 
 
Regarding to the GMOs related issues, the Directive will also cover damages if the potential 
risks will cause damage to protected species, natural habitats, water and soil when the damage 
has occurred during the contained use of GMOs or their deliberate release into the 
environment. It might be worthy to point out that, regarding the damage the biodiversity, a 
public liability model would be more ‘utility’ in such cases. Certainly numbers of civil liability 
regimes may provide strict liability for hazardous activities, however they do not cover the 
unforeseeable harm. While a public liability model, it gives the public bodies power to carry out 
clean-up activities and then reclaim the financial cost from the operator – this avoids any need 
to ‘value’ the damage to the environment. It does not provide for financial damages to be 
awarded in the normal sense.265 
 
3.9 The Recent Reform of the Rules for GMOs Authorized for Cultivation 
The reform of the rule on GMOs cultivation authorization has been prepared for a long period. 
                                                 
264  Ibid, Article 6. 
265  Christopher Rodgers, ‘Implementing the Community Environmental Liability Directive: Genetically Modified Organisms 
and the Problem of Unknown Risk’ in Luc Bodiguel and Michael Cardwell (eds), The Regulation of Genetically Modified 
Organisms: Comparative Approaches (OUP 2010); see also , L Bergkamp, ‘The Commission’s White Paper on Environmental 
Liability: a weak case for an EC strict liability regime’ (2000) 9(4) European Environmental Law Review 105 as there is a 
different oppoinion on the public liability model posited in the Environmental Liability Directive. 
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The Commission submitted a proposal of amendment on the GMO legislation to extend the 
grounds on which Member States could restrict or prohibit the cultivation of EU authorized 
GMOs on their territory.266 In the explanatory memorandum of proposal, the Commission 
explained that “national, regional or local levels of decision making are considered to be the 
most appropriate frameworks to address the particularities linked to GMO cultivation”. The 
proposed amendment has now been adopted into EU law as Directive (EU) 2015/412267 (“The 
2015 Directive”). The 2015 Directive claims “to grant Member States, in accordance with the 
principle of subsidiarity, more flexibility to decide whether or not they wish to cultivated 
GMOs on their territory”.268 According to the Directive, the Member States of the European 
Union have the right to restrict or ban GMO cultivation within all or part of their territory based 
on non-scientific reasons.269 This is a major development as the European Union shifts the 
power toward to the Member State and it allows Member States to make the decision on GMO 
cultivation on the basis of considerations of their own national situations as the priority. The 
provision applies to both the future authorizations and to GMOs which have already been 
authorized at EU level.270 
 
The EU’s action has been influenced by the awareness of the circumstance that the cultivation 
of GMOs is an issue which can be more thoroughly addressed at Member State level, since it 
has strong national, regional and local dimensions, given its link with land use, local 
agricultural structures and the protection or maintenance of habitats, ecosystems and 
                                                 
266  Global Agricultural  Information Network (GAIN), EU‐28 Agricultural Biotechnology Annual 2016, GAIN Report Number: 
FR1624  (USDA  Foreign  Agricultural  Service,  12  June  2016) 
https://gain.fas.usda.gov/Recent%20GAIN%20Publications/Agricultural%20Biotechnology%20Annual_Paris_EU‐28_12‐6‐20
16.pdf accessed 28 Oct 2017 
267  Directive (EU) 2015/412 of the European Parliament and of the Council of 11 March 2015 amending Directive 2001/18/EC 
as  regards  the possibility  for  the Member  States  to  restrict or prohibit  the  cultivation of genetically modified organisms 
(GMOs) in their territory (OJ L68/1). For a more thorough discussion on the value and impact of the Directive (EU) 2015/412, 
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Internal Market: New Legislation on National Flexibility’ (2016) 79 (2) Modern Law Review 317 
268  Ibid, Recital 8. 
269  Global Agricultural Information Network (GAIN), EU‐28 Agricultural Biotechnology Annual 2016, GAIN Report Number: 
FR1624 (USDA Foreign Agricultural Service, 12 June 2016) 
https://gain.fas.usda.gov/Recent%20GAIN%20Publications/Agricultural%20Biotechnology%20Annual_Paris_EU‐28_12‐6‐20
16.pdf accessed 28 Oct 2017 
270  Laura Salvi, ‘The EU Regulatory Framework on GMOs and the Shift of Powers toward Member States: and Easy Way Out 
of the Regulatory Impasse?’ [2016] 3 EFFL 201 
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landscapes.271 The pivot and core of the modified structure of regulatory competence in this 
matter has been identified in the principle of subsidiarity, which constitutes the means to 
reconcile the objectives of harmonization at a European level with the need for flexibility 
related to the diversity of situations in the various European countries, in the framework of the 
correct and effective functioning of the European market.272 
 
The directive formally confers Member States the right to adopt legally binding acts restricting 
or prohibiting the cultivation of GMOs on their territory, without however affecting the 
common procedure for marketing authorisation, which still remains firmly at the EU level. The 
objective appears to be twofold: improving the authorisation process of GMOs on one side and 
ensuring consumers’, farmers’ and operators’ freedom of choice on the other, thus ensuring a 
greater degree of clarity to stakeholders regarding the cultivation of GMOs in the Union.273 
  
In line with the aim of a proper and effective functioning of the internal market, the Directive 
also provides that the restrictions or prohibitions adopted pursuant to it should refer to the 
cultivation and not to free circulation and the import of genetically modified seeds and plants 
propagating material as, or in, products and of the products of their harvest. Generally, it is 
prescribed that compelling grounds conform with Union Law, in particular as regards the 
principle of non-discrimination between national and non-national products, the principle of 
proportionality, provisions on the free movement of goods set out in Articles 34 and 36, as well 
as in compliance with international obligations.274 
 
According to the new directive, restrictions or prohibitions may be adopted by Member States 
either in the course of the authorisation procedure or thereafter, and independently from the 
measures that Member States cultivating GMOs are entitled or required to take by application 
of Directive 2001/18/EC to avoid the unintended presence of GMOs in other products. 
                                                 
271  Recital No 6 of Directive No 2015/412/EU 
272  Laura Salvi, ‘The EU Regulatory Framework on GMOs and the Shift of Powers toward Member States: and Easy Way Out 
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In case a State intends to exercise its powers to adopt restrictions or prohibitions during the 
authorisation procedure for a certain GMO or during the renewal of such authorisation, this 
intervention will take the form of the possibility to request that the geographical scope of the 
written consent or authorisation shall be adjusted to the effect that all or part of its territory is to 
be excluded from cultivation, at the latest 45 days from the date of circulation of the assessment 
report under Article 14(2) of Directive 2001/18, or from receiving the opinion of the EFSA 
under Article 6(6) and Article 18(6) of Regulation 1829/2003. The demand is then presented by 
the Commission to the other States and to the notifier/applicant, who may decide to adjust or 
confirm the geographical scope of its initial notification/application within 30 days.275 
 
If no action is taken during the course of the authorisation procedure, or if the notifier does not 
answer the geographic adjustment request, the State may opt for the adoption of a 
comprehensive ban or restrictions of a GMO cultivation in its territory. This restriction may 
also involve a group of GMOs defined by crop or trait, which has already been authorised at the 
EU level. The Member State shall communicate a draft of those measures and the 
corresponding grounds invoked to the Commission, who may “make any comments it 
considers appropriate.” This communication may take place before the GMO authorisation 
procedure has been completed under Part C of Directive 2011/18/EC or under Regulation (EC) 
No 1829/2003. For a period of 75 days starting from the date of such communication, the 
Member State concerned shall refrain from adopting and implementing those measures, and 
ensure that operators refrain from planting the GMO concerned.276 
 
Besides, Directive 2015/412 allows Member States to adopt transitional measures in order to 
apply the provisions of the Directive to products which have been authorised or which were in 
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consent/authorisation and as from the date of entry into force of the Union authorisation, adopt the measures, as originally 
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the process of being authorised before the act is enforced, signally, demanding that the 
geographical scope of a notification/application submitted, or of an authorisation granted under 
Directive 2001/18 or Regulation 1829/2003, is adjusted.277 
 
With regard to the reasons Member States may put forth to justify restrictions on cultivation 
(the so-called “compelling grounds”), the Directive specifies that they must be distinct from 
and complementary to those assessed according to the abovementioned acts. Member States 
may demand that the cultivation of a certain GMO or of a group of GMOs is banned or 
restricted on the ground of “environmental policy objectives” (different from and 
complementary to the assessment of risks to health and the environment which is carried out by 
the EFSA or other competent authorities), 278  “land use,” “town and country planning,” 
“socio-economic impact,” 279  “agricultural policy objectives,” “coexistence” and “public 
policy”.280 Whether such reasons are invoked individually or in combination, they shall in no 
case conflict with the environmental risk assessment carried out in the EU context by EFSA.281 
That is to say, a Member State will not be able to base a restriction or a prohibition on 
cultivation in its territory on risks that EFSA has already assessed. 
 
It should be noticed that the 2015 Directive applies to GMOs for cultivation only, the GM food 
and feed are not yet the object of the Directive. The Commission, in the view of above 
consideration, proposed to amend the Food and Feed Regulation in the same way as to allow 
Member States to restrict or prohibit the use, on part of all of their territory, of GM food and 
feed authorized by the EU for compelling reasons other than the risk to human or animal health 
or to the environment—that is, criteria other than those assessed by EFSA in its risk 
                                                 
277  Directive 2015/412/EU Recital No 26, and Article 26(c) 
278  Ibid, Recital No 14.  For example,  the maintenance and development of agricultural practices which provide a better 
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assessment.282 However, this proposal was not carried through. 
3.10 Conclusion 
After persistent efforts and practices, the European Union has now established a ‘farm to fork’ 
regulatory framework governing the GMOs comprehensively from evaluation, authorization, 
production, tracing and marketing. It is generally recognized that the EU’s approach regarding 
to the GMOs and genetic technology management at the most developed level in the 
worldwide. The whole legislative framework is constituted by number of Regulations and 
Directives which created a ‘safety net’283 to ensure the higher level on protection of human and 
animal health as well as the ecological environment safety. In spite of arguments and opposition 
along the way of the development of the regime, the EU contributes greatly in expansion the 
content of international GMOs legislation and plays a role as exemplification to other countries. 
As it has been introduced in Chapter 3, the current comparatively weak management on GMOs 
in China is urgently needed to be improved. The EU provided valuable and resourceful model 
to Chinese legislation especially regarding to (but not limited to) the multi-level government on 
GMOs, the traceability and labelling regime, the transparency of information as well as the 
public participation regime. The next chapter would comparatively study on the EU legislative 
framework and Chinese legislative framework and take one step forward to discuss the 
feasibility and necessity of adopting EU approaches into the Chinese context.  
                                                 
282  Proposal  for a Regulation of  the European Parliament and of  the Council amending Regulation  (EC) No 1829/2003 as 
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Chapter 4 Multi Level Environmental Governance of GMOs: Comparative 
Aspects 
Chinese government has heavily invested in biotechnology research and the biotechnology 
plays a critical role in the national development strategy. The amount of total investment on 
biotechnology research and development from the Chinese government is estimated to be 12 
billion Yuan (approximately $1.9 billion) since 2008, with a matching investment from private 
industry.1 The amount far exceeds any other country’s public investment in biotechnology.2 It 
is expected that Chinese government expenditure on agricultural biotechnology will accelerate 
in the near term. 
 
In September 2014, the President Xi Jinping released his remarks on the agricultural  
biotechnology publicly for the first time, he affirmed the governmental support for the 
agricultural biotechnology research to prevent the foreign companies “dominating the 
agricultural biotechnology product market”, yet emphasized the commercialization should be 
carried forward with cautious attitude and approaches. 3  In February 2015, the Chinese 
Communist Party pledged in its annual high-level policy paper on agriculture that ‘to 
strengthen research, safety management, and public outreach on biotechnology’.4 
                                                 
1  USDA Foreign Agricultural Service, GAIN Report No. CH16065, ‘Agricultural Biotechnology Annual—China Moving Towards 
Commercialization of  Its Own Biotechnology Crops’; all  the published GAIN  reports by USDA Foreign Agricultural Service 
could  be  found  on  <  https://gain.fas.usda.gov/Recent%20GAIN%20Publications/Forms/AllItems.aspx>,  last  accessed  on 
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2  Ibid. 
3  Ibid. 
4  This  high‐level  policy  paper  is  so  called  ‘the No.  1  Document’.  It  is  the  first  policy  document  issued  by  the  Chinese 
Communist Party each year. The document is reserved for important issues, such as agriculture.) The document built on the 
comments President Xi Jinping made on biotechnology during a major policy speech on agriculture in December 2013 at the 
Central  Conference  on  Rural  Work  by  the  Central  Committee  of  the  Communist  Party.  He  stated,  ‘Biotech  is  a  new 
technology, and a new  industry with bright prospect. As a novel  issue, biotechnology attracts social disputes and doubts, 
which is normal.    For this issue, I want to emphasize two aspects, one is guaranteeing safety and the second is indigenous 
innovation.  That  is,  we  shall  be  bold  in  research,  but  cautious  in  commercialization.  The  industrialization  and 
commercialization of genetically modified crops shall strictly follow the technical procedures provided by Chinese regulations; 
the industrialization and commercialization of genetically modified crops shall be steady and make sure no problem occurs, 
and  all  safety‐related  factors  shall  be  considered.    The  research  and  innovation  shall  be  bold,  so  we  can  take  the 
commanding heights in biotechnology, and not let large foreign companies dominate the agricultural biotechnology product 
market.’ USDA Foreign Agricultural Service, GAIN Report No. CH16065,  ‘Agricultural Biotechnology Annual—China Moving 
Towards Commercialization of Its Own Biotechnology Crops’ 
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The government of China is in the process of revising laws and regulations governing 
biotechnology. In July 2016, the Ministry of Agriculture (MOA) released the “Revised 
Administrative Measures for Safety Assessment of Agricultural Genetically Modified 
Organisms”5, which was earlier notified to the WTO SPS Committee (SPS notification 881)6. 
The regulations defined in MOA Decree No.7 (2016) revises MOA Decree No. 8 (2002), the 
previous regulations governing biotechnology. The amendments remove timelines for 
approvals, extend the National Biosafety Committee’s term from three years to five years, and 
emphasize that entities engaging in GMO research and experiments are accountable for safety 
management. On several occasions, MOA officials have revealed that they are revising 
labelling requirements for GMO products and plan to establish minimum threshold levels for 
labelling, which is expected in the next two or three years. In 2015, MOA reported that it is 
exploring the feasibility of establishing a public solicitation mechanism to enhance public 
involvement in the agriculture biotechnology review and decision-making process. 
 
The 13th Five-Year Plan for National Science and Technology Innovation (13th FYP)7 issued 
by the State Council in August 2016 revealed that China will push forward the 
commercialization of key products, including the new generation Bt cotton, Bt corn, and 
herbicide-tolerant soybeans. The 13th FYP also pledges to establish the technical system for 
biosafety evaluation to guarantee safety of GE products. In 2016, MOA revealed a roadmap for 
the commercialization of GE crops in China, starting with cash crops “not for food use”; 
followed by crops for input for feed and industrial use; food crops; and finally staple food crops 
(rice, wheat, and soybeans). 
 
In summary, China has made great efforts in the development of various areas including science, 
technology and legislation since the Reform and Opening-up Policy took place in the late 1970s. 
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At present, China is moving towards commercialization of its own biotechnology crops and the 
government is also in the process of revising laws and regulations governing biotechnology. It 
obviously would be a long way and it could be difficult during the process. Regarding to the 
legislations, some of Chinese laws regulating agricultural biotechnology followed example of 
other countries in certain aspects, but in many areas new legislation and policy guidance needs 
to be formulated, drawing on the valuable lessons and practical experience of other countries in 
the management and development of agricultural GMOs.8 China and the EU share many 
characteristics in common for GMOs legislation - for example, both explicitly follow the 
precautionary principle, and both have adopted mandatory labelling requirement. On the other 
hand, China and the EU as two very different countries/regions, choose different strategies and 
map out the legal and mechanisms based on their own conditions including state situation, 
economic development level, biotechnology development level and trend as well as the need 
for biosafety protection. Simply ‘copying and pasting’ the EU legislative model into the 
Chinese system is not only unlikely to be productive but also not practically possible. 
Notwithstanding, the EU system of multi-level governance for GM technology in agriculture is 
a model that can offer valuable insights for the development of appropriate governance 
arrangements in China.  
 
4.1 General Background Comparison 
Since the regulation of GMOs was first established in the early 1990s globally, countries have 
gone through initial formation, gradual modification and evolution of their own rules. 
 
4.1.1 Governance on GMOs biosafety in the EU 
If there is any country or region would be a paradigm for a cautions and conservative approach 
to the regulation of new GMOs, it must be the European Union. Since 1980s, European 
                                                 
8  Yu Zhuang and Wenxuan Yu, ‘Improving the Enforceability of the Genetically Modified Food Labelling Law of China with 
Lessons From the European Union’ (2013) 14 (3) Vermont Journal of Environmental Law 465 p 470 
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countries began to pay attention to biosafety issues, such as the environmental assessment and 
managing the release of Genetically Modified Organisms. Since then, the European Union 
issued a series of legal documents which were also absorbed by EU member states into their 
own national biosafety-related legal documents, and they developed more detailed examination 
and approval procedures as well as technical guidance. The European Union is considered as 
the strictest in biosafety management and some members even totally ban on the sale of certain 
GM products as well as field tests and conduct strict GM foods labelling systems. The 
precautionary principle is an important concept for biosafety legislation.9  
In the European Union, biosafety management is based on the classification of biosafety 
regulations. Biosafety regulations in the EU are divided into two categories. The first category 
is horizontal legislation, which involves the use of genetically modified micro-organisms in a 
closed facility, deliberate release of GMOs and occupational safety of labors exposed to 
biological agents. The second category is product legislation, which includes pharmaceutical 
products, animal feed additives, plant protection product, novel food and plants seeds.10 While 
GMOs in the EU are regulated at two authoritative levels: The European Commission (EC) and 
European Food Safety Authority issue harmonized rules on GMOs; EU member states have 
individual rules and regulatory agencies within their territory.11 Companies hoping to sell and 
market their GMO-containing foods in a certain European country must apply for approval at 
the country level first; if approved, the company can proceed by notifying other countries via 
the European Commission. If there is any objection from other member states, additional 
evaluations will be conducted by the EU. A draft proposal is then submitted from the EU and 
voted on by representatives from EU member states. If vetoed, the proposal must be submitted 
to the EU for another round of votes.12 
 
The EU’s cautionary attitude on GMOs is due to several different economic, political and 
societal reasons. Economically, limiting the sale of GMOs protects domestic agricultural 
business by setting a higher trade barrier for large GMO exporters. In European politics, 
                                                 
9  Dayuan Xue (ed.), Biosafety and Regulation for Genetically Modified Organisms (Beijing Science Press, 2009), p.183 
10  Ibid. p.184 
11  p.184 
12   Han,  Y  et  al.  2013.  “Evolution of GMO Regulations  in  the  European Union  and  Indications  for China.” Zhejiang Agric 
Sci 11:1482–1489. 
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environmental and often “anti-GMO” groups have been taking a larger role in policymaking at 
regional, state or even European levels. Finally, the rising consumer demand for “natural” or 
“organic” food, which is often manipulated by social media, has led to a culture of distrust of 
GMOs. Some environmental groups and lobbies are reported to be active in attacking GMOs, 
trying to protect their own claims of being “natural” and “healthy.” Politicians, like those who 
passed a bill to ban foods directly containing GMOs from school lunches in Taiwan,13 are often 
very sensitive to the opinions of their electorates. They carefully avoid any public rejections of 
these controversial issues, trying to stay aligned with their electorates for the benefit of their 
political careers. The impact of the EU’s restrictive policy on GMOs not only increases costs 
for manufacturers but also delays the development of modern biotechnology. Further, other 
countries considering the EU as a potential export market must wait and see, hoping to mirror 
policies from these large countries/regions with whom they heavily trade. Some of these 
“wait-and-see” countries choose to follow the EU as a model, whereas others may choose to 
mirror the U.S., a representative of a GMO “soft”-regulating country, to maximize benefits 
from exporting their crops.14 
 
4.1.2 GM Governance in China 
With the passing and implementation of the updated Food Safety Law in October 2015, China 
would now probably be categorized as falling on the stricter side of GMO labeling. The new 
law in China specifically includes an article on GM food that requires mandatory GMO labeling. 
Those who violate the labeling requirements will be punished with fines or even suspension of 
their license. However, specific rules on how to label GMOs with regard to the font size and 
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14  Cantley, M. 2012. “European Attitudes on the Regulation of Modern Biotechnology and Their Consequences.” GM Crops 
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bioengineered,” or “not genetically modified through the use of modern biotechnology”; and food products derived from 
GM materials which meet ‘the same safety, labeling, and other regulatory requirements’ which apply to all foods regulated 
by  FDA  did  not  have  be  labelled  as  ‘GM  food’.  However,  in  2016  the  ‘The  National  Bioengineered  Food  Disclosure 
Standard ’was signed by the President, which means the United States may also establish requirements on labelling human 
foods  derived  from  genetic  technology.  For  further  information,  please  see,  ‘Labelling  Food  Derived  from  Genetically 
Engineered  Plants’  <  https://www.fda.gov/Food/IngredientsPackagingLabeling/GEPlants/ucm346858.htm>  (last  accessed 
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other detailed requirements have still not been announced. China is also well aware of the 
variances in other countries on GMO labeling: The U.S. represents countries requiring only 
voluntary labeling; most European countries require mandatory labeling once the GMOs 
exceed a certain threshold in a product; Japan requires mandatory labeling only on certain 
processed foods.15 
 
Surveys conducted from 2007 to 2008, and in 2010, showed that the majority of Chinese 
consumers are not opposed to purchasing GM foods. Most Chinese people have heard about 
GMOs, but consumer awareness is not high. Consumers with higher income or greater 
knowledge of GMOs are more willing to purchase them.16 However, in one specific case in 
Hunan, China, in 2012, fear mongering, rather than scientific media coverage of a Golden Rice 
experiment, fueled a long-lasting debate about GMO safety in China and resulted in 
unnecessary worries, concerns and even fear among Chinese consumers.17 
 
China’s GMO regulations could date back to the early 1990s, covering each process of genetic 
engineering from research and development to premarket testing of the use of GM products. By 
the end of 2000, China had approved about three-fourths of the 443 applications for the 
biosafety review of GMOs submitted for approval by research institutes and producers of 
GMOs. In 2002, China started to require that all food products containing GMOs receive a 
safety assessment and go through an approval process, in addition to being labeled accordingly. 
However, these labeling requirements were not fully executed, and there was criticism from 
Chinese academic researchers in the early 2000s regarding the loopholes in the GMO laws and 
regulations that were not well coordinated between different authoritative agencies.18 With the 
increasing need for GMO regulation brought by biotechnology development and rising 
consumer demands for mandatory labeling, China made updates to its GMO regulations in 
October 2015. However, it is not yet clear how the chnges to GM governance they will 
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implement are to introduced. Meanwhile, there is also a need for the Chinese government to 
better communicate with consumers and the media so that the public will be better informed 
and educated about the science on such controversial issues. 
 
4.2 Multi-level Governance and Agricultural Biosafety 
Despite bringing new opportunities that biotechnology in agricultural production offer 
worldwide, the uncertainty surrounding whether the use of GMOs may negatively affect the 
environment, food safety and ecosystems has always been a major concern for the Chinese 
government when making the decisions. Around the world, especially in the developing 
countries which is populous and heavily relied on agricultural productions, the legislation on 
agricultural biosafety has been drawing increasing attention from the government. The 
establishment of the legislative framework has always been a key point of governmental work 
in China and so far a series of key legislations have been enacted regarding to the GMOs 
management and administrative regime. However, there are still challenges to the country due 
to the agricultural GMOs biosafety management in the practices and the implementation.19 The 
sector will explain the current situation of the agricultural biosafety governance and in the EU 
and China.  
 
4.2.1 Multi-level governance and the politics of agricultural GMOs in the EU 
The EU legislation on GMOs has been designed and structured to ensure a difficult balance 
between safety concerns and the safeguard of health and the environment, premises upon which 
the entire European legal order is built, and interests related to the construction of an efficient 
and competitive internal market: a balance between trade and risk.20  
 
The first regulatory intervention carried out by the EU in the area of GMOs took place in the 
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early 1990s, with the adoption of Directives 90/219/EEC21, on the use of genetically modified 
microorganisms in a confined environment and 90/220/EC, on their emission in the 
environment for experimental purposes and GM products market placement.22 
 
The legal framework established by these instruments was soon considered fragmentary and 
incomplete. Therefore, after several years, and following some serious food scandals, a deep 
reform process occurred in the area of GMOs, mainly resulting in the adoption of Directive 
2001/18/EC on the deliberate release of GMOs into the environment, 23  which basically 
concerns the cultivation of GMOs, and so affects agriculture and environment, and of 
Regulation (EC) No 1829/2003 on marketing and labelling of GM food and feed,24 whose 
objectives pertain to quality of life, human health, animal welfare and consumer protection. 
These two pieces of legislation are both built in the light of a precautionary approach and 
provide that any GMO shall not be cultivated (or marketed) within the Union unless previously 
assessed by EFSA for what concerns its potential risks for health or the environment and, then, 
authorised by the EU Commission. 
 
Based on the analysis of the consolidation process of EU governance of GMOs, two different 
and opposing trends may be observed. On the one hand, the EU has moved towards a 
“communitarisation”25 of the matter, through a centralization of decision-making at the EU 
level as regards the procedural arrangements granting scientific assessment and marketing 
authorisation of GMOs,26 in accordance with a “one door one key” approach. On the other 
hand, since the reduction of regulatory powers held by the Member States, the EU has had to 
deal with the numerous national pressures and instances aimed to acknowledge further 
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22  Council Directive 90/220/EEC of 23 April 1990 on  the deliberate  release  into  the environment of genetically modified 
organisms OL J117, 8.5.1990   
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flexibility and discretion for Member States, specifically with regard to the cultivation of 
GMOs.  
 
In March 2015, the European Commission (EC) released a proposal that would allow Member 
States to refuse to approve new licenses for the development and release of GMOs for 
cultivation for non-scientific reasons. The adoption of Directive 2015/412/EU27 fits into the 
long and complex evolutionary, and somehow also regressive, process which has witnessed EU 
harmonization initiatives, on the one hand, and nationalist efforts to reassign regulatory powers 
to the Member States, on the other.28 
 
It has been observed that the adoption of Directive 2015/412/EU nearly carries a symbolic 
value when studied within the European integration process. In- deed, it appears to be the first 
and most significant act through which the Union has set a re-transfer of powers from the 
European level to the national level, thus embracing a reverse trend to the one that has been 
characterizing the integration process for years. 
 
The directive formally confers on Member States the right to adopt legal binding acts restricting 
or prohibiting the cultivation of GMOs on their territory, without however affecting the 
common procedure for marketing authorisation, which still remains firmly at the EU level. The 
objective appears to be twofold: improving the authorisation process of GMOs on one side and 
ensuring consumers’, farmers’ and operators’ freedom of choice on the other, thus ensuring a 
greater degree of clarity to stakeholders regarding the cultivation of GMOs in the Union.29 
 
In line with the aim of a proper and effective functioning of the internal market, the Directive 
also specifically pointed out that the Member States adopted the restriction or prohibition 
measures should refer to the GMOs cultivation rather than the circulation and import activities 
                                                 
27  Directive (EU) 2015/412 of the European Parliament and of the Council of 11 March 2015 amending Directive 2001/18/EC 
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of GM seed and plants contain GMOs. Generally, it is prescribed that compelling grounds 
conform with Union Law, particularly in accordance of the non-discrimination principle 
between national and non-national products, the principle of proportionality, provisions on the 
free movement of goods set out in Articles 34 and 36 of the TFEU, as well as in compliance 
with international obligations.30 Currently, there are nineteen Member States have ‘opted out’ 
of approving GM crops for cultivation for all or part of their territories. Additionally, the 
Directive requires those Member States in which GM crop cultivation takes place to take 
appropriate measures aimed at preventing possible transboundary pollution into adjoining 
Member States in where cultivation of GM crops is prohibited.31 This effectively means that 
cultivating Member States bear the responsibility and liability associated with cultivating GM 
crops. 
 
The Member States that want to restrict or prohibit GM crops cultivation have two options. The 
first option is: during the authorization procedure, a Member State may ask to amend the 
geographical scope of the application to exclude part of or all its territory. The manufacturer of 
the GM plant has 30 days to adjust or confirm the scope of the application. If the manufacturer 
does not answer, the scope is adjusted according to the Member State’s demand. Member States 
are allowed to ask for their territory to be reintegrated into the geographical scope of the 
authorization after it has been granted. And the second option is that after a GM variety has 
been authorized for cultivation in the EU, a Member State may adopt national opt out measures, 
by invoking grounds such as environmental or agricultural policy objectives, town and country 
planning, land use, coexistence, socio-economic impacts, or public policy. These opt out 
measures may restrict or ban the cultivation of a GM variety or of a group of GM varieties 
defined by crop or trait.32 
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4.2.2 The governance of agricultural GMOs biosafety in China 
The legal framework governing the agricultural GMOs biosafety in China is composed of four 
‘pillars’ which refers to four types of laws.33 The following section will introduce each one of 
them separately. 
 
The Environmental Protection Law,34as the fundamental law regulate all issues relating to the 
environmental protection and the protection of specific habitats, therefore, in certain degree, it 
provides the biosafety protection the legal basis. Article 17 of this law states that the “people's 
governments at various levels shall take measures to protect regions representing various types 
of natural ecological systems, regions with a natural distribution of rare and endangered wild 
animals and plants, [and] regions where major sources of water are conserved . . . .”35 This 
wording provide the agricultural GMOs biotechnology management the legal ground at the 
level of the law.36 
 
The second pillar include specific legislations addressing agricultural GMO biosafety issues. 
China has enacted the following regulations and administrative measures in order to achieve 
better governance on agricultural biosafety: Administrative Regulation on Biosafety of 
Agricultural GMOs (2001); 37  Management Measures on Agricultural Safety Assessment 
(2002)38; Management Measures on GMOs Labeling (2002)39; Management Measures on 
Safety of Agricultural GMO Import (2002) 40  and Approval Measures on Processing 
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Agricultural GMOs (2006)41. Among them, the 2001 Regulation which issued by the State 
Council plays the leading and fundamental role the rest of them provide the specific rules and 
requirements in accordance to the 2001 Regulation regarding to classification-based 
administration and evaluation, 42  labeling, 43  licensing for production 44  and business 
operations, 45  and examination and authorization procedures. 46  Therefore, the above 
legislations constitutes the legal framework for managing agricultural GMOs research, 
production, and processing; business operations; import and export; supervision; and 
examination.47 
 
There are also regulations were enacted to address other relevant biosafety issues including 
the genetic engineering safety management, forestry biological safety, genetically modified 
food safety and the cross boarder movement of genetically modified products.48 For example, 
the Administrative Measure on Genetically Engineering Safety Management (1993) 49 
provides requirement on taking risk management and safety measures during the genetic 
engineering research in the laboratory; The Administrative Measure on Examination and 
Approval of Developing Forestry Transgenic Engineering Activities (2006)50 governs the 
biosafety of transgenic engineered forests; The Administrative Measures on Inspection and 
Quarantine of Import and Export GMO  Products (2004) 51  regulates the inspection on 
transboundary movement of GM products for both import and export activities.  
 
The last but not the least, the legal framework of biotechnology framework is completed by a 
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series of technical standards and norms set up for the agricultural GMOs biosafety evaluation. 
The Ministry of Agriculture, the General Administration for Quality Supervision, Inspection 
and Quarantine (AQSIQ) and the Ministry of Environmental Protection are the main 
department who responsible for the testing and assessment on the safety of agricultural GMOs 
and the risks to the environment, the specific job is carried out by the testing institutes affiliated 
to the departments mentioned above.52  
 
In order to fulfill the legislations and strengthen the implement of the law, the Chinese 
government have designed different competent authorities or agencies to be specifically 
responsible for management of GMOs biosafety in their correspondent area. At the national 
level, the Ministry of Agriculture play the leading role on the biosafety management in 
general of agricultural GMOs related activities under the supervision of the State Council. In 
addition, the Inter-Ministerial Joint Conference for Biosafety of Agricultural GMOs is 
established within the State Council which mainly deal with the significant issues regarding to 
the agricultural GMO biosafety. 53  The local competent agricultural agencies and health 
departments above the county level shall be involved in the management and supervision on 
agricultural biosafety and GM food safety.54 Also the Ministry of Agriculture is in charge of the 
examination, supervision and management of GMO labellings at the national level together 
with the General Administration of Quality Supervision, Inspection, and Quarantine which is in 
charge of the inspection, testing and verification the labelling process of GMOs.  
 
Regarding to the risk evaluation, the National Agricultural GMOs Biosafety Committee 
established by the Ministry of Agriculture is responsible for the evaluation on the agricultural 
biosafety which is constitutes by the specialists and experts from different disciplines including 
agriculture, medicine, sanitation, food industry, environmentology and detection and inspection. 
In 2016, the specialists and experts from the field of bioinformatics, genomics, biophysics and 
genome editing technology have also been invited to the group of committee members in 
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Biosafety Legislation in China: Current Situation, Challenges and Solutions’ (2012) 13 (4) Vermont Journal of Environmental 
Law 865 p868 
53  Ibid, Article 5 
54  The 2001 Regulation on Biosafety of Agricultural GMOs, Article 4   
  1
accordance with the development of the new technology.55 The risk evaluation shall strictly 
follows the classification based administration and evaluation system which has been 
established under the 2001 Regulation 56  which shall cover all stages related to GMOs 
including research, experiments, production, processing, and business operations that import 
and export of GMOs.57  
 
According to the 2001 Regulation, the research and field experiment, production and 
processing, business operation, import and export, and transboundary movement of GMOs 
and their products shall obtain licensing accordingly from the competent authorities at the 
national and local level.58 The competent authorities including the Ministry of Agriculture, 
the Ministry of Environmental Protection are in charge of issuing the relevant licenses 
including the Certificate of Agricultural GMO Biosafety,59 Certificate of Non-Genetically 
Modified Agricultural Produce,60 Permit of Agricultural GMOs Processing,61 Inspection and 
Verifying Approval Document of Agricultural GMOs Labeling,62 Approval Document of 
Importing Agricultural GMOs,63 Permit of Transboundary Movement of Genetically Modified 
Products.64  
 
4.3 Risk Assessment 
It is fair to say that differences between diverse administrations on GMOs safety adopted by 
different countries around world are not merely about the various measures and approaches, 
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but the guiding principle of GMO safety evaluation behind.65 It could be very obvious that the 
countries heavily relied on the production and export of agricultural GM products are mostly 
less cautious regarding to the safety administration.66 For example, the United States adopted 
the substantial equivalent principle as its conceptual foundation on biosafety management 
regime.67 The core point of this principle is that if a GM food could be proved as substantially 
equivalent to its counterpart conventional food, then the GM food shall be treated no differently 
from the conventional food. It is, however, the biotechnology itself and the process of research 
and production shall be strictly regulated and examined.68 Therefore, the GMOs and the 
products in the US are assessed based on risk analysis and sound science principle.69 As major 
grower country, Canada, Brazil and Argentina also adopted similar principle to the US on the 
GMOs biosafety management system.70 
 
On the contrary, EU’s attitude towards the GMOs are very cautious and the general public in the 
EU also hold skepticism to the safety of GM products.71 As a large importing country, the 
safety administration measures on GM product at all stages in the EU is very strict while the 
safety evaluation which carried out in the final products of GMOs is considered as the strictest 
in the worldwide. The logic behind the attitude to the GMOs is that although currently there is 
no scientific evidence could prove the GMOs are hazard to human and animal health and the 
environment, the potential risk and long-term impact of GMOs are uncertain. Therefore, the 
European Union adopted the Precautionary Principle as the fundamental principle guiding the 
legislative framework and safety administration on GMOs. Each Member States also 
established their own GMO safety administration system in accordance with the principle. 
Around the world, the EU could be considered as the region that implements the strictest 
                                                 
65  Jianping Kou, Qiaoling Tang, Xianfa Zhang,  ‘Agricultural GMO Safety Administration  in China’,  (2015) 14(11)  Journal of 
Integrative Agriculture 2157 p.2158 
66  Jikun Huang and Qingfang Wang, ‘Agricultural Biotechnology Development and Policy in China’ (2002) 5 (4) AgBioforum 
122 
67  Dayuan Xue (ed.), Biosafety and Regulation for Genetically Modified Organisms (Beijing Science Press, 2009) p.189 
68  Jianping Kou, Qiaoling Tang, Xianfa Zhang, ‘Agricultural GMO Safety Administration in China’, (2015) 14(11) Journal of 
Integrative Agriculture 2157 p.2158 
69  Li  Y  H,  Liu  J.  ‘The  safety  management  model  exploration  of  agricultural  GMOs’  (2011)  2  Quality  and  Safety  of 
Agro‐Products 43 
70  Jianping Kou, Qiaoling Tang, Xianfa Zhang,  ‘Agricultural GMO Safety Administration  in China’,  (2015) 14(11)  Journal of 
Integrative Agriculture 2157 p.2158 
71  Ibid. 
  1
administration on GM products.72  
 
4.3.1 The EFSA and risk assessment in the EU  
 
In the European Union, the primary concern for GMO planting and cultivation is the 
environmental protection and ecological safety.73 The applicant’s environmental monitoring 
plan need to be thoroughly examined and evaluated by the EFSA GMO Panel as a part of the 
risk assessment. The European Food Safety Authority (EFSA) is the keystone of European 
Union risk assessment regarding food and feed safety, animal health and welfare, nutrition, 
plant protection and plant health. In close collaboration with national authorities and in open 
consultation with its stakeholders, EFSA provides independent and transparent scientific advice 
and clear communication on existing and emerging risks associated with the food chain. On 
request from the European Commission, European Parliament or Member States or on its own 
initiative EFSA provides scientific opinions on issues falling within its remit.74 
 
EFSA and the Scientific Panel on Genetically Modified Organisms (GMO Panel) provide 
independent scientific advice on the safety of: GMOs such as plants, animals and 
micro-organisms, on the basis of Directive 2001/18/EC on the deliberate release into the 
environment of genetically modified organisms; Genetically modified food and feed, on the 
basis of Regulation (EC) No 1829/2003 on genetically modified food and feed. 
 
EFSA and the GMO Panel carry out risk assessments in order to provide scientific opinions and 
advice for risk managers. Its risk assessment work is based on reviewing scientific information 
and data in order to evaluate the safety of a given GMO. This helps to provide a sound 
foundation for European policies and legislation and supports risk managers in taking effective 
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and timely decisions. Most of EFSA’s work on GMOs is carried out in the context of 
authorisation applications, since all GM food and feed products must be evaluated by EFSA 
before they can be authorised in the EU. 
As part of its work on the safety assessment of GMOs, EFSA assesses for all GM applications 
not only possible adverse effects on human and animal health, but also the impact on the 
environment. This arises from the legal framework for the release of GMOs into the 
environment. EFSA’s GMO Panel evaluates the Environmental Risk Assessment of GM plants 
and GM microorganisms, carried out by companies asking for a market authorisation. 
 
The GMO Panel considers, for example, if GM plants have adverse effects on non-target 
organisms; if they are more persistent and/or invasive than their conventional counterparts, or 
what their impact on the biodiversity would be. The GMO Panel developed a guidance 
document for the risk assessment of GM plants and derived food and feed which assists 
applicants in the preparation of their applications.75 The GMO Panel has updated its guidance 
with respect to environmental risk assessment in 2010, strengthening the requirements for GM 
applications submitted to EFSA for evaluation with respect to data generation, collection and 
analysis.76 In addition, specific guidance has been developed on the evaluation of possible 
effects of GM plants on non-target organisms.  
 
The GMO legislation requires applicants to monitor for possible environmental effects 
associated with the cultivation of GMOs following their introduction in the EU and to report 
findings on a regular basis to the Member States and the European Commission. During the 
pre-market risk assessment phase, EFSA’s GMO Panel looks at the scientific quality of the 
post-market environmental monitoring plan proposed by the applicant. Such a plan must be part 
of the application for a GMO intended for cultivation in the EU.77 For those GMOs which were 
approved for cultivation, EFSA’s GMO Panel will also be able to assess the annual reports 
containing information gathered from the monitoring of GM plants authorised for cultivation in 
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the EU. 
 
EFSA endeavours to develop networking and stronger cooperation with the Member States, and 
to strengthen its relationship with institutional partners (European Union and international) and 
stakeholders, as recommended by EFSA’s Management Board. In accordance with EFSA’s 
strategy for cooperating with Member States, the EFSA Scientific Network for Risk 
Assessment of GMOs (the GMO Network) was established in 2010. Since its inaugural meeting 
in November 2010, the GMO Network has met once per year. 
 
Members of the GMO Network are organisations nominated through the EFSA Advisory 
Forum contact point from the Member States: one Member Organisation for molecular 
characterisation / food-feed safety area of competence and one Member Organisation for 
environmental risk assessment (ERA) area of competence. The Member Organisations appoint 
selected experts (and alternates) to attend meetings in light of the topics on the agenda. A 
maximum of two experts per country are invited to the annual meetings.78 
 
4.3.2 GMOs safety evaluation system in China 
The transgenic biotechnology is designated as a strategic emerging industry regarding to the 
national development plan. China has adopted a safety evaluation procedure for GMOs based 
on the following principles, which are: the principle of substantive equivalence, the principle 
of prevention, the principle of case-by-case analysis, the principle of staged evaluation, the 
principle of science-based analysis and the principle of familiarity.79 According to the 2001 
Regulation and its auxiliary administrative measures 80 , any activities relating to the 
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agricultural GMOs including research, field trail, production, processing, import and export 
within the territory of China shall be the object of the safety evaluation in order to prevent 
possible hazard or risks to human and animal health and the environment.81 The agricultural 
GMOs safety evaluation is carried out by the combination of graded approach and 
multi-staged approach. The graded approach divided the GMOs into Classes I, II, III and IV 
according to the extent of their risks to human beings, animals, plants, microorganisms and the 
ecological environment. To be specific, Class I refers to no or unlikely risk; Class II refers to 
low risks; Class III refers to medium risks and Class IV refers to high risks;82 while the 
multi-staged approach refers to research in laboratory, intermediate test, environmental release, 
pre-production test and the issue of safety certificate.83 
 
All the applications for the GMOs authorization need to pass the safety evaluation and shall be 
submitted to the National Agricultural Biosafety Committee which is formed by the Ministry of 
Agriculture.84 The members of the Committee are the scientists and experts from different 
disciplines and mainly recommended by the members of the Inter-Ministerial Joint Meeting. 
The Inter-Ministerial Joint Meeting system is established by the State Council and constituted 
by the head of relevant departments which are the Ministry of Environmental Protection, the 
General Administration for Quality Supervision, Inspection and Quarantine, the Ministry of 
Science and Technology, the Ministry of Commerce, the National Development and Reform 
Commission and the National Health and Family Planning Commission.85 The members of the 
National Agricultural Biosafety Committee meet 3 times a year and make decisions on the 
applications based on the result of safety evaluations of the agricultural GMOs.86 The Ministry 
of Agriculture shall, based on the demand of safety evaluation of agricultural GMOs, entrust the 
competent technical testing institutions to carry out the safety evaluation and provide scientific 
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ground to the safety evaluation and management.87 
 
The agricultural GMOs biosafety evaluation and management system include the report regime 
and approval regime. The report regime is applicable to the research on GMOs belong to safety 
Class III and IV and intermediate test; and the approval regime is applicable to the 
environmental release, pre-production test and the application of safety certification. 88 
Regarding to the report regime, any unit who intend to be engaged into research and experiment 
of GMOs belong to the safety Class III and IV, and intermediate test of all agricultural GMOs 
shall submit the safety evaluation report of agricultural GMOs and provide relevant technical 
data and document; the agricultural GMOs biosafety group within the unit is responsible to 
examine and verify the safety evaluation report and provide examination report. The unit will 
submit the report to the Ministry of Agricultural. Then the Office of Agricultural GMOs 
Biosafety Administration within the Ministry of Agriculture will preliminary examine the 
report, record the report into register, consult with the National Agricultural Biosafety 
Committee and provide the feedback in written form. Furthermore, the agricultural GMOs 
biosafety group within the research unit need to report to the Ministry of Agriculture annually 
on the implementation situation of biosafety management.89 As to the approval regime, any 
unit intending to apply for environmental release, pre-production test and safety certificate, 
shall fill in the agricultural GMOs safety evaluation application form and provide relevant 
technical document. The agricultural GMOs biosafety group within the unit shall review the 
application form and technical document then submit them together with the review comment 
to the competent agricultural authorities at the provincial level where the testing will be carried 
out. 90  The competent agricultural authorities shall then record the application of safety 
assessment of agricultural GMOs into record and ensure the basic condition of testing site is 
true and the precautionary measures are feasible.91 A written examination suggestions shall be 
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provided thereafter. Applicants submits application to the Office of Agricultural Biosafety 
Administration and the Office shall make decision on whether or not accept the application 
within two months after receiving. The Ministry of Agriculture then organizes National 
Agricultural Biosafety Committee to carry out safety assessment. The approval of the safety 
assessment and the safety certificate of agricultural GMO are signed by the minister, and a copy 
of the approval and the safety certificate will be sent to the competent agricultural 
administrative department of the region where the test will be carried out or the safety 
certificate will be used.92 Both of the production license and business license issued by the 
Ministry of Agriculture need to be obtained in case of the production and markering of 
genetically modified plant seeds, breeding livestock and poultry, aquacultural breeding, and the 
producer and business operator are obliged to report to the local agricultural administrative 
department at regular intervals about the relevant situation of production and business.93  
 
In addition, regarding to the imported agricultural GMOs, the examination and approval will 
be various depending on the different purpose of use of the imported agricultural GMOs. The 
imported agricultural GMOs are divided into 3 categories regarding to their purpose of use, 
which are: agricultural GMOs for research and test; agricultural GMOs for commercialization; 
agricultural GMOs to be used for processing raw material.94 The Office of the Agricultural 
Biosafety Administrative shall make respond within 2 months on whether or not to accept the 
case; within 270 days, the MOA and the national inspection and quarantine department shall 
make the decision on approving or disapproving the application and inform the applicant the 
result.95  
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4.4 Co-existence Policy 
‘Co-existence’ implies two or more things existing in the same place at the same time; and in an 
ideal world, coexistence should be regarded as essentially passive.96 Co-existence is not a new 
issue. Co-existence measures have long been used in the seed industry for production of high 
purity conventional stocks. Within a farming community, growing similar crops for different 
markets in the same farming region is not a new challenge. For many years, what might be 
considered as incompatible crops – for example specialty maize grown for human consumption 
and waxy maize grown for the starch industry – have been grown in the same areas or even on 
the same farm. Different types of wheat, barley and rice are similarly grown in close proximity 
and channelled to different uses. Farmers can follow simple but effective procedures to achieve 
agreed standards of quality and purity in their harvested product. The introduction of GM crops 
has however provided a new challenge in finding the appropriate co-existence measures and it 
has become a critical issue because global cultivation of GM crops has increased rapidly since 
their introduction in 1996.97. It is important to bear in mind that coexistence always refers to 
GMOs that have passed the very strict authorisation process, including comprehensive 
assessments of health-related or environmental risks. Therefore, environmental or 
health-related risks do not concern the formulation of coexistence rules.  
 
As early as 2006, the EU Commissioner for Agriculture and Rural Development noted that the 
complex issue of coexistence often reflected conflicting goals among producers and consumers. 
Some farmers focus on enhanced competitiveness and see an important role for GMOs, while 
others prefer traditional practices. Some European consumers value ‘quality production’ and 
products ‘linked to traditional practices and geographic origin’.98 These values are consistent 
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with the European model of agriculture that balances socio-economic, as well as environmental 
and territorial considerations. Other consumers value food produced by organic farmers or with 
traditional methods; some believe that GMOs are not compatible with traditional production. 
Many producers and consumers prefer to avoid mixing GM and other crops.  
 
However, it might not only be about people’s preferences. Friends of the Earth Europe asserted 
that: ‘GMO contamination is a new type of pollution created by industry. It involves living and 
replicating organism, and because it involves the building blocks of life (genes), is irreversible 
as well as increasing over time. It can occur at any stage along the food chain as a result of 
natural processes and human intervention: from seed production, to crop growing, to harvesting, 
to storage, to transport, to processing and packaging’.99 
 
There is no doubt that the very concept of ‘coexistence’ and its effectiveness is controversial 
and has engendered years of continual debate. And the issue the co-existence of GM crops and 
non-GM crops has caused attention from the major developed countries and regions for a time. 
The United States, Japan and the EU have all already set up policies and regulations on the 
co-existence of GM crops and non-GM crops.  
 
However, China does not have a co-existence policy. As China is the sixth largest producer of 
agricultural biotechnology crops in the world by area,100 this omission is surprising and could 
cause potential problems in the management of GMO crops and concerns as to the protection 
afforded by the GM governance arrangements to both farmers and consumers. By contrast, the 
EU has focused on co-existence from the early stages of its legislative process of GMOs. 
 
In the EU, the European Council, European Parliament, and various committees have 
considered the issue and the European Commission published a set of guidelines in July 2003 
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about the coexistence of GM and non-GM crops.101 The guidelines are based on the principle 
that coexistence is about providing farmers and consumers with a practical choice between 
conventional, organic or GM food and feed production. These guidelines for Member States 
suggest best agricultural practices to follow when growing GM and non-GM crops so as to 
enable the farming community to continue growing non-GM crops without exceeding the 
labelling threshold. Since the publication of the Commission guidelines, a number of Member 
States (e.g., Denmark, Netherlands, and Spain) have developed country-specific guidelines 
and/or legislation that provide rules for the growing of GM crops. While some argue that 
Community-level legislation should govern co-existence, others believe that Member States 
should develop measures and implement them. In the end, policy-makers decided that it is for 
the best interest of various Member States to regulate coexistence to ensure that critical 
‘geographical, ecological and climatic conditions’ that affect crop production can be 
considered.102 
 
Article 22 of Directive 2001/18 states: “Member States may not prohibit, restrict or impede the 
placing on the market of GMOs, as or in products, which comply with the requirements of this 
directive.” At the same time, Article 26a says “Member States may take appropriate measures 
to avoid the unintended presence of GMOs in other products.” 
 
In order to meet the requirement of being “appropriate”, any co-existence measures taken by 
Member States must be: Aimed at avoiding economic loss to other farmers; proportionate to the 
legitimate objective (ensuring that non-GM products adhere to GM content less than the 0.9% 
labelling threshold); and compatible with basic principles of EU law (especially free movement 
of goods). 
 
In March 2015, a research project, which was funded by the EU, called ‘Practical 
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Implementation of Coexistence in Europe’ (PRICE) released its conclusions. It involved a 
research consortium consisting of fourteen universities, agencies and firms under the 
co-ordination of the Technical University of Munich, Germany. The main results are the 
following: 
 
The current measures implemented to ensure coexistence of GM and non-GM crops 
in the EU are practically feasible, both at farm level and along the supply chain. 
However, they come with additional costs, which are currently met partly by 
consumers and partly by other supply chain stakeholders. 
 
Over a two-year period, field trials with GE corn were conducted in Spain, applying 
buffer zones or different sowing dates resulting in asynchrony in flowering. In this 
study, researchers concluded that the current isolation distances set up by most 
member states were disproportionate and may lead to unnecessary costs and burden. 
For a wind-pollinated plant such as corn, separation distances of about 20 meters are 
sufficient to ensure coexistence without cross pollination of non – GM crops by GM 
plants. 
 
Another team developed a decision-making tool that evaluated the effect of specific 
buffer zones or of a difference in flowering time on the probability of 
cross-pollination for corn. It thus makes it feasible to implement proportional 
coexistence measures.103 
 
The EU’s policy on co-existence could be seen as a successful co-existence of GM and non-GM 
crops in the worldwide. Because it is not just possible in theory, it is a practical reality. Since 
1998, growing numbers of European farmers have chosen to plant approved GM varieties on 
their farms, and have demonstrated that they are fully capable of managing the farm-level 
practices that allow them to do so in harmony with their neighbours and with their own non-GM 
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crops. The key to this success is a regulatory and political environment which provides 
European farmers the freedom to choose their agricultural practices and which is based on 
principles of proportionality and non-discrimination.  
 
The coexistence of transgenic and non-genetically modified crops in the European Union laid a 
theoretical foundation which China could learn as a reference for the establishment of a 
practical, feasible and sound coexistence legal system. Moreover, the legislative practice and 
operational experience of European Union’s coexistence police provide a practical basis to 
China's coexistence regime. The decision makers shall explore the proper mode and measure of 
coexistence on the basis of China's specific national conditions. 
 
4.5 Labelling and Traceability 
The purpose of labelling regulation is to protect the consumers’ right to know by providing the 
true information so they could make informed choices, while the traceability enables GMOs 
products especially GM foods and feeds can be traced and under the supervision at all stages of 
the supply chain. Traceability also makes labelling of all GMOs and GM food and feed 
products possible. It allows for close monitoring of potential effects on the environment and on 
health. Where necessary it can allow the withdrawal of products if an unexpected risk to human 
and animal health and to the environment safety is detected. Currently, there are numbers of 
countries have adopted labelling approaches for GMOs which are various based on the different 
national conditions. Among them, the United States, Argentina and Canada as the major 
producer and exporter country of GM crops, apply voluntary labelling approaches on GMOs,104 
while the EU and China have adopted mandatory labelling requirements. 
 
The legislation on GM products labelling adopted by China is similar to the EU yet have 
some differences. To be specific, the EU and China both adopted mandatory requirements to 
products which contain, consist of GMOs, or produced from GMOs. One of the major 
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differences between EU and China’s labelling legislations is the requirement on traceability. 
The Food and Feed Regulation of the EU established a comprehensive traceability regime for 
GM food and feed products which ensures at each stage of related to the GM food and feed 
production and processing, the relevant information is available to be obtained by the operators 
and the comprehensive traceability regime will also facilitate the labelling requirements to be 
fulfilled in accordance to the legislation.105 The labelling legislation of GMOs in China is also 
follow the process-based principle, the traceability mechanism provided in the legislations is 
comparatively incomplete and lack of feasibility.106 
 
Another key element in the EU Food and Feed Regulation is the threshold approach applied 
to the labelling requirement. 107  Accordingly, this approach tolerances adventitious and 
technically unavoidable GMO presence in the final GM products and it set the threshold as 
0.9% of the food ingredients considered individually or food consisting of a single ingredient. 
GM Labelling will be exempted if the GMO presence is lower than 0.9% in the final GM food 
and feed. However, China has not yet adopted a similar approach. Furthermore, the labelling 
legislations in the EU provide very specific requirements on labelling and the range of products 
covered by the legislations is broad.108 In comparison, the GM labelling requirements in 
Chinese legislation is mostly vague and lack of feasibility, also the subject of the GM labelling 
(which was listed-out in the Administrative Measure on Labellings of Agricultural GMOs) is 
comparatively limited and needed to be updated.109 
 
It is generally agreed that the labeling rules are unclear in China and enforcement is weak and 
inconsistent, the EU’s GM food labelling regulation will be a valuable model to China in order 
to improve the legislations on GMOs labelling and therefore achieve a higher level of 
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agricultural biosafety management.  
4.5.1 Review of the EU’s legislation on GMOs labelling and traceability 
From the perspective of the legislative principle and legislative concept, the Chinese 
legislation on GM food labelling is similar to the EU’s. The GM labelling and traceability 
regime which constructed by the Regulation 1829/2003110 and the Regulation 1830/2003111 
is regarded as the most comprehensive management regime on GMOs and will be very 
valuable to China and also will help China to avoid similar problems that the EU already have 
encountered.112 
 
The history of EU’s establishment of GMOs labelling could be traced back to 1990s. The first 
legal requirement on GM food labelling was stated in the Regulation (EC) No. 258/97.113 
From that time on the EU has made persistent efforts on reviewing and improving the 
legislation on GM labelling.114 Subsequently the Regulation 1139/98115 expended the range 
of labelling varieties which included the GM maize varieties and GM soy varieties. The 
following Regulation 50/2000 include the all GM additives and GM flavoring in to the object 
of GMO labelling requirement. 116  In 2003, the Regulation 1829/2003 and Regulation 
1830/2003 were enacted and the current GMOs labelling and traceability management regime 
was therefore completed. The Regulation 1829/2003 applies to both foods and animal feeds 
which produced from GMOs or contain ingredients produced from GMOs while the 
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Regulation 1830/2003 provide legal requirements for traceability and labelling of GMOs. 
These regulations apply to products originating in the EU and imported from third countries. 
Bulk shipments and raw materials must be labeled, as well as packaged food and feed.  
 
In the EU, the products exempt from labeling obligations are: Animal products originating 
from animals fed with GM feed (meat, dairy products, eggs); Products that contain traces of 
authorized GM ingredients in a proportion no higher than 0.9 percent, provided that this 
presence is adventitious or technically unavoidable; products that are not legally defined as 
ingredients according to Article 6.4 of Directive 2000/13/EC117, such as processing aids (like 
food enzymes produced from GE microorganisms).  
 
Labeling regulations for food products are presented in Regulation (EC) No 1829/2003, 
Articles 12 to Article 13: 
 
Where the food consists of more than one ingredient, the words ‘genetically 
modified’ or ‘produced from genetically modified [name of ingredient]’ must 
follow in brackets immediately after the ingredient concerned. A compound 
ingredient with a GE component should be labeled “contains [name of ingredient] 
produced from genetically modified [name of organism].”; 
 
Where the ingredient is designated by the name of a category (e.g., vegetable oil), 
the words “contains genetically modified [name of organism]” or “contains 
[name of ingredient] produced from genetically modified [name of organism]” 
must be used; 
 
The designations may appear in a footnote to the ingredients list, provided they 
are printed in a font at least the same size as that of the list of ingredients. 
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Where there is no list of ingredients, the words “genetically modified” or 
“produced from genetically modified [name of ingredient]” must appear clearly 
in the labeling. For example, “genetically modified sweet corn;” or “containing 
caramel produced from genetically modified corn” for a product with no list of 
ingredients. 
 
In the case of products without packaging the labels must be clearly displayed in 
close proximity to the product. 
 
Labeling regulations for animal feed are presented in Regulation (EC) No 1829/2003, Articles 
24 and Article 25: 
 
For feed containing or consisting of GE ingredients, the words “genetically 
modified” or “produced from genetically modified [name of the organism]” must 
follow in brackets immediately after the name of the feed. 
 
For feed produced from genetic engineering, the words “produced from 
genetically modified [name of organism]” must follow in brackets immediately 
after the name of the feed. 
 
Alternatively, these words may appear in a footnote to the list of feed. They shall 
be printed in a font of at least the same size as the list of feed. 
 
In addition, the traceability rules defined in Regulation 1830/2003 require all business 
operators involved to transmit and retain information on GM products in order to identify 
both the supplier and the buyer of the product.118 Operators must provide their customers 
with the following information, in writing: an indication that the product, or certain 
ingredients, contains, consists of, or is obtained from ‘GMOs’; information on the unique 
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identifier(s) for these ‘GMOs’; in the case of products consisting of or containing mixtures of 
‘GMOs’ to be used only as food or feed or for processing, this information may be replaced 
by a declaration of use by the operator. It has to be accompanied by a list of the unique 
identifiers for all those ‘GMOs’ that have been used to constitute the mixture.119 In addition, 
for a period of five years after every transaction within the supply chain, every operator must 
keep a record of this information and be able to identify the operator from whom they bought 
the products and the one to whom they supplied them.120 
 
The unique identifier approach is a great contribution by the European Union regarding to the 
implement of traceability regime. In 2004, the European Commission devised a system of 
unique identifiers to be assigned to each GMOs and promulgated the Regulation (EC) No 
65/2004 to establish this new system.121 The Annex of this regulation prescribes the format of 
the identifier. The function of the unique identifier is that in any stage of the GMO product to be 
placed on the market from production to distribution, the information of the former supplier of 
the product and the next operator of the product (on step up and one step down) could be 
tracked through the information recorded in identifier. To the GMOs, the format of unique 
identifier is created by the Organization for Economic Cooperation and Development and it has 
been used for its Bio-Track product database and the Biosafety Clearing House.122  The 
European Commission requires a document accompanied to each GMOs food and feed or 
GMOs for processing to indicate each GMOs ingredient the product concerns. 123  The 
Cartagena Protocol on Biosafety to the Convention on Biological Diversity in Article 18(2) 
provides specific requirements for those accompanied document of GMOs food and feed.124 
The Commission requires the applicant must develop the unique identifier for each GMO food 
and feed as the condition in the authorization decision125 and it shall be recorded in the relevant 
register.126 
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4.5.2 A review of Chinese legislation on GM food labelling 
The 2001 Regulation is not only the core regulation of the biosafety management in China but 
also it firstly established the mandatory labelling requirement to GMO products.127 The 
GMOs labelling is currently regulated under the 2002 Administrative Measures on the 
Labelling issued by the Ministry of Agriculture in accordance to the 2001 Regulation issued 
by the State Council.128 According to the Measures, there are three categories of GM 
products are required to be labelled mandatorily: the genetically modified animals, genetically 
modified plants and genetically modified micro-organisms; products directly processed from 
genetically modified agricultural products; and products produced from agricultural 
genetically modified organisms or products consisting of genetically modified organisms 
ingredient, while the products that are made using GMOs but where the presence of the GM 
material is no longer detectable in the final product.129 There is also a range of specific GM 
products listed out in the Appendix of the Administrative Measure of Labelling which are the 
subject to the mandatory labelling requirement: soybean seeds, soybeans, soybean powder, 
soybean oil, and soybean meal; maize seeds, maize, maize oil, and maize powder; rapeseed for 
planting, rapeseeds, rapeseeds oil, and rapeseed meal; cotton seed; tomato seed, fresh tomato, 
and tomato paste.130  
 
The Administrative Measure issued by the Ministry of Agricultural specifically targets GMO 
labelling. According to the Measure, the Ministry of Agriculture under the State Council is 
designated to be in charge of examination and approval as well as the supervision on GMO 
labellings in the nationwide. 131  The department of agricultural administration of local 
government above the county level shall be responsible to supervise and manage the 
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compliance of GMO labeling requirements, including the review and approval of GMO 
labeling for imported products.132  
 
It seems that the GMOs labelling legislation in China is already in place and could provide the 
implementation of the labelling requirement a legal ground. However, after nearly 15 years of 
legal practice, the current situation of GMO labelling enforcement is not promising.133 The lack 
of compliance and enforcement of the labelling requirement is caused by many reasons, mainly 
because of the loopholes existing in the current legislation.  
 
First of all, the labelling requirements are not explicit. Take the GM soybean oil as an example, 
according to the 2001 Regulation, the GM soybean oil should be labelled as it is the “products 
directly processed from genetically modified agricultural products”134; however, if this GM 
soybean oil be mixed with other oil and processed as a new cooking oil, whether this 
re-processed products or other deep-processed products need to be labelled as GMOs products 
is not regulated by the current legislation.135  
 
Secondly, the scope and coverage of labelling requirement causes confusion since it is both 
widely defined in the 2001 Regulation which are three categories (the genetically modified 
animals, genetically modified plants and genetically modified micro-organisms; products 
directly processed from genetically modified agricultural products; and products produced 
from agricultural genetically modified organisms or products consisting of genetically 
modified organisms ingredient, while the products that are made using GMOs but where the 
presence of the GM material is no longer detectable in the final product) and narrowly listed in 
the Administrative Measure on GMO Labelling which are 5 groups of GM products (soybean 
seeds, soybeans, soybean powder, soybean oil, and soybean meal; maize seeds, maize, maize 
oil, and maize powder; rapeseed for planting, rapeseeds, rapeseeds oil, and rapeseed meal; 
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cotton seed; tomato seed, fresh tomato, and tomato paste).136 In addition, the legislation of GM 
labelling in China does not provide requirement to GM feed which is not appropriate since there 
are large amount of GM feed imported into Chinese market and the meal of soybean seed, 
cotton seeds and rapeseed after oil pressing are mostly used for animal feed purpose.137 Thirdly, 
the standardized format requirements of GM labelling including the pattern, character font, 
character size and colour are not provided by the legislation. Therefore, some producers or 
business operators may take the advantage of this loophole and use vague and obscure language 
in the labelling or make the labels less obvious. According to a survey carried out about the 
consumers’ attitude on GM foods, there are half of the interviewed consumers found it difficult 
to recognize the GM labeling on the package of the product.138  
 
Furthermore, the threshold approach allows adventitious or technically unavoidable presence 
of GM material in the final products and could enhance the feasibility and enforceability of the 
GM labelling legislation. China has not yet adopted a threshold approach regarding to the 
GMOs labelling and this “zero percent tolerance without a reasonable adventitious presence 
threshold is both unrealistic and misleading.”139 Lack of setting threshold in the current 
Chinese labelling system, it is difficult to handle pollution caused by adventitious or 
technically unavoidable presence of GMOs and the ‘zero threshold’ is neither scientifically 
practicable nor legally reasonable.140 The last but not least, the current legislation is lack of 
one important element that it does not specifically emphasis on implementing the traceability 
of GMO products, or in other words, the current regulatory framework does not require 
tracing GMOs and its products at all stages from research to marketing through the 
distribution chain.141 
 
The above discussed shortcomings of Chinese GM product labelling is not new issues to the 
legal scholars and experts of the relevant field, the appeal to the government of amendment on 
                                                 
136  Yu Zhuang, Wenxuan Yu, p.469 
137  Dayuan Xue (ed.), Biosafety and Regulation for Genetically Modified Organisms (Beijing Science Press, 2009) p250 
138  See Dayuan Xue, p.248 
139  Yu Zhuang, Wenxuan Yu, ‘Improving the Enforceability of the Genetically Modified Food Labelling Law in China with 
Lessons From the European Union’ (2013) 14(3) Vermont Journal of Environmental Law 465, p.470 
140  Dayuan Xue, p.248 
141  Yu Zhuang, Wenxuan Yu, p.470 
  1
GM products labelling has been ongoing in the recent decade. In May 2015, after a long period 
of waiting, the newly revised Food Safety Law142 which is China’s highest-level food law, was 
promulgated and came into force in October, 2015.  It explicitly provides that the ‘production 
and distribution of GM food must label prominently pursuant to law’ 143  and stipulates 
correspondent administrative punishment for law-violation.144 The 2015 Food Safety Law 
unfortunately fails to address certain critical issues, such as what constitutes GM food and the 
labeling methods deemed to be ‘prominent’. Although the 2015 Food Safety Law provides a 
legislative basis for mandatory labeling of all GM food for the first time, it still lacks the 
detailed rules sufficient to command compliance and to be enforced. 
 
4.5.3 Possible improvements for the GM labelling legislation in China 
It is obvious that the Chinese legislative framework on biosafety management has been 
impacted by the EU biosafety management regime in several aspects, in regard to the GMOs 
labelling approach, the EU also set up a valuable module for China to learn from. However, 
China is different from the European Union in many aspects regarding to the political regime, 
national conditions, economic development. Therefore, China shall consider about its own 
national situation while adopting the GMOs labelling regime of the EU, for example, in China 
the consumers may comparatively have less knowledge about GMOs safety in food production 
than the European consumers, and generally speaking Chinese customers have less income, 
therefore, the food price might take a more important role in customers’ choice in China.145 
Also, there are great numbers of private and individual-owned business of food production and 
processing which cause practical difficulties in management and supervision of the GM food 
labelling.146 Therefore, China shall adopt EU’s approach in a customized way regarding to its 
own social conditions in order to achieve a more effective and enforceable management on 
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GMOs products labelling. 
 
Based on the analysis of both the EU and China’s GM labelling legislations, there are some 
valuable experiences which China could learn from the EU in order to improve the GM food 
labelling legislation. Firstly, the range of labelling on the GMOs and its products needs to be 
largely broadened and the labelling on animal feed shall also be considered;147 secondly, 
specific and detailed requirements on the format of labellings on GMOs products should be 
provided in the legislation; thirdly, a threshold regime needs to be adopted in Chinese GMO 
labelling system; and finally, in order to enhance the traceability, the unique identifier system 
shall be introduced into the current labelling system. The detailed proposal for improving the 
Chinese legislative framework will be discussed in the following chapter. 
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Chapter 5 Conclusion 
5.1 Introduction 
It is not surprising that debates around the safety of GMOs to the environment and human 
beings continued for nearly thirty years since the agricultural transgenic crops have been 
commercialized. The transgenic technology is very new and its utilization in agricultural and 
food production is relevant to every one of us as consumers, and because of its environmental 
implications. It is also a process for different countries and international society to explore 
and develop the legislation regime of biosafety. Given the increasing cultivated area of GM 
crops, and public concern over the safety of transgenic technology and products, the 
regulation of agricultural biotechnology presents challenges for environmental governance for 
public authorities around the world, and these must be addressed.  
 
Different countries choose strategies and map out the legal regime and mechanisms based on 
their own conditions including the biotechnology development level and trend as well as the 
need for biosafety protection. Yet from the perspective of the legislation and management, the 
biosafety legislation in general could be divided into two representative types. The first one is 
‘technology-based management’, mainly adopted by the European Union and its member 
states. Under the technology-based management, the policy maker considers the modern 
biotechnology has potential and unforeseen risks and the precautionary principle is regarded 
as the fundamental principle of the legal framework. Thus, any research activity and products 
related to the modern biotechnology should be assessed and managed. The other one is 
‘product-based management’ represented by the countries including the US and Canada. 
Under this legislative and management mode, the transgenic technology is considered as 
neutral and has no substantial difference from the traditional biotechnology; therefore, 
following the substance equivalent principle the legislation and management should be focus 
on the product itself instead of the technology.1  
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China has now become the world’s largest importer of genetically modified crops and one of 
the largest producers of GM cotton. At the same time, the Chinese government has made great 
efforts to develop a robust legal framework for the regulation of the development, risk 
assessment and marketing of GM products and foodstuffs containing GM ingredients. A new 
and comprehensive administrative framework for the regulation of GM crops and food has been 
established since 2001. This thesis has attempted to present a survey of the current legislative 
framework in China on GMOs. One of the principal objectives of this thesis is to provide 
proposals to address unsolved problems relating to the development, approval and 
marketing/commercialization of agricultural biotechnology for the future in China. 
 
The study of GMO politics and regulations in this thesis is an example of how contemporary 
conceptions of biotechnology are an outcome of social, political, economic, and scientific 
interpretations and strategies deployed by various actors involved in the regulation of that 
specific technology. One conclusion that might be derived from the investigation presented in 
Chapters 3, 4 and 5 is that the designing of regulatory framework for agricultural GMOs could 
be influenced by many considerations, including domestic and international ones. Many 
competing interests are involved, both internationally and domestically.  
 
Internationally speaking, the EU and the US represent the two opposing philosophies shaping 
the regulation of agricultural GMOs worldwide. The survey presented in Chapters 2 and 3 
showed that the EU’s precautionary approach has been very influential in the design of the 
whole regulatory framework in China. The thesis elaborated upon the regulation and 
administration on agricultural biotechnology in the EU and China and concluded in Chapter 4 
that there are some similarities, but also some differences, between the two legislative regimes. 
The reason for choosing the EU as the model and the comparator for interrogating potential 
changes to, and improvements in, GM governance in China are many. To start with, the EU and 
China share common points in regulating agricultural biotechnology, for example, both follow 
the precautionary principle, and both have adopted mandatory labelling requirements for food 
products contain GM material or ingredients. Moreover, the EU is well known as its high level 
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of legal protection for human health and the environment and is experienced in GMOs 
legislation. The earliest regulation on GMOs of the EU could be traced back to 1990s, and the 
challenges and the solutions which the EU has developed over that period since 1990 could be a 
valuable reference point for evaluating the performance of the governance arrangements for 
GM releases and food production and marketing in Chinese law. Another obvious reason to 
adopt the EU governance model as a comparator is that China, like to the EU, is not a major 
exporter of GM products, but an importer. As an importer, the issues of biosafety and food 
safety are challenging. For these reasons, the EU was chosen for its well-developed and useful 
legislation model.  
 
Considering the domestic factors, the use of transgenic technology offers benefits and 
opportunities to the agricultural development and agricultural production. Some countries in 
the aspect of agricultural production and trade has already be benefited from the application of 
agricultural biotechnology. For example, the US is the most successful country in the world in 
using transgenic technology as the core in the agricultural technology; Brazil and Argentina 
respectively became the second and third largest soybean exporters after developing major GM 
soybean production and export. South Africa changed from being a net corn importer into a net 
corn exporting market after GM maize was introduced and grown. The similar story happens to 
other countries because of the adoption of GM technology and the extensive planting of new 
varieties of GM crop. It could be seen that many countries especially the developing countries 
have chosen the GM technology as the strategic priority in order to improve their 
competitiveness of agricultural production in the worldwide.2 
  
China has embraced agricultural GM technology with enthusiasm since the middle of 1980s, 
mainly for economic and political reasons. Considerable public funds have been invested in this 
area. In the future, China is expected to continue pursuing the development of agricultural 
biotechnology because the technology is expected to ultimately become the solution to various 
existing problems of the Chinese agricultural sector, including production efficiency, food 
                                                 
2  Jianping Kou, Qiaoling Tang, Xianfa Zhang, ‘Agricultural GMO Safety Administration in China’, (2015) 14(11) Journal of 
Integrative Agriculture 2157, 2163 
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security, food safety and environmental protection.  
 
There is no doubt that China is in the process of rapid development which is bracing yet 
stressful. China has to deal with problems left over by the boom of industrialization and 
urbanization, for example the difficulties cause by huge population, limited arable land and 
resources. The national food security and sufficient agricultural products supply is the priority 
of Chinese government and also the fundamental policy concern likely to underpin all the 
development in the future. Under the multiple pressure, merely rely on traditional agriculture 
will limit the possibility of increasing the total grain output and enhancing the quality of the 
grain, therefore, the promotion of research and development programmes on agricultural 
GMOs become an important and even imperative strategic option to the Chinese government in 
order to ensure the food security.3 To certain extent, agricultural GM technology is in itself 
potentially neutral in its effects on the environment and public health: genetically modified 
seeds, for example, pose no threat to human health or the environment unless they are planted, 
and much will then depend on how the resulting crops are managed while growing in situ, and 
how the produce subsequently derived from the harvested crops is processed and then marketed 
in the food chain. In other words, whether the technology is safe or not depends on both ways of 
how it is used and how it is developed and used within agricultural production. The 
identification of deficiencies in the governance arrangements for GM agriculture in China, and 
the means to adapt and improve the regulation of GM crop development and use, is therefore a 
matter of some importance for the development of a strong, safe and successful agricultural 
sector in China.  
 
Recommendations for improvements to the governance arrangements for the development, 
approval and marketing of products that use agricultural biotechnology are made in section 5.4 
below. These are based on three fundamental governance principles: 
1. Transparency of Decision Making, that is the need to introduce requirements for all 
relevant scientific and governmental decisions as to (for example) risk assessment and 
product authorizations to be published in a manner that makes them available to 
citizens, 
                                                 
3  Ibid, p2163 
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2. A Robust Scientific Evidence Base for Decision Making, including where necessary peer 
review of all recommendations on risk assessment by appropriate expert bodies. This is 
necessary to underpin and strengthen public confidence in decision making on GM 
products, and  
3. A Recognition of the Importance of Measures to Maximize Public Choice in using GM 
and non-GM products e.g. by ensuring that the labeling of food products that contain 
GM ingredients is robust and appropriate to inform consumer choice in the market 
place.  
 
5.2 Research Questions and Main Findings 
The thesis took as its principal focus the analysis of the way in which multi-level governance 
operates somewhat differently in China and the EU in the governance of the development, 
marketing and production of agricultural products using biotechnology. This inquiry was 
organized around the following research questions: 
 
RQ 1 What can China learn from the EU in relation to the regulation of 
agricultural biotechnology? 
RQ 1.2 What is the role of law in regulating agricultural biotechnology and 
its use in food production in the EU, and China? 
RQ 1.3 What is the role of the precautionary principle in EU and Chinese 
law on agricultural biotechnology and its use in food production?  
RQ 1.4 What principles are applied in undertaking risk assessments prior to 
authorizing the use of biotechnology products in food production in the EU, 
and China? 
RQ 1.5 What are the principal differences between the regulatory regimes 
for agricultural biotechnology and its use in food production in the EU and 
China? 
RQ 1.6 What can China learn from the EU and its member states, and from 
their regulatory approach to biotechnology and its use in food production? 
RQ 2 To what extent, and how, can regulatory measures minimize the risk of 
environmental damage arising from the use of agricultural biotechnology, 
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while also maximizing its potential benefits in food production? 
RQ 3 .1 To what extent, and if so how, do regulatory measures in China 
promote and protect “organic” (‘green food’) food production? 
RQ 3.2 Should China adopt coexistence measure for GM and non-GM 
production, and if so what model should be adopted for GM coexistence 
measures? 
RQ 4 What reforms to the regulation of agricultural biotechnology are 
desirable and/or necessary in order to protect the environment in the PR of 
China while also maximizing its potential benefits in food production?  
 
In order to interrogate these questions, the thesis has adopted a comparative approach as its 
methodology. By mapping out the regulatory framework in both the EU and China, the range of 
key questions which were identified in the beginning of this work have been answered while 
this studied was carried out chapter by chapter.  
 
Chapter 2 introduced the regulation and the management regime of agricultural biotechnology 
in China. It firstly provided an overview of the development of agricultural biotechnology and 
identified the goals and strategies of GMOs research and development and the early stage of 
biosafety legislation. The following section mainly focused on the institutional aspect of the 
GMO regulations in China. It explained the Chinese legal hierarchy and the historical evolution 
of GMO regulation as the background knowledge. Furthermore, this chapter in detail illustrated 
the substantive aspects of the GMO regulation, including the regulation of GMO research, 
regulation of production and processing, regulation of marketing, regulation of GMO labelling 
and regulation on imports and exports of GMOs. As it has been stated in the chapter, there is no 
‘law’4 specifically regulates the GMOs in China. The current regulations on GMOs are enacted 
by the State Council in 2001 and its three auxiliary Administrative Measures are enacted and 
implemented by the Ministry of Agricultural. The subject of the current GMO regulations in 
China mainly include the research relevant activities, evaluation, production, processing, 
                                                 
4  The legal hierarchy is divided into five levels according to their legislative body and effect. The ‘Law’ is usually enacted by 
the National People’s Congress and the National People’s Congress Standing Committee.   
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marketing and import and export activities within the territory of China. Finally, this chapter 
summarized the international influence on reforming the regulatory framework on 
biotechnology in China. 
 
As to the characteristics of the GMO regulation in China, the following features may be 
identified. Firstly, China used legal binding regulations, rather than the voluntary guidelines. 
Instead of revising the existing regulation, a new regulatory mechanism needs to be built up 
specifically target to regulate the agricultural GMOs. China has made a series of regulation and 
administrative measures on GMOs safety management and the competent authorities and their 
responsibilities are confirmed.5 According to the current regulations, all GMO products need to 
pass the safety evaluation and obtain permission for processing and production before entering 
market.6 Also, the labelling requirement is compulsory for all kinds of GMOs products. There 
is also an import approval management mechanism has been set up regarding to import 
activities of agricultural GM products. In addition, a technical supportive system for 
standardizations including safety evaluation specifications, trial specifications and criteria 
specifications is also available.7 Thus, the current regulatory system governances and regulates 
all research activities and processing and production related to agricultural GMOs in China. 
 
Secondly, China took a multi-ministry approach, and as a result several ministries and agencies 
are involved in the regulatory framework. The regulation of GM technology in agricultural is , 
in China, a good example of multi-level governance in which key decisions about differing 
aspects of the research, development, testing, safety appraisal, market release, then production, 
of GM crops are taken by different public bodies, scientific panels and governmental agencies  
Nevertheless decision-making has on the whole become more transparent, as relevant 
documents and information can be found on official websites or as its official publications. The 
Ministry of Agricultural plays the leading role in this regulatory framework. Biosafety and 
environmental considerations are, in theory, taken into account, but the overriding priority of 
                                                 
5  Jianping Kou, Qiaoling Tang, Xianfa Zhang, ‘Agricultural GMO Safety Administration in China’, (2015) 14(11) Journal of 
Integrative Agriculture 2157, p2161 
6  Ibid. p.2161 
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the MOA is increasing agricultural production. Arguably, the introduction of a more active role 
for the Ministry of Environment is necessary if environmental protection issues and concerns 
are to be addressed effectively in the governance arrangements for GM agriculture in China.  
 
Chapter 3 introduced the European Union’s regulatory regime for GMOs. This chapter 
analyzed the historical reason of EU’s current cautious attitude to the adoption of the use of 
GMOs in agricultural production. Then a detailed introduction of the role of the precautionary 
principle in the EU’s environmental legislation system had been provided. The study of the 
legal frame work has been divided into two main sections: the regulations on contained use and 
the deliberate release of GMOs, and then the regulation of GM food and feed. The three guiding 
principles of EU laws on the commercial use of GMOs could be summarised as safety (for 
human and animal health and the environment), freedom of choice for consumers, farmers, and 
businesses (rules on coexistence, labeling and traceability), and case-by-case evaluations. 
Based on the development timeline of regulation, the study on GM food and feed was presented 
respectively as the legislative framework pre-2003 and post-2003. 
 
This chapter also highlighted some key issues with strong EU characteristics including the 
multi-level governance of GMOs in the EU and the coexistence policy.  The multi-level 
governance has always been considered a unique feature of the EU’s character in its policy 
making – although our analysis of Chinese legislation and decision making on biotechnology in 
Chapter 3 showed that it, too, displays strong traits of multi-level governance (albeit organized 
in a different manner from those in the EU)8. The EU’s agricultural biotechnology regulations 
occur at three levels which are the EU level, internally with individual member states and 
externally within international conventions, in other words, the agricultural biotechnology 
regulation is the subject of at least three ‘layers’ of multi-level governance. Profound and 
long-lasting disagreement over the proper role for agricultural biotechnology led to legislation 
that attempts to share authority and avoid hierarchical decision making within the EU.  
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The multi-level governance in the EU requires institutions which enable collaboration, learning 
and discussion in order to escape the limited solutions or deadlocks that might occur when 
using harder edged techniques of law and government. Another highlighted factor in the EU’s 
agricultural biotechnology regulation is the coexistence policy. Under normal agriculture and 
climatic conditions, the possibility of the adventitious presence of authorised GM material (for 
example GM genes) in ‘non-GM’ crops grown in proximity to GM crops cannot be excluded 
e.g. as a result of cross pollination of non-GM crops by wind drift or by insects. Therefore, 
suitable coexistence measures will be necessary during cultivation, harvest, transport, storage 
and processing to ensure the coexistence of GMOs with conventional and organic crops. The 
necessity for the adoption of an effective coexistence policy is based on several reasons. First 
reason is to avoid unintended presence of GMOs in non-GM (for example ‘organic’) crops. The 
objective of coexistence measures is to avoid unintended presence of GMOs in other products, 
preventing the potential economic loss and impact of the admixture of GM and non-GM crops. 
Moreover, the coexistence policy could protect consumer's choice since the choice of the 
consumers between genetically modified and non-genetically modified food is possible with a 
functioning traceability and labelling system, and an agricultural sector producing the different 
types of products. Thirdly, the coexistence policy allows EU countries have flexibility with 
regard to their national, regional and local needs for GMO cultivation to achieve the lowest 
possible level of GMOs in organic and other crops.  
 
A comparison study was addressed in the chapter 4. In this chapter, different aspects of 
environmental governance of GMOs have been compared between EU and China. The chapter 
attempted to identify and assess the similarities and differences between the two regulatory 
regimes. It also sought to evaluate the extent to which the Chinese regulatory framework and 
governance regime of agricultural biotechnology could be reformed using best practice evident 
in the EU regulatory approach. There is no doubt that the EU’s regulatory regime on GMOs 
provides the strictest rules and comprehensively protects the human-being’s health as well as 
the environment. However, because of the different national conditions, national development 
strategies, demands on agricultural productivity, and the existing legal framework, China may 
not able to adopt the entire EU model and use it to revise the current regulatory framework of 
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agricultural biotechnology. Still, the European Union’s model laid theoretical foundation and 
practical experience which China could learn from as a reference.  
 
5.3 Limitations of the Research  
The aim of the research is to supply different solutions for regulating the agricultural 
genetically modified technology in China in order to minimize the risk of environmental 
damage arising from the use of agricultural biotechnology while also maximizing its 
commercial benefits both to farmers and the country.  
 
The case studies on GM agriculture in Hu Bei Province and Guang Dong Province were 
informed by gathering extensive Chinese scientific and legal research papers and policy 
documentation from NGO’s, scholars in law and policy study, agricultural biotechnology 
scientists, and from discussions with governmental officials with a role in authoring GMOs for 
use in agriculture.  A very important factor that this disclosed was the evident mistrust by the 
public of assurances of the safety of GM products by public officials and scientists. This could 
be traced back to the year of 2012, the illegal planning of Bt rice (the Golden rice) in China 
significantly discouraged Chinese people’s confidence on GMO safety management. Even 
though the variety of the GM plant was not assessed as risky to human or the environment, it 
caused the public to have the low acceptance to GMOs.9 The subsequent effects were serious. 
Till the recent days, the articles of demonizing GMOs and even the ‘GMOs conspiracy theories’ 
are still widely spread through media and internet in China. It potentially deepens the fear of 
general public to unfamiliar technologies, and it turns the fear into distrust to the government 
whom encourages the development of such a new technology and to the scientists whom have 
been involved into the transgenic research.  
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5.4 Prospects and Proposals 
Biotechnology is considered as a strategic emerging industry by the Chinese government 
and offers great resources and funding in biotechnology research and development.10 
Recently the MOA revealed a roadmap for the commercialization of GM crops in China, 
starting with cash crops “not for food use”; followed by crops for input for feed and 
industrial use; food crops; and finally the staple food crops.11 This shows the cautious 
attitude of Chinese government on promoting the commercialization of GM crops. It had 
also been specifically emphasized in the No.1 Central Document12 in 2016 that ‘…the 
research and supervision of agricultural transgenic technology should be enhanced and be 
cautiously promoted on the basis of safety.’13 The commercialization of transgenic 
agricultural crops needs to be cautiously promoted based on China’s own national 
situation including the biotechnology ability, the economic demand and the public opinion 
and the process needs to be steady. The foundation of the commercialization of the 
agricultural GM crops is the safety of GMOs which requires in great amount of scientific 
researches and resource. The current scientific programmes related to the GMOs research 
funded by the national government covers the security isolation for variety GM crops, 
long-term environmental monitoring and toxicological and allergenicity evaluation of 
newly expressed material in GM crops.14 The domestic academics recommended that the 
governmental funding should also cover the further research on the safety evaluation of 
new variety of GMOs and the assistant technical support for the evaluation.15 
 
The purpose of biosafety regulation is to ensure any new agricultural technology to meet certain 
                                                 
10  Jianping Kou, Qiaoling Tang, Xianfa Zhang, ‘Agricultural GMO Safety Administration in China’, (2015) 14(11) Journal of 
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14  Jianping Kou, Qiaoling Tang, Xianfa Zhang, ‘Agricultural GMO Safety Administration in China’, (2015) 14(11) Journal of 
Integrative Agriculture 2157, p2163 
15  Ibid. 
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standards in order to protect human and animal health and environment. By the analysis of the 
current situation of biosafety regulation and commercial use of GM crops in China with 
comparison with the European Union, it could be concluded that China have constructed the 
basic legal framework for GMOs management, however the further improvement needs to be 
made in order to streamline the regulatory process of agricultural biotechnology and bring the 
governance of GM technology into a higher level by taking into account of the following 
aspects.16 
5.4.1 Proposals for strengthening the environmental governance of GM technology 
 
The first proposal is to establish a new comprehensive law on GMOs biosafety to replace the 
current related regulations and administrative measures. This is also the constant appeal from 
domestic scholars in the field of environmental law over the years.17 The development of 
GMOs’ research is fast and the utility of its products in China is increasing, the current 
situation is entirely different from the time when the 2001 Regulation was enacted.18 The 
agricultural biosafety is an essential and indispensable part of the biosafety legislation 
framework. Compare to other legislations on the GMOs biosafety, the agricultural biosafety 
legislation in relatively complete however there are still some gaps and defects, for example 
the lack of comprehensive traceability and the co-existence measures are absent. A 
comprehensive legislation on biosafety would not only provide the agricultural biotechnology 
regulations a legal basis with in the legal hierarchy, or normative order, for the environmental 
governance of GM technology in China, but also will benefit the implementation of the 
management on agricultural GMOs.  
 
After years of the legal practice of the current regulatory framework, the shortcomings of the 
lack of a comprehensive law on GMOs biosafety is obvious. The current legal framework is 
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not effectively systematic, comprehensive or appropriately coordinate with the other areas of 
the environmental regulation in a Chinese context. The existing regulation and administrative 
measures are enacted by different government departments which merely focus on certain 
aspect of the GMOs biosafety on the basis of departments’ responsibilities. In case of the 
GMOs safety emergency happens which beyond certain department’s responsibility, the 
current legal framework may lead to management failures. 19  The current biosafety 
management is mainly undertook by the Ministry of Agriculture, at the mean time the 
departments of science and technology, hygiene, forest, commerce, environmental protection, 
quality supervision and inspection also share the corresponding responsibilities. Because of 
the lack of comprehensive legislation on GMOs biosafety, it is inevitable for the overlapping, 
conflict and omission to happen regarding to the function of administration.20 To draft and 
promulgate a comprehensive legislation will be great opportunity not only effectively for 
remedying the defect exists in the current regulation system but also clarifying the 
responsibility and cooperation between different government departments in order to 
strengthen the management on biosafety in each step from the research to the production of 
the GMOs. 
 
Secondly, the public participation mechanism needs to be established and safeguarded in the 
biosafety especially the agricultural biosafety legislations. The 2001 Regulations and its three 
auxiliary administrative measures did not have articles relating to public participation in the 
decision-making process of GMO authorisations or the GMOs safety management. However, 
in the wider context, common environmental and resource protection regulations in China 
usually include articles of encouraging public participation in management and supervision in 
general provisions.21 It is also commonly required in international biosafety legislations. For 
example, the Article 13 of Convention on Biological Diversity requires the contracting parties 
to “promote and encourage understanding of the importance of, and the measures required for, 
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the conservation of biological diversity, as well as its propagation through media, and the 
inclusion of these topics in educational programmes.”22 China is a party of CBD and the 
Biosafety Protocol, the national legislation on GMO biosafety management should fully 
reflects the requests of international laws. The reason behind the lack of encouraging public 
participation in current agricultural GMOs regulation might because that the policy makers 
considered the public is not interested and this kind of issue is too complicated and involves 
expertise.23 Although the biosafety might be considered as a scientific issue which is requires 
professional scientific knowledge to participate and not directly relevant to ordinary citizens, 
public right of participation shall not be differed since GMO products are closely related to 
human health and the environment. Therefore, the competent authorities shall be involved to 
produce the relevant information including risk assessment and other relevant documents in a 
non-technical format which enable the general public to read and understand. The Ministry of 
Agriculture or the Ministry of Science and Technology would be the appropriate authority to 
undertake this job. 
 
To establish mechanisms of public participation in biosafety, the first step to empower the 
public with the right to information on the environmental and public health risks associated 
with GMOs for which an authorization has been applied, and a right to make representations 
to the public bodies making a decision on their approval for release and development. The 
public participation could play a valuable role in the biosafety protection primarily based on the 
right to know the true situation of the environmental release, commercial production of GMOs 
and the GMO products on the market. As an important part of the environmental right, the right 
to know is mainly guaranteed by legal procedures and is a restriction on the administrative right 
of government.24 The public will be able to participate into the decision making only after 
knowing their living circumstances, consumed food and market management. The right to 
know is the most basic right in public participation. The second right is the right to participate in 
decision making. The right to participation empowers the public to participate in environmental 
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risk assessment and policy making process at all stages of GMOs research, field experiment, 
commercial production and marketing. The public will only understand the current issues and 
object of policy making by completely participate at all stages, and thus provide sound 
suggestions. The concept of the public shall cover not only the ordinary citizens, but also 
scientists and experts in various disciplines, related administrative authorities and 
Non-Governmental Organizations. Wide comments are helpful in making right decisions. In 
order to protection public’s right to participate in the decision making, the information 
disclosure and access need to be available to the public.25 This would greatly assist the building 
of public trust in biotechnology in its application to GMOs administration processes in China. 
Furthermore, the ‘public’ should include ordinary individuals, groups and NGOs related or 
affected by certain program such as event, dialogue or proposed plan of action. Authorities 
includes competent agencies managing the programs shall connect to the public. There are two 
types of ordinary public participation: negotiation and intervention. The difference between the 
two types is the degrees of the influence, sharing, control and decision public participation is 
caused in policy making. Methods of public participation should include information exchange 
such as asking for comments, interview, questionnaire survey, hearing, seminar, feasibility 
study meeting.26  
 
The GMOs safety emergency management system is another comparatively weak link in the 
Chinese legal framework on biosafety management. From the scientific perspective, there are 
potential risks in each activity related to the GMOs including the laboratory research, test, 
environmental release, commercialization, transboundary movement and the waste disposal. 
The groups and individuals involved into the related activities as well as the supervision 
departments should adopt the precautionary measures in order to cope with the risks. In order 
to minimize the damage to the personal and property security and the ecological environment 
when the potential risks become the real accident, the precautionary and preventive measure 
should be arranged in the legal system in advance.  
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The emergency management is an important part of the current Chinese legal framework. The 
existing emergency management legal regime involves the war state law, the general 
emergency law, the terrorist events law, the turbulence law, the disaster law and the accidental 
emergency law; the environmental emergency management is usually contained in the 
accidental emergency law.27 The GMOs emergency management method is provided by four 
administrative regulations and measures. First of all is the very first biosafety protection 
legislation—the Administrative Measure on Genetically Engineering Safety Management.28 
Article 21 of the Measure stated that the units engaged into the genetically engineering should 
formulate emergency measures against the accidental emergency. On the one hand, the Article 
21 is a milestone that it introduced the substantial emergency measure plan for the first time 
into the biosafety management; however, on the other hand, the further detailed provision of 
implementation is absent. The second regulation is the Administrative Regulation on the 
Biosafety of Agricultural Genetically Modified Organisms29 which clarified the responsibility 
of the competent authorities under the emergency situation. The Article 39 of the Regulation 
states that the agricultural administrative departments are entitled to keep the GMOs used for 
illegal research, test, production, processing, operation or import and export sealed and 
detained. The third regulation is the Administrative Measure on Safety Assessment of 
Agricultural Genetically Modified Organisms.30 The responsibility of the unit which engaged 
into the agricultural GMOs test and production to set up the emergency plan for the accident 
is regulated in the Article 35. However, neither the Article 39 in the 2001 Regulation nor the 
Article 35 in the Administrative Measure on Safety Assessment of Agricultural GMOs 
provide the further detailed content of the emergency plan and caused the lack of operability 
for those regulations. The fourth regulation is the Administrative Regulation on Biosafety of 
Pathogenic Microbe Laboratory issued by the State Council did offered the detailed 
emergency plan31 however the legal object of the regulation is merely the laboratory 
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28  Administrative Measure on Genetically Engineering Safety Management, Decree No.17 (1993) of the State Commission of 
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Ministry of Agriculture 
31  Administrative Regulation on Biosafety of Pathogenic Microbe Laboratory, Decree No. 424 (2004) of the State Council; 
see Article 40, 45 and 48. 
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management of pathogenic microbe. 
 
Based on the analysis of the current emergency management system and existing problems, 
the policy makers need to consider of learning from other countries’ experience and follow 
the example commonly adopted by the international environmental law. Additional efforts 
should be focus on laying down detailed and feasible emergency plan which should include 
but not limited to the personnel placements, the emergency fund arrangement, information 
disclosure plan, the duties of competent authorities and the entity or individuals engaged into 
the GMOs related activities.32 
 
The final proposal that this research project suggest is the establishment of a new law 
establishing a governing liability for environmental damage arising from the cultivation of GM 
crops and a suite of remedies to ensure the biosafety of products that include (or are produced 
using) GMOs. Even the most comprehensive preventive measure and the emergency response 
system could not guarantee the zero loss once the risks of GMO research and development, 
production, transportation, environmental release, storage and marketing activities turn into 
real harm, and when it happens it is necessary to compensate the injured party and bear the 
corresponding legal liability for the environmental damage. The liability and remedy is one of 
the most important elements in the biosafety law system and the relevant section in Chinese 
biosafety law is still at early stage that only three provisions directly regulate damages related to 
biosafety. These include the Article 28 in the 1993 Administrative Measure on Genetically 
Engineering Safety Management33 which provides “in the case of damage resulting from a 
violation of this law, the entities and individuals that are liable shall cease infringement, 
eliminate pollution and compensate for losses. In serious cases, the persons responsible shall 
be subject to criminal sanction. Serious cases include 1) seriously pollute the environment; 2) 
harm or affect the public health; and/or 3) seriously damage ecological resources and affect 
the ecological balance.” This provision follows the principle of fault liability in accordance 
                                                 
32  Wenxuan Yu and Canfa Wang, ‘Agro‐GMO Biosafety Legislation in China: Current Situation, Challenges and Solutions’ 
(2012) 13 (4) Vermont Journal of Environmental Law 865, p881. 
33  Administrative Measure on Genetically Engineering Safety Management, Decree No.17 (1993) of the State Commission of 
Science and Technology 
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with the environmental protection law. However, the definition of some core concept, for 
example “serious pollution”, “affects public health” and “serious damage to ecological 
resources” are not explicitly interpreted. The Article 54 of the 2001 Regulation stipulates that 
“in the case that research, testing, production, processing, storage, transport, sale or import, 
export of agricultural GMOs in violation of this law causes damage, the responsible entities 
and individuals shall take the responsibility.” This stipulation also follows the principle of 
liability for fault. However, it is difficult for practical implement due to the lack of explicit 
provisions on subject of compensation, amount of compensation, liability exemption 
conditions. Thirdly, the Article 57 of the Administrative Regulation on Biosafety of 
Pathogenic Microbe Laboratory34 provides that “if the legislate rights and interests of a party 
concerned are damaged by an approval decision in violation of the law, then the 
administrative department of health or the administrative department of veterinary who made 
the approval decision shall be liable for the compensations.” This provision is also vague 
regarding to the critical concept. It is thus evident that scattered provisions, on one hand, is 
lack of operability in the practice and on the other hand, could not comprehensively cover the 
range of the biosafety law. 
 
The establishment of the liability regime is still a difficult issue in the whole international 
biosafety legal system.35 The Convention on Biological Diversity is an international law 
document on bio-diversity conservation as well as a guide used to establish a comprehensive 
global legal framework, which only provides very general authorization provisions on 
biosafety damages liability remedies: the conference of the parties shall examine the issue of 
liability and redress based on the studies to be carried out, the examination shall include 
restoration and compensation for damage to biodiversity, except when such liability is a 
purely internal matter.36 The relevant negotiation between the contracting parties is still also 
                                                 
34  Article 57 in the Administrative Regulation on Biosafety of Pathogenic Microbe Laboratory, Decree No. 424 (2004) of the 
State Council. See also Christopher Rodgers, “Environmental Risk, Environmental Liability and the Regulation of 
Biotechnology: Mediating Law and Biology?” Chapter 7 pp.95‐115 in (Hocking ed.) The Nexus of Law and Biology: New 
Ethical Challenges (Ashgate, 2009); Maria Lee, EU Regulation of GMOs: Law and Decision Making for a New Technology 
(Edward Elgar Publishing Limited, 2008) p136 
35. Dayuan Xue (ed.), Biosafety and Regulation for Genetically Modified Organisms (Beijing Science Press, 2009) p255 
36   Article  14  of  the  Convention  on  Biological  Diversity  1992,  last  accessed  on  5th  October  2017  < 
https://www.cbd.int/convention/ > 
  1
ongoing. To the Chinese policy maker in order to improve the legislative work on biosafety 
liability shall learn from the legal principles, mechanisms and regimes from the current 
international environmental and biosafety law as well as follow the progress made on related 
international negotiations. The experience from other countries and regions shall also be 
considered. Based on the analysis of current domestic legislative situation on the GMOs 
damages liability, the legislative work shall be focused on the principle of liability fixation, 
liability of joint damage, liability exemption condition and the environmental damage 
compensation regime. 
 
5.4.2 Labelling and consumer choice 
 
The GMOs labelling is currently regulated under the 2002 Administrative Measures on the 
Labelling issued by the Ministry of Agriculture in accordance to the 2001 Regulation issued 
by the State Council.37 According to the Measures, there are three categories of GM products 
are required to be labelled mandatorily: the genetically modified animals, genetically 
modified plants and genetically modified micro-organisms; products directly processed from 
genetically modified agricultural products; and products produced from agricultural 
genetically modified organisms or products consisting of genetically modified organisms 
ingredient, while the products that are made using GMOs but where the presence of the GM 
material is no longer detectable in the final product.38 Based the analysis on the shortcomings 
of labelling legislation in China which was provided in Chapter 5, the labelling system could 
be possibly improved in the following aspects. 
 
To start with, the range of labelling on the GMOs and its products needs to be extended. The 
current labelling requirement mainly focus on the raw material and directly processed 
                                                 
37  Administrative Regulation on the Biosafety of Agricultural Genetically Modified Organisms, promulgated by the Decree 
No. 304 of the State Council of the People’s Republic of China of 2001 on May 21, 2001, and effective as of the date of 
promulgation 
38  Administrative Measure on Labelling of Agricultural Genetically Modified Organisms, Decree No.10 (2002) of the Ministry 
of Agriculture, issued on 5 January 2002 (MOA Decree 10/2002) Art. 6 
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products of agricultural GMOs (the labelling requirements are applicable to GM soybean, GM 
maize, GM rapeseed, GM tomato, GM cotton and their primary processed products.) In 
compare to the EU labelling regime, the range of GM products should be expanded largely. 
For the GMOs which already entered into the market, not only the GMOs product and its 
primary processed products (for example the GM soybean and the soybean oil directly 
processed from the GM soybean) but also the re-processed and deep-processed products of 
GM products (for example, the soy sauce brewed by GM soybeans or mixed cooking oil 
which consist of soybean oil processed from GM soybeans) need to be included in the range 
of labelling requirements. In other word, any food for consumption which is produced from 
GMOs, contains GMOs ingredients or consists of GMOs should be included in the scope of 
labelling regulation. Furthermore, the labelling on animal feed shall also be considered.39 At 
the present, there is a large proportion of animal feeds contain GMO ingredients that the meal 
of the GM soybeans, rapeseed and cotton seed after pressing oil are mainly used as animal 
feeds, also the quantity of directly imported GM feeds is expected to be increased.40 
Therefore, China should, it is suggested, adopt EU’s approach which not only to enhance the 
labelling management on GM foods but also shall apply labelling requirements on GM feeds 
to achieve a comprehensive management on the labelling of GMOs. 
 
Secondly, a threshold regime needs to be set in Chinese GMO labelling system. From 
perspective of the practical experience, in the process of production, transportation and 
processing of GMOs and their products, it is very likely to have minor traces of GMO 
materials presented in the non-GM products due to the adventitious or technical unavoidable 
factors. Under the current Chinese labelling legislations, products with any traces of GMOs 
need to be labelled as products containing GMOs despite the fact that some operators’ 
originally have no intention of using GMO product, the ‘contamination’ of their products with 
GM material is often adventitious or accidental. Furthermore, China signed the CBP in 2000 
and became a Party of the Protocol in 2005. The handling, transport, package and labelling of 
GMOs in transboundary movements has been a core agenda of the Biosafety Protocol, this 
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40  Dayuan Xue (ed.), Biosafety and Regulation for Genetically Modified Organisms (Beijing Science Press, 2009) p.250 
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‘0% threshold’ methods also cause difficulties to export and import activities.41 In order to 
make the labelling more manageable from the scientific perspective considering the 
adventitious or technically unavoidable presence of GMOs, numbers of countries in the 
worldwide has adopted reasonable threshold in accordance with their own national situation. 
The EU adopted the threshold as 0.9% which set up by the Food and Feed Regulation42; in 
Australia the threshold is 1%, in Japan it is 5% and in South Korea, the threshold is 3%.43 
Considering about China’s own situation, domestic scholar Xue suggest that China shall adopt 
1% as the threshold for GMOs labelling.44 His recommendation is made on the basis of the 
assessment of the domestic technology level as he stated that, China has reached the 
international research level in detection of agricultural GMOs and able to carry out the 
qualitative detection and quantitative detection of major GM products. The sensibility of 
quantitative detection is 0.5% and the qualitive detection is 0.1%.45 Including the tolerance 
on the differences due to detective sensibility of different facilities, 1% is considered as 
reasonable. Therefore, labelling will be exempted to the product if the GMOs traces it 
contains is lower than 1%. Furthermore, the adoption of the 1% threshold which is similar to 
the mainstream in the worldwide is expected to promote the international trade of Chinese 
agricultural GMOs products and non-GM agricultural products. Moreover, accompanied with 
the labelling requirement, China shall follow the example of the EU and considers adopting 
the unique identifier method in order to strength the management on the traceability. The 
provision of the unique identifier will bring the management of GMOs products to a higher 
level after they are placed into the market. The purpose of the traceability is every single 
GMO product, or each GM ingredient contained by the product could be traced back to its 
origin in order to enhance the management during the marketing process and to protect the 
consumers’ right to know and right to choose. The unique identifier method introduced by the 
European Union is regarded as the most effective way to the traceability management,46 it is 
also the foundation of the development of the whole traceability regime. 
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Lastly, the format of the GMO labels should be regulated towards a consistent and proper 
pattern. According to a survey carried out about the consumers’ attitude on GM foods, there 
are half of the interviewed consumers found it difficult to recognize the GM labeling on the 
package of the product.47 Since the ultimate aim of the labelling regulation is to provide the 
information to the customers and to ensure they make the informed choice. Without a visible 
and standardized label, it is impossible to achieve the goal of the regulation.48 Therefore, the 
Chinese labelling regulation shall apply explicit requirements on the format of GM labels, for 
example, the location of the labels, the size and colour of characters. In addition, the relevant 
requirement shall be regulated under the law rather than guidelines provided by the competent 
agency to ensure the effective implement. 
 
5.4.3 Co-existence of GMOs and non-GM agriculture 
 
Co-existence is not a new issue since the co-existence measures have been used in the seed 
industry for production of high purity stocks, neither it is a new challenge within agricultural 
production for growing similar crops for different markets. In the conventional farming, 
farmers could follow procedures to achieve ideal standards of quality and purity in their 
products. The introduction of GM crops, however, raises new challenges in setting up the 
appropriate co-existence measures. The co-existence relevant regulation is absent in Chinese 
legal framework. Considering about the present situation in China that GM crops (especially 
GM cottons) are growing in large area while more GM varieties are expected to obtain the 
commercialized cultivation permission in near future, the adoption of co-existence measure is 
urgent to China. In the European Union, ‘the Member States may take appropriate measures 
to avoid the unintended presence of GMOs in other products.’49 This wording gives the 
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Member States certain discretion on prohibiting, restricting or impeding the GM products in 
their own territory both at farm level and along the supply chain. China is conducted by 34 
provinces and each province is different regarding to the farming conditions and agricultural 
production target. Therefore, China shall follow the example of the EU which allow 
considerable flexibility in the provinces, with different approaches to respond to their diverse 
conditions, for example as to the size of farms, different levels of commitment to organic 
farming and varied geographical and ecological conditions. Measures to ensure the 
co-existence of different forms of agriculture include staggered sowing, weed management 
and careful cleaning and maintenance of equipment; separations distance or buffer zones 
between crops might amount to GM free zones on various scales. 
5.5 Conclusion 
From the study executed in this thesis, the EU’s comparatively sound and advanced 
governance regime on agricultural biosafety has various aspects which could be referenced by 
Chinese policymakers in the process of improving the current Chinese system on managing 
GMOs: for example, as to the public participation in decision-making processes, the design 
and implementation of co-existence measures as well as the GM product traceability system. 
Nevertheless, China is a large agricultural country in rapid development and designated the 
biotechnology as the development strategy for agriculture which have a very different state 
condition from the EU in respect of agriculture and economy, the EU model does not provide 
all the answers to the Chinese situation. 
 
On the other hand, the safety issues around the GMOs involves extensive aspects including 
the genetic engineering technology, the assessment on GMOs food safety, the evaluation on 
the ecological risk, the environmental detection and supervision, the risk administration of 
GMOs, the social-economic impact, the international and domestic biosafety law and 
management regime as well as the public participation. The biosafety of the GMOs is not only 
a scientific issue but also a social issue. The policy maker might be in pursue of a rigorous 
and perfect legal system and powerful implementation however, it is not all the meaning the 
  1
biosafety legislation. No matter how powerful the administration is or how perfect the legal 
system is, whether or not the use of modern biotechnology in agricultural production is safe 
cannot be answered by law and the law can never take the place of science to find the answer. 
The law in the biosafety management should play a role on maximizing the effective and 
rational administrative on all links from research to marketing; protecting the right and benefit 
of each subject involved into the issue; building efficient response mechanism in order to 
minimize the impact of possible hazard and damage and; safeguard the ecological 
environment and sustainable development of the human society. 
 
In the meantime, while the agriculture biotechnological research is widely promoted, the 
establishment of a comprehensive biosafety legal framework is out of synchronization. Under 
the current situation, the legislative work of improving the current regulations and filling the 
legislative gaps is urgently needed and the reform of the legal framework is expected to take 
place as soon as possible. The proposed solutions that this research project has concluded on 
the Chinese legislation and governance for agricultural biotechnology would contribute to 
improving the effectiveness of multi-level governance and the robustness of decision making 
in Chinese law. 
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